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ABSTRACT
CATIONIC FACIALLY AMPHIPHILIC PHENYLENE ETHYNYLENES AS
HOST DEFENSE PEPTIDE MIMICS
MAY 2005
LACHELLE ARNT, B.S., STATE UNIVERSITY OF NEW YORK AT BUFFALO
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Gregory N. Tew
The goal of this research is to design molecules that capture the essential
elements and biological properties of host defense peptides without the use of amino
acids or peptide-like backbones. This is accomplished via a weto-phenylene ethynylene
backbone with polar amine and nonpolar alkyl groups as side chains. These molecules
are shown to form stable monolayers at the air-water interface with the polymer chains
assuming an edge-on structure with the aromatic rings perpendicular to the water
surface and the polar amines groups below the water surface. Furthermore, these
molecules aggregate in solution with the addition of a non-solvent, as expected with
facially amphiphilic molecules. When tested against biological systems, the result is
promising: growth inhibition against a wide variety of bacteria at relatively low
concentrations with minimal disruption towards red blood cells. The average minimal
concentration needed to disrupt bacterial growth is 2 ug/mL and occurs in less than 5
minutes. Furthermore, tests indicate negligible evolution of bacterial resistance over a
month-long experiment. Incorporation of these compounds into polymeric substrates
x
proves to be an effective way of preventing bacterial growth on surfaces. Further
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CHAPTER 1
HOST DEFENSE PEPTIDES: AN OVERVIEW
1.1 Introduction
The extensive over-use of antibiotics to treat non-bacterial infections is causing
a rapid increase in bacterial resistance. As this trend continues, society heads towards
an era where today's antibiotics will be rendered useless. The Center for Disease
Control and Prevention (CDC) estimates that more than 50 million unnecessary
antibiotic prescriptions are written each year.(l) This translates into antibiotics being
prescribed for up to 80% of the patients seen in a clinic while only 20% of the patients
require antibiotic treatment.(2) For example, 100% of the 18 million prescriptions
written each year for the common cold and 80% of the 16 million prescriptions for
bronchitis are unwarranted.(l)
The occurrence of bacterial resistance from antibiotic overuse is shared by
patients and doctors. This evolution of resistance can be reduced or even eliminated in
two ways: doctors need to require more patient information before prescribing an
antibiotic coupled with the patient not demanding antibiotics from health-care providers
when prescribed treatment is deemed unnecessary. Ultimately, this continued antibiotic
abuse will render today's antibiotics useless. The prevalence of antibiotic resistance
could result in more trips to the doctor's office, longer recovery times, or the use of
more toxic drugs, or, potentially, death. The CDC estimates that nearly 2 million people
in the United States each year that acquire a bacterial infection while in the hospital and
90,000 of them die due to bacterial resistance towards antibiotics.(3) Thus, there is an
I
enormous need to find new antibiotics and antimicrobial agents to replace the ones that
are becoming ineffective.
1.2 Evolution of Bacterial Resistance toward Common Antibiotics
Bacterial resistance is an outcome of forced evolution by society's demands.
Most organisms contain a few prevalent genomic mutations that give them the ability to
withstand attack from antibiotics. Resistance occurs because the antibiotic successfully
kills the weak, defenseless bacteria, while selecting the strong, mutated bacteria to
survive. These mutated, now resistant, bacteria grow and multiply becoming the
predominant microorganism. In this case, antibiotics do not cause the resistance in the
microbes, but rather select the stronger, resistant bacteria to flourish. It is estimated that
virtually all bacteria are resistant to one or more of the drugs required to treating an
infection.(4) Unfortunately the amount of resistance is continually rising. Figure 1.1
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Figure 1.1: Increase in bacterial resistance over the past few years (adapted from
NNIS 2003 report).
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One pathway bacteria use to develop resistance is by interfering with the
antibiotic's mechanism of action.(5) This can be easily accomplished by the production
of hydrolyzing or modifying enzymes that either degrade the antibiotic or change the
chemical structure rendering the antibiotic ineffective. For example, penicillin kills
bacteria by inhibiting cell wall synthesis. Penicillin resistant bacteria produce enzymes,
called Penicillinase, which hydrolyze the antibiotic rendering it useless. Production of
hydrolyzing enzymes, like Penicillinases, is a common pathway of antibiotic resistance
in many bacteria.
Another mode of resistance is accomplished through altering the antibiotic's
target, such as modifying the cellular structure.(2, 5) This can be achieved by
modification of the cell wall making it thicker and less permeable or by varying an
internal cellular component. Erythromycin, a frequently prescribed antibiotic, attacks
bacterial ribosomes and prevents protein production. By slightly altering ribosomal
structure, bacteria can prevent the antibiotic from binding to the ribosome. This route is
also taken by other bacteria to become resistant to streptomycin and gentamicin.
A third mechanism of resistance commonly used by bacteria is through the
production of efflux pumps.(2) This pathway is enabled by the production of enzymes
that actively remove the antibiotic from the interior of the cell. Many cells can increase
the number of efflux pumps present in a bacterial strain resulting in an increase in
antibiotic resistance. This is a common route taken to develop resistance to
tetracyclines and chloramphenicol.
3
1.3 The New Wave of Antibiotics
Antibiotics with specific protein targets or receptors allow microbes to mutate
and become resistant to the administered drugs. Ideally, antibiotics that will not
succumb to the mechanisms of bacterial resistance should be developed. A general
membrane disruption pathway without specific targets can significantly reduce or
eliminate the evolution of resistance. Nature provides an excellent starting point for
insight into broad-spectrum antibiotics which are effective against multiple
microorganisms. Multicellular organisms successfully live and flourish in the presence
of microbes (including bacteria, fungi, and viruses) due to their ability to produce
antimicrobial, or host defense peptides (HDPs), which fend off microbial attack.(6)
Since HDPs have broad-spectrum activity, they can provide a model system for the
generation of novel antibiotics.
HDPs are natural peptides that provide the first line of defense against bacterial
infection and are widespread throughout several eukaryotic systems. Due to their
prevalence, it is thought that they played a fundamental role in the evolution of complex
multicellular organisms.(6) Despite their long-term existence, they have retained their
effectiveness as antimicrobial agents. This makes HDPs an attractive source for
understanding how to effectively prepare antibiotics which induce negligible bacterial
resistance.
There is widespread diversity in the sequence, structure, and size of HDPs, but
they can be separated into two general categories; anionic and cationic molecules.
There are a limited number of anionic HDPs which are mostly found in sheep, goats and
most recently in cattle. (7) The class of cationic HDPs is much larger and includes
several hundred peptides which are common in all types of organisms ranging from
insects to fish to humans.(7, 8) Table U lists several cationic HDPs as well as their
natural hosts and how many different variations of peptides are found in each lumily.(X)
Tabic 1.1: Brief list of cationic HDPs (adapted from reference 8).








Cationic I IDPs are a large class of natural peptides that continue lo be
discovered and isolated at a rapid rate from a variety of organisms including vertebrates,
invertebrates, anthropoids, plants, insects, and mollusk species.(9, 10) These peptides
can be synthesized on demand and stored in large amounts in the granules of neutrophils
and secretions of the mucosal epithelia, so that the host is ready to defend against
infection from a variety of microorganisms. (1 1 ) Since HDPs have retained their
efficacy over the years, they are thought to work by a different pathway than
conventional antibiotics. While conventional antibiotics have specific microbial targets,
generally HDPs work through selective, non-reeeptor-based, interactions with microbial
membranes.
Cationic I IDPs can be categorized into five families of peptides based on
structural features: a-helices, \\- sheets, looped structures (connected by a single
disulfide bond), extended structures, and cyclic structures (connected by a peptide
bond)(l 1) of which the first two classes are the most common.(lO) Examples of
peptides from the first two categories are shown in Figure 1 .2: Magainin (a-helical) and
Defensin (p-sheet). The majority of the known cationic HDPs have been studied by
circular dichroism to elucidate the structural class they belong and some peptides have
been investigated by two-dimensional nuclear magnetic resonance (NMR) to determine
their three dimensional structures.(lO)
Figure 1.2: Examples of two host defense peptides a) a-helical Magainin and b) p-
sheet Defensin.
Even though HDPs have very different structural features, they have three
characteristic properties: they are relatively small (less than 50 amino acids), basic
(arginine- and lysine-rich), and amphiphilic (containing hydrophobic and hydrophilic
moieties).(8, 11,12) After these common characteristics of HDPs were determined, the
correlation to potency was investigated. Tossi and coworkers indicated that there are at
least six parameters that influence the potency and spectrum of activity of HDPs: size,
sequence, degree of structuring, charge, overall hydrophobicity, and amphipathicity.(8)
The degree of structuring relates to the general structure adopted by the peptide: some
peptide sequences have structured and unstructured portions. The overall
hydrophobicity is related to the ratio of hydrophobic to hydrophilic moieties within the
peptide sequence. In general, these parameters are interrelated, thereby altering one can
highly influence one or nu>,e ofthe others. For example, a modification to the charge of
a peptide affects the overall hyclrophohieity which could in turn affect the degree of
structuring.
1.4.1 Parameters (hat Influence Biological Activity
The interrelationships of the parameters discussal in the previous section make
it challenging to choose a specific parameter to investigate. Some researchers have
narrowed all the above parameters down to one fundamental underlying structure, the
amphipathic design.(6) Amphipathicity is the ability of a molecule to segregate
hydrophobic and hydrophilic segments to opposite sides of the structure. This is
commonly referred to as a facially amphiphilic (FA) structure and can be seen in Figure
1.2 with the segregation of the hydrophobic (shown in green) and hydrophilic (shown in
blue) moieties of Magainin and Defensin,
The classic example of the importance of a FA structure for antibacterial activity
was demonstrated by lloughlen and coworkers in 1992 with the synthesis ol peptides
composed of lysine and leueine.( 1 3) In the study, they systematically varied the
sequence of the amino acids to give different degrees of amphiphilicity and determined
that the peptides with the highest degree of amphiphilicity were the most biologically
active. Before this study, Degrado and coworkers made similar u-peplides composed of
lysine and leucine but only reported the peptide secondary structures and not the
antibacterial activity. ( 14) The same principle of the necessity of I 'A for antimicrobial
activity was shown with fi-peptides by (iellman and coworkers. ( 15, 16) The difference
between a- and (5-peptidcs comes from the presence of a carbon between the carboxyl
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and the amine group, as shown in Figure 1




R OH H 2NM ( OH
a-amino acid \ p.am ino acid
R
Figure 1.3: Chemical variations between the structures of a- and p-amino acids.
While the importance of a FA structure has been illustrated, the several other
parameters need to be considered as well. Many research groups focus on determining
the effect of the degree of structuring of peptides, however, it should be noted that it is
very complicated to experiment with this parameter without affecting other parameters
such as sequence and charge. Houghton and coworkers investigated the antimicrobial
effect in relation to the FA structure and the degree of structuring.(13) They found that
peptides with alternating lysine and leucine amino acids had more of a (3-sheet like
structure while the FA peptides (lysine and leucine segregated to opposite sides of the
helix) were a-helical. Hancock and coworkers used two methods to examine the effect
of increasing the helicity of a peptide. In this first study, they introduced a preformed
helix, as opposed to an unstructured peptide in solution,(17) while in the second study
they made specific amino acid substitutions that increased the helix forming
potential^ 1 8) In the first case, the increase in the degree of structuring with a preformed
helix reduced antibacterial activity, but on the other hand, increasing the helix potential
by amino acid substitutions increased the activity. Sitaram and coworkers also found
that disrupting the secondary structure by introducing diastereo amino acid analogs
resulted in loss of biological activity.(19) Overall, the effect of secondary structure on
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antibacterial activity seems contradictory, but the available data suggests that a specific
secondary structure is not important for antibacterial activity.
The influence of peptide charge, hydrophobicity, and length have also been
closely examined.C20.22) Some research groups have found that alterations in these
three categories do not significantly affect the antimicrobial activity,(20) while others




.2 shows some of the results from I kmcock and coworkers showing that
length, degree ofcharge, and hydrophobicity do not affed antibacterial activity.(20) In
comparing the structures with similar lengths and overall hydrophobicity while varing
the charge (CM3 and CP29), illustrates no significant change in the MIC against E. coll
CP29 and CM5 show that increasing the hydrophobicity slightly changes the
antibacterial activity but it is not significant. (Tu2 and CPo3 represent a change in
peptide length without greatly affecting charge and hydrophobicity but again results in
no significant change in activity.
Table 1.2: Effect from peptide alterations ofcharge, hydrophobicity, and length on







CM3 26 +9 52 1
CP29 26 +6 50 2
CM5 26 +6 65 5
CPa2 30 +9 60 2
CPa3 23 +8 57 4
In contrast to the results suggesting these parameters do not affect the
antibacterial activity, Nicolas and coworkers performed an elegant study using
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Dermaseptin as a HDP model.(22) By significantly shortening the sequence from 34
amino acids to 18, they found a peptide which retained the antibacterial activity of the
parent compound. Sitaram and coworkers did a similar study using Melittin and
showed that by decreasing the peptide size from 26 to 1 5 residues, the antibacterial
activity is decreased; however the 1 5 residue compound is also 300 times less hemolytic
than the parent compound.(23) In both these models, not only was the size of the active
compound decreased, but the sequence chosen encompassed most of the amphiphilic
segment, thus, resulting in a much less hydrophobic compound.
Between the contradicting results about size, hydrophobicity, and charge as well
as those discussed above for degree of structuring, the literature can become confusing.
Attempting to compile results from a broad spectrum of HDPs and pathogens has
proven difficult.(6, 8, 24) However, some generalizations can be made: amphipathicity
is necessary, smaller peptides retain biological activity with the optimal size between 1
2
and 46 residues, the hydrophobic to charged residue ratio is optimal between 1 : 1 and
2: 1 , and there is a direct correlation between cationicity and potency (net positive charge
of at least 2, usually 4-6) since the initial electrostatic interaction is very important.(8,
1 2, 24-26) Controlling the antimicrobial activity using many of the aforementioned
parameters provides a good starting point for research, but HDPs must also show
selectivity to be successful host defense agents.
1.5 Selectivity
Selectivity of these host defense peptides demands that they must be able to
differentiate between host and invader cells. This feature is most likely derived from
I (J
the fundamental differences between bacterial and mammalian cell membranes. Figure
1
.4 shows diagrams of the two membranes, bacterial and mammalian, and an immediate
difference can be observed. Both the inner and the outer leaflets of the bacterial
membrane (Figure 1.4a) contain negatively charged phospholipids, while only the inner
leaflet of the mammalian membrane (Figure 1.4b) contains negatively charged
phospholipids. The additional negative charges aid in electrostatic interactions between
the cationic peptide and the bacterial membrane. This driving force for association is in
addition to any hydrophobic interactions the peptide has with the membrane. The
combination of the electrostatic and the hydrophobic interactions allows HDPs to have
the unique characteristic of being highly water soluble but also have favorable
interactions with phospholipid bilayers.(8) Water solubility is not a requirement with
HDP mimics since they are not stored within the host for extended periods of time,
although some degree of water solubility is necessary for antimicrobial activity.
neutral phospholipid
(^JL**^. negative phospholipid
Figure 1.4: Diagrams of a) bacterial membranes and b) mammalian membranes.
Aside from the absence of negatively charged phospholipids in the outer leaflet
of untransformed mammalian cells, there are other properties that determine selectivity
1 1
towards bacteria. These properties ineh.de the lower transmembrane potential and
presence of cholesterol in the animal cell membrane.(8, 27) Also, unlike bacteria, the
respiratory and maoromolecule synthesis in mammalian cells is not coupled to the
cytoplasmic membrane.(8) These propcrt.es no. only make animal cells much more
rigid than bacterial cells, but
.1 also means that if HDPs have secondary interactions thai
inhibit cellular mechanisms through the membrane, then they should have less ol an
















Figure 1.5: Schematic of differences In gram-negative and gram-positive bacterial
Cell nails.
Even though many HDPs have broad spectrum activity against both grain
positive and negative bacteria, fungi, viruses, protozoa, and yeasl cells,(6, (), 11, 28, 29)
some peptides are specific to one type of microorganism. This selective aelivily ean be
accounted for by the Specifics Of the microbe cytoplasmic membranes, lor example,
there is wide variation in gram-negative and -positive cytoplasmic membranes of
bacteria, as seen in Figure 1 .5.(2) In gram-negative bacteria there are two cell
membranes, the outer and the cytoplasmic membrane, while in gram-positive bacteria
there is only a cytoplasmic membrane. Another major difference is the presence of
lipopolysaccharides (LPS) on the external leaflet of the outer membrane of gram-
negative bacteria. These molecules are known to be negatively charged, however, it is
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also speculated that they also repel hydrophobic molecules.(30) Figure 1 .6a shows a
general schematic of Lipid A,(2) while 1 6b shows a chemical structure of a synthetic E.
coli Lipid A.(31) Lipid A structures vary significantly depending on bacterial strain, but
the sequence of major components is generally uniform and the fatty acid tails are
connected to the glucose group by ester amine linkages.(2, 31-33) The surface of gram-
positive bacteria is also negatively charged due to the presence of teichoic and
teichuronic acids. The negative charges from both gram-negative and
-positive
membrane features add to the overall negative charges of the lipids in the outer leaflet of
the membranes thus allowing electrostatic interactions with cationic molecules.







Figure 1.6: a) Schematic of LPS b) chemical structure of Lipid A from E. coli.
HDPs are also known to be selective towards cancerous, or transformed cells
over non-cancerous, or untransformed mammalian cells.(9, 34-37) This selectivity
comes from the differences in the membranes of transformed and untransformed cells.
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Typically, cancerous cells have a small amount (3 to 6%) of negatively charged
phospholipids in the outer leaflet of the cell membrane which induce favorable
electrostatic interactions between HDPs and those membranes, similar to that of
bacterial cells. Recently the use of HDPs for anticancer drugs have been investigated
and show promising initial results.(34, 36)
1.5.1 Factors that Influence Selectivity
All the characteristic parameters of cationic HDPs discussed in Section 1.4 can
affect selectivity towards bacterial over untransformed mammalian cells. A significant
amount of work has been done to determine exactly how to control and increase HDP
selectivity, since natural HDPs are often toxic, limiting their therapeutic use. While the
literature is filled with seemingly contradictory results from a wide variety of HDPs and
pathogens, it is generally accepted that three parameters highly affect the selectivity:
hydrophobicity, charge density, and size.(8, 21)
Hydrophobicity is a complex parameter: there is a delicate balance between
having too much and too little hydrophobicity.(21) If the peptide is too hydrophobic
then it is not sufficiently soluble in water to be stored at the concentrations needed for
host defense and cannot be rapidly transported to the invaded site. Yet, if the peptide is
not hydrophobic enough, then there is no driving force for interactions with the
hydrophobic region of the membrane bilayer and the molecule will not be membrane
permeable. This is problematic because both electrostatic and hydrophobic interactions
with cell membranes are required for membrane disruption.
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Tweaking the hydrophobic^ of a peptide is often accomplished through single
residue substitution. It has been reported that changing the hydrophobieity of a single
amino acid will significantly change the selectivity of that peptide.(38) (hanging a
single residue will also effect the hydrophobic moment of a peptide, since the
hydrophobieity is not equally spread out over an entire peptide sequence.^ 1 ) Most
naturally occurring peptides have 40-60% hydrophobic amino acids and, in general, the
selectivity for bacterial membranes is decreased as the peptide hydrophobieity is
increased.(8, 21)
Initially, charge density appears to be inversely related to hydrophobieity when
relating to amphiphilic peptides, but this is not always the case. Some peptides have a
reduced amount of charged residues, but a large number of polar residues, while others
have a balance between positively and negatively charged residues. Extensive work has
been done to optimize the amount of charge in a peptide, often by single residue
substitutions(18. 39) or changing the terminal amino acids of the peptide.(40, 41) From
these experiments, it has been determined that increasing the net cationic charge
improves the selectivity. Unfortunately, charge density can only be effective up to a
certain point as too much charge interferes with secondary Structuring.(8)
The size of a peptide also plays an important role in determining the selectivity
towards bacterial cells. Several studies have shown that il is possible to reduce the size
of 1 1 Dl's and retain or even improve their activity. (8, 22, 23, 42) Some researchers have
shown that the optimal length for the highest selectivity is 14 residues. ( I I, I J) Table
1.3 shows results from a study done on the influence ofpeptide length On biological
activity, from this data, il can be seen thai there is a huge effect on antibacterial
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activity: there is inactivity at both extremely short and long peptide lengths. This data
also suggests that longer peptides are more hemolytic. The 14-residue peptide had the
lowest MIC as well as minimal hemolysis at more than 6 times the MIC. In general, the
first 20 residues in a peptide sequence provide sufficient antimicrobial activity and a
reasonable basis for the design of new antimicrobial peptides or improvement of natural
peptides.(8)














1.6 The Development of Resistance to HDPs
There are three generalized pathways for bacterial resistance to develop towards
HDPs: 1) the production of more proteases, 2) thickening of the cell wall, and 3) change
in the electrostatics of the cell wall. If the cell starts to produce more proteases, these
enzymes can recognize peptide sequences, degrade them, and render the HDPs
ineffective. This would be similar to penicillin resistance from the production of
Penicillinase. If the bacterial cell wall thickens, antibacterial peptides relying on
spanning the membrane for cell disruption could be rendered ineffective. Most of the
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recently reported HDP resistance falls within the third category resulting in a reduction
of the net negative surface charge.(44-48) In gram-negative bacteria, this occurs
through modification of the LPS layer, specifically acylation of Lipid A, on the
cytoplasmic outer membrane (Figure 1.6).(44, 46-48) Conversely, gram-positive
bacteria can incorporate teichoic acids which lack D-alanine, resulting in a reduction of
negative surface charge.(45) In both cases, the decreased net negative surface charge
results in decreased binding efficiency of positively charged molecules, including
HDPs. Currently, resistance reported against HDPs is minimal compared to the
widespread resistance towards common antibiotics.
1.7 The Future Potential of HDPs as Antimicrobials
HDPs have several advantages that will aid in their use as future antimicrobial
agents. Most HDPs kill bacteria rapidly, with a three or more logarithmic decrease of
viable cells in 5 minutes at four times the minimal inhibitory concentration (MIC).(37,
49) They are broad spectrum and work well against many clinically resistant mutant
bacterial strains with low MICs (between 0.25 and 4 ug/mL).(10, 37) They are proven
to be good topical therapeutic agents against microbial infections.(50) Due to the
encouraging characteristics of HDPs, several peptides have been commercialized for use
as antibiotics;(l 1, 37) both Agennix (Houston, TX) and AM Pharma (Bilthoven, the
Netherlands) have developed anti-infective peptides based on natural HDP sequences,
while Helix BioMedix, Inc. (Bothell, WA) and Dermegen, Inc. (Pittsburgh, PA) have
both introduced topical therapeutics that are active against many infective agents.
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Despite all these seemingly optimistic results from HDPs, there are some
negative characteristics. First, peptides are very complex structures that require time
and cost intensive programs to generate. This has been addressed by some companies
and researchers trying to find smaller analogs of HDPs that are still as biologically
active and selective. However, it is not realistic to use high cost materials for
antimicrobial agents, either topical or as systemic therapeutic agents because this high
cost is conveyed to the consumer. If the cost of such medications can be reduced
significantly, then more realistic applications and commercialization can be explored.
Another issue with the use of HDPs as antimicrobial agents is their toxicity. It is
true that some peptides show selectivity towards invader cells over host cells, but there
are also peptides that are not selective, or are selective only to their natural hosts and not
transferable to other hosts. Many of the commercialized peptides seem to have
applications in topical therapies where there is less stringent regulation with regard to
toxicity since the medication is not ingested. However, the use of these agents as
systemic therapeutics requires more definitive understanding of toxicity and selectivity
towards invader cells.
The use of HDPs as antimicrobials is also hampered by their susceptibility to
proteolytic degradation. All cells can produce enzymes which can recognize these
peptides and degrade the sequence, destroying the effectiveness of HDPs. The
production of more proteases is a plausible way that bacteria can exhibit resistance to
HDPs as discussed in Section 1 .6. With the production of proteases, the bacteria can




The strategy investigated here is to design materials that will mimic the
biological activity of HDPs. Many researchers have reported structures to be used as
HDP mimics, however all of them include amide bonds and several of them do not
show the desired selectivity^15, 16, 51-56) We extend and change the status quo to
mimic HDPs by capturing the essential design elements without limiting the chemical
structure to a peptide-based molecular composition. The abiotic, conformationally
flexible, wefa-phenylene ethynylene (meta-PE) backbone will be used as a scaffold for
the production of cationic facially amphiphilic molecules. This fully hydrocarbon
backbone will allow us to begin to probe whether simple, truly abiotic molecules
containing no chirality can have similar antimicrobial properties to HDPs. Furthermore,
with the addition of polar and nonpolar groups, these molecules should assume the
desired amphiphilic structure. The work reported here showcases the first facially
amphiphilic polymers based on a meta-PE backbone.
Through variation of the side chain structures on the meta-PE molecules, we will
probe to determine the effect of charge, degree of hydrophobicity, and overall
amphipathicity needed to effectively mimic HDPs. Tuning the chemical structure will
provide the first polymeric and oligomeric structures without amide bonds to show
selectivity towards bacteria over red blood cells. Limiting the size of the molecules will




This dissertation describes the preparation, characterization, and biological
activity of several novel me/a-phenylene ethynylene molecules to be used as 1 1DP
mimics and antimicrobial agents. Chapter 2 discusses the synthesis of novel molecules
based on roeta-phenylene ethynylene backbones. Both discrete oligomers and polymers
were synthesized to be tested as antimicrobial agents. In Chapter 3, the characterization
at the air-water interface and in solution of these molecules is presented. The polymers
form stable monolayers at the air-water interface as seen by Langmuir experiments,
revealing conformational and packing properties of the polymers. Solution aggregation
of these molecules was studied by fluorescence and turbidity measurements. Chapter 4
discusses the biological activity of these molecules, indicating that the polymers and
discrete oligomers show selectivity towards bacterial cells over human red blood cells.
The bacterial activity is broad spectrum (20 bacteria studied) and the MIC was found to
average 2 ug/mL and be as low as 0.4 ug/mL. These discrete molecules are also
incorporated into polymer plugs and were found to prevent biofilm formation. Chapter
5 attempts to probe the mode of the antimicrobial action of these molecules. It has been
shown that these molecules are membrane active but whether this is the lethal event or
if further cellular interactions cause cell death is still under investigation. Chapter 6
contains all the experimental data, such as NMR, GPC, MS, and elemental analysis, and
parameters that are not found in the other chapters. The appendix describes a side
project investigated with these materials which was published in Macromolecules in
2004. This involved solution studies with several different polymers to probe whether
these molecules can form a helix. (57) Overall, it will be shown that meta-PE molecules
20
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CHAPTER 2
THE SYNTHESIS OF ME7M-PHENYLENE ETHYNYLENE MOLECULES
2.1 Introduction
Phenylene ethynylene (PE) polymeric backbones have become more prevalent
due to the discovery of efficient ways to couple aromatic halogens and terminal
alkynes.(l-13) A very effective coupling reaction is the Sonogashira reaction which
utilizes a combination of a palladium catalyst, copper iodide, base, and metal ligand.
The palladium source ranges from Pd(II) to Pd(0), including Pd(PPh3 )4 , Pd(PPh3)2Cl,
and Pd(dba)2 . All the reported reaction conditions can be utilized to synthesize either
para, ortho, or meta polymers depending on the monomer substitution. The literature
has numerous papers that use the Sonogashira reaction to synthesize para-PE
backbones( 14-24), most of which explore these molecules for electronic devices.
Sonogashira reaction conditions are just as useful for making meta-PE molecules, a
backbone that is much less studied.(25-28)
The driving force for synthesizing me/a-derived molecules is to produce novel
PE molecules with defined substitution patterns that under certain conditions assume
facially amphiphilic (FA) structures where the hydrophobic and hydrophilic moieties
segregate to opposite sides of the molecule as shown in Figure 2. 1 . These molecules
will not only add to the meta-PE literature, but will provide a scaffold for building FA
structures on a conformationally flexible backbone.
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Figure 2.1: Facially amphiphilic structure where hydrophilic (blue circles) and
hydrophobic (green triangles) moieties segregate to opposite sides of the molecule
Para-PE molecules have been studied extensively for their fluorescent
properties( 1
,
12, 29-31) and potential uses as molecular wires.(32-36) Our group has
studied the para substituted polymers shown in Figure 2.2 for the stabilization of oil
droplets in acidic aqueous solution.(37) Depending on the solvent conditions, droplet
size can be controlled. At this time, it is unknown what other factors may contribute to
the changes in droplet size.
OC5H 11
(H 3C) 2N
Figure 2.2: Example of facially amphiphilic para-PE molecule.
()rtho-PE(\ 1, 38) and meta-PE(4, 5, 26, 28, 39, 40) molecules have been
investigated for folding properties. Moore and coworkers have made stable helical
structures by varying the side chains of a meta-PE backbone and controlling the solvent
composition. (28) Our group is currently working on understanding the solvophobic
folding properties of several orlho-PE derivatives by using different side group
substituents. This is shown schematically in F igure 2.3. The stability of the helix varies
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depending on the substituents used, such as ethers or esters.( 1 1 ) Being able to design a
helix where one-third of the helix has hydrophilic side chains while the other two-thirds
is hydrophobic can lead to some very interesting facially amphiphilic helices which
under specific solvent conditions can form multi-helix bundles.
TMS
Figure 2.3: Cartoon of ortho-PE with ether groups folding from an extended to a
helical structure.
There are many goals of the isomers of PE molecules studied in our group,
antimicrobials, foldamers, and self-assembly; however, the unifying property is the
design of a facially amphiphilic (FA) structure. In all these molecules, the hydrophobic
nature of the molecule comes from a combination of side chains and backbone and the
hydrophilic moieties are generally side chains of either ethylene glycol or amine
substituents. These molecules fit into the literature, not only for their applications, but
also their FA structure. There are only a few papers in the literature, other than those
published by our group, that market phenylene ethynylene molecules as being
amphiphilic(28, 41-43) so there is definite room for expansion in this field.
This chapter demonstrates that by using functionalized dihalogenated monomers
and the commercially available we/a-diethynyl benzene, it is possible to synthesize a
series of meta-PE polymers and oligomers with various non-polar (NP) and polar (P)
groups. The meta-PE backbone is flexible and can adopt different structures, including
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an extended or helical conformation, as shown in Figure 2.4. When the backbone has
large enough NP groups, the molecule will prefer an extended FA structure rather than
helical structure in solution where the P and NP groups on opposite sides of the
molecule as shown in the top structure of Figure 2.4. At the air-water interface, all the
meta-PE polymers designed with a FA structure should assume an extended
conformation. All the characterization data that is not presented in this chapter
Chapter 6.
is in
Figure 2.4: Extended and helical structures of //^/-substituted PE molecules
2.2 Monomer Synthesis
2.2.1 Alkoxy Substituted Monomer
In order to build the proposed FA structures, monomers with appropriate
functionality must first be synthesized (Figure 2.5). The commercially available 3,5
diiodo-4-hydroxy-benzonitrile, 1, was reacted under Mitsunobu conditions to
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incorporate an alkoxy group. Several different alkyl chain lengths were prepared
ranging from C5 to CI 2. Next, the nitrile functionality was successfully reduced with
Borane-THF to yield the benzyl amine, which was protected right away as the terf-butyl
carbamate (Boc) since concentration and storage of the primary amine often lead to
multiple degradation products. Borane-THF gave good yields of the primary amine
with limited dehalogenation, which often occurs with aryl iodides and bromines under
reducing conditions. The final compounds, 8, 9, and 10, were pure, functionalized
monomers ready for use in Sonogashira coupling.
R,OH, DIAD,
PPh 3 , THF, 2h
0 °C to rt
CN
1. BH3 , THF. 18h,
0 °C then reflux
2. MeOH
3. Boc20, NaOH,
DMF/H20(3:l) ( 8h £HBoc
2, R,=C 5H 11,92% 8, R,=C 5H n ,62%
3, Rj = C8H 17 , 90% 9, R! = C 8H 17 , 63%
4, R, = C 12H25 , 90% 10, R, = C 12H25 ,
64%
Figure 2.5: Synthesis of alkoxy substituted molecules.
The monomer transformations were followed by 'H NMR, 13C NMR, and GC-
MS. The final monomer composition was confirmed by elemental analysis. As an
illustration, Figure 2.6 shows the 'H NMR for the pentoxy side chain monomer
synthesis.(44) Figure 2.6a shows the resulting NMR from the introduction of the
pentoxy side chain, 2. The triplet, at 4.0 ppm is from the methylene next to the oxygen,
with the following peaks accounting for the rest of the methylene groups in the alkoxy
chain progressively becoming further away from the aromatic ring. With the reduction
of the nitrile group, Figure 2.6b shows a new singlet in the NMR accounting for the
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methylene group at 3.9 Ppm
.
Finally protection of the free amine, 8, introduces a singlet
at 1
.4 ppm accounting for the nine protons of the Boc group, shown in Figure 2.6c. The
amine proton can be seen as a broad peak at 4.8 ppm while the methyl amine is now a
doublet at 4.2 ppm. The trends of the other monomers with longer alkoxy chains are
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Figure 2.6: !H NMR of C5 synthesis.
2.2.2 Synthesis of CO Monomers
A series of molecules without the alkoxy substituents or any substituents para to
the amine (denoted as CO) were synthesized as shown in Figure 2.7. Dibromobenzoic
acid, 11, was purchased as the starting material and the acid group was reduced in good
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yield using lithium aluminum hydride in ether without the loss of bromide. The benzyl
alcohol 12, was reacted with N-bromosuccinimide and triphenylphosphine to yield the
benzyl bromide, 13. This was followed by reaction with sodium cyanide to yield the
benzyl nitrite, 14. Reduction with Borane-THF gave the free amine which was
subsequently protected with the Boc group yielding a white crystalline solid, 16. This
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Figure 2.7: Synthesis of CO molecules.
The monomer transformations were followed by ]H NMR, l3C NMR, and GC-
MS. The final monomer, 16, was confirmed by elemental analysis. Figure 2.8 shows
the progression by !H NMR. The benzyl alcohol, 12, results in a triplet at 7.6 ppm
accounting for one proton and a doublet a 7.5 ppm accounting for two protons in the
aromatic region. The simplicity of the aromatic region is expected due to the 1,3,5-
substitution which eliminates ortho proton coupling resulting in singlet peaks. The
benzyl protons are a singlet at 4.7 ppm. Throughout the rest of the transformations, the
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aromatic peaks do not shift significantly, but the benzyl protons shift upfield to 4.4 and
3.7 ppm for the benzyl bromide, 13, and benzyl nitrile, 14, respectively. Upon reduction
to the free amine and protection with the Boc group, 16, the ethyl protons produce peaks
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Figure 2.8: 'H NMR of CO synthesis.
2.2.3 Synthesis of Other Monomers
Various iterations of similar monomers were synthesized to develop structure
property relationships. Figure 2.9 shows several other monomer synthetic schemes used
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to make dihalogenated monomers for polymerization. Scheme A shows a reaction
introducing an ether substituent with a nonpolar pentyl group. In this reaction,
potassium hydride removes the proton from the pentanol and displaces the bromide of
13. This reaction was also used in scheme D to introduce a triethylene glycol P group,
23. In scheme B, the Mitsonobu reaction was utilized to introduce an ethyl amine group
to the methyl functionalized molecule, 18, resulting in monomer 19 with both P and NP
substituents. Scheme C utilizes an esterification reaction to introduce a methyl ester
group in place of the carboxylic acid yielding 21. Next a transesterification reaction was
done using potassium carbonate and triethylene glycol monomethyl ether to make the
Peg-ester monomer 22. These monomers were all characterized by *H NMR and GC-
MS before being used for polymerization as described in the following section.
Br
HO'






























Figure 2.9: Dihalogenated monomer synthetic schemes
33
2.3 General Polymer Synthesis
A general polymerization scheme is shown in Figure 2. 1 0 for the dihalogenated
monomer series. The polymerization utilizes Sonogashira coupling between the
halogen and the terminal acetylene of mcta-diethynyl benzene. This is carried out in an
air-free Schlenk flask under a nitrogen atmosphere. The diethynyl benzene was
weighed directly into the flask followed by the addition of reagents, solvent, and
purging with nitrogen before being sealed. A ratio of 1.03:1 diacetylene:dihalogen was
used to account for acetylene-acetylene coupling.(45) The reaction was allowed to stir
at room temperature for 30 minutes, until a homogeneous solution was formed, before
submerging in a 65°C oil bath overnight. The formation of salt precipitate was observed
after a couple of hours while the reaction solution remained clear. For the alkoxy-
substituted monomers, the solution remained a yellowish-orange color, while for the
monomers without the alkoxy moiety, the solution often turned dark. After the
completion of the reaction, the polymer, as a yellow solid, was recovered by
precipitation from methanol and fully characterized by NMR, fluorescence, and GPC.
The amine was deprotected using 4M HC1 in dioxane with quantitative yield. These
harsh conditions do not affect the polymer backbone or substituents as evidenced by
NMR and fluorescence.
Pd(PPh 3 )4 , Cul
DIPA, toluene, 78°C
R2 R3
Figure 2.10: Representative polymerization conditions.
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The 'H NMR for both the protected, 24p, and deprotected, 24d. pentoxy
polymers can be seen in Figure 2.1 1. Polymer 24p, with the amine still Boc protected,
is shown in the top spectrum. Coupling between the aromatic protons makes the
aromatic region between 7.0 and 8.0 ppm very complicated. The peak from the amine
proton is present at 4.9 ppm and the two methylene groups give rise to the peak at 4.3
ppm with the peaks from the rest of the alkoxy chain between 2.0 and 0.7 ppm. There is
no evidence of terminal acetylene protons suggesting that the end groups are most likely
halogens. The most notable differences upon deprotection of the polymer to 24d are the
presence of the amine protons at 8.5 ppm and the absence of the Boc group at 1 .4 ppm.
Peaks from the alkoxy protons and the backbone aromatic protons remain unaffected
during the deprotection. Minimal shifting of these protons is due to the solvent change
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Figure 2.1 1: NMR of protected (24p) and deprotccted (24d) polymers with alkoxy
side chains
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Representative polymer structures and their molecular weight characterization
data is shown in Table 2.1. The data is taken from gel permeation chromatography
(GPC) in THF calibrated versus polystyrene standards. GPC is known to overestimate
the molecular weight of rigid polymers. In fact, fractionation and collection of a
polymer sample analyzed by MALDI-ToF verified that the GPC does overestimate the
molecular weight of these polymers by a factor of two. Even still, the corrected
molecular weight of the resulting polymers ranged from about 2000 g/mol to 15,000
g/mol with polydispersities between 1.3 and 4. The high polydispersity values are
expected since this is a step-polymerization; however, they can be kept below 2.0 if the
reaction time is less than 14 hours.
Table 2.1: Summary of Polymers synthesized,
Number R
2 R3 Mn*(xl0-3 ) PD1
24p 0(CH,)4CH 3 CH 2NHBoc H 17.8 2.3
25p 0(CH 2)7CH3 CH 2NHBoc H 7.7 1.3
26p 0(CH 2 ) nCH 3 CH 2NHBoc H 10.1 1.4
27p 0(CH2)2CH3CH 2CH 3 CH 2NHBoc H 10.1 1.6
28p H (CH2 )2NHBoc H 5.3 1.5
29p (CH2)2NHBoc H 0(CH 2 )4CH 3 4.6 1.8
30p H 0(CH2CH20)3CH3 H 4.8 2.3
31p CH 2NHBoc 0(CH 2)4CH3 0(CH2 )2NHBoc 23.5 2.3
32 H 0(CH2CH 20)3CH3 0(CH 2CH 20)3CH 3 10.0 1.5
33 H COO(CH 2CH20)3CH3 COO(CH 2CH20)3CH 3 5.1 3.8
* Representative Mn values from GPC in THF against PS standards
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2.4 Synthesis of Discrete Oligomers
Discrete oligomers 34p and 35p, shown in Figure 2.12 were also synthesized
from the above monomers (16, section 2.2b, and 8, section 2.2a) using similar
conditions as the polymerization but changing the stoichiometry from 1 .03: 1 to 0.4:
1
diacetylene:dihalogen. The reaction resulted in several spots that could be monitored by
TLC under both long and short wave UV illumination. Since both the monomers used
were Afunctional, there were several longer oligomers formed during the reaction in
addition to the structure of interest with three aromatic rings. Flash column
chromatography was used to separate 34p and 35p from the crude reaction mixtures to
yield white solids (30% and 35% respectively). Quantitative deprotcction was achieved
with the same conditions used for the polymeric analogs in Section 2.3.
NHBoc NHBoc
OC 5H„ OC 5H„
33p
NHBoc NHBoc
Figure 2.12: Two discrete oligomers synthesized. In general, they represent two
classes of oligomers: with and without alkyl side chains.
The 'll NMR spectrum fbr34p is shown in Figure 2.13. The NMR splitting
patterns for the discrete compounds are much narrower than those of the polymers and
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the molecule is C2 symmetric, so the ortho, meta, and para splitting can be assigned.
The triplet in the aromatic region of the lH NMR accounting for one proton at 7.7 ppm
is assigned as Hd . This proton is the furthest downfield because of its proximity to the
ethylene groups, allowing for easy identification. The triplet centered around 7.6 ppm is
assigned as Hc and Hh while the doublet of doublets at 7.5 ppm account for He and H„.
There is triplet centered around 7.4 ppm accounting for Hf. The signals between 7.4 and
7.3 ppm account for Ha , Hb , H„ and H, The discrete oligomer was also characterized by
high resolution electrospray ionization to confirm the molecular structure. Both the loss
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Figure 2.13: !H NMR of CO oligomer, 34p
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2.4.1 Structure-Activity Relationship of Oligomers
In an attempt to investigate the structure-activity relationship (SAR) of these
discrete oligomers, several modifications to the original structures were made, including
modifications of the bromine end groups, the amine side chain, and the alkoxy side
chain. Most of the modifications were performed on the dihalogenated monomer before
coupling with diethynyl benzene since reaction and purification of the monomer gave
higher yields than post-oligomerization reactions.















The bromine moieties provide a convenient handle with which to perform
reactions, resulting in modification of the oligomer end groups, as shown in Table 2.2
The Sonogashira reaction was utilized to introduce new carbon-carbon bonds for the
end groups; entries 36p, 37p, and 38p in Table 2.2. The general reaction scheme is
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shown in Figure 2.14. Various end groups with propargyl moieties, amines (42) and
alcohols (41), were introduced by mono-substitution of 16 to yield 43 and 44. The
mono-substituted monomer could be purified by column chromatography and then
coupled with diethynyl benzene yielding the new oligomers 36p and 38p. This reaction
had significantly lower yields than the original reaction even with only one halogenated
site to react with the acetylene. This is most likely due to a change in electrophilicity of
the substituted monomer, but monomer purity could also be a factor. When the
Sonogashira reaction to introduce propargyl alcohol moieties was done directly on 34p
(in an attempt to make 38p), the yield was very poor (-8%), although both the mono-
and di-substituted oligomers could be isolated from the crude reaction mixture (entry
37p and 38p). Even with the drop in yield of the oligomerization reaction, the two-step
reaction using the pre-functionalized monomer had a higher yield than one-step reaction
trying to disubstitute the oligomer.
H
\ Pd(PPh 3 )4 , Cul
TEA, 65°C, 14hrs
NHBoc NHBoc
Ft, = OH (41 16 = OH (43) 52%
NHBoc (42) NHBoc (44) 47%
Figure 2.14: Modification through the bromine end group with alkynes.
Recently, Buchwald and coworkers published a series of papers on the
substitution of arylbromides with amines.(46-48) Entry 39p in Table 2.2 utilizes the
chemistry shown in Figure 2.15, to introduce P end groups onto the oligomers. In this
case, ethylene diamine, with one amine protected, was reacted with 16 using copper (I)
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iodide as the catalyst, potassium phosphate as the base, and N.N-Diethyl-2-hydroxy-
benzamide as the ligand in anhydrous DMF at 90°C overnight to yield 45. This reaction
is not exceedingly air sensitive but it is moisture sensitive so care was taken to make
sure the reaction was anhydrous and kept under a nitrogen atmosphere at all times. The
yield of this reaction was greater than 50%, similar to yields reported in the literature.
NH2(CH2 )2NHBoc
Br









Figure 2.15: Modification through the bromine end groups with amines.
The last entry, 40p, in Table 2.2 is similar to 34p, however there are no halogen
end groups. This molecule has a similar synthetic scheme to that of the CO monomer,
16, Figure 2.8, but the starting material is 3-bromobenzoic acid rather than 3,5-
dibromobenzoic acid. The reactions have the same general work up and yields;
however the Rf of the products via Thin Layer Chromatography (TLC) did change
significantly from the dibrominated versions and the products were all viscous oils
rather than solid. The overall yield of the five step reaction scheme was 52%, similar to
that of the dihalogenated monomer; however, coupling of the monomer with diethynyl
benzene provided a great synthetic challenge. The recovered yield of that reaction was
8%, unexpectedly low since there was only one possible reaction site on the halogenated
monomer. This significant drop in yield is most likely due to impurities within the
monomer which change the stoichiometry and increase potential side reactions. By H
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NMR and GC-MS, the purity was >95% but this does not aeeount for impurities that are
either inorganic or non-volatile. All the products within this synthetic scheme are
viscous oils which often cause purification to be more challenging. The low yield was
not a problem since the goal was to make a few milligrams, enough for characterization
and bacterial studies.









The amine side chain of the oligomer also provides a good handle for
modification. Table 2.3 shows the variations of the side chains while keeping the P
nature. The original CO oligomer, 34p, has an primary ethyl amine P group which can
react with l,3-Bis(/er/-butoxycarbonyl)-2-methyl-2-thiopseudourea and mercury (II)
chloride in dimethylsulfoxide to introduce a guanidine group, entry 46p, increasing the
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hydrophilicity of the resulting structure. This reaction, shown in Figure 2.16,






Hg2Cl2 , DMSO, RT, 14h NHBoc
Figure 2.16: General scheme for modification of amine with guanidine groups.
Another modification at the amine side chain is the introduction of an amide
bond, entry 47p. This amide bond is introduced by coupling 3,5-dibromobenzoic acid,
11, and (2-Amino-ethyl)-carbamic acid tert-butyl ester with EDC and HOBt to form 52,
as shown in Figure 2. 1 7. This coupling yields 63% product and the by-products of EDC
and HOBt are water soluble and easily removed by extraction. This is an advantage
over other coupling reactants such as DCC that require extensive precipitation and
crystallization for quantitative removal. This monomer was reacted with diethynyl
benzene to form 47p in 47% recovered yield. Presumably the yield is higher than 34p
due to the difference in electrophilicity of the ring with the addition of an ester group.
Since the ester group is electron withdrawing, the insertion of the palladium between the








Figure 2,17: Amidation reaction.
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The last two modifications in Table 2.3, 48p and 49p, show changes to the
earbon chain between the aromatic backbone and the amine P group. The changes in
length of the amine side chain provide a set of molecules that have only slight
differences in structure while keeping the same net charge. Figure 2.18 and 2.19 shows
the monomer synthesis for entries 48p and 49p, respectively. 1 In both schemes, the
starting material was 3,5-dibromobenzoic acid, 11, which can be reduced using lithium
aluminum hydride. For 54, the benzyl alcohol, 12, was reacted with sodium azide and
triphenyl phosphine in DMF at 90°C to produce 47 which was then protected with the
Boc group resulting in the dihalogenated monomer 54. For 55, the bromide of 13 was
displaced with an acetonitrile anion using N-butyl lithium. The nitrile was reduced with























Figure 2.19: Synthesis of propyl amine monomer.
When purifying 49p, it was possible to separate longer oligomers 50p and 51 p which
had 5 and 7 aromatic rings, respectively.
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The presence or absence of alkoxy side chains also acts as a handle for synthetic
modification. Table 2.4 shows the modifications done with the alkoxy side chain.
Entry 35p shows the first oligomer made with an alkoxy side chain. This molecule
utilizes monomer 8 made in Figure 2.5. The same schematic can be followed using
methanol in the first step to produce a methoxy side chain, as shown in entry 58p of
Table 2.4. The last entry, 59p, shows the modification of 8 with a guanidine group
using the same reaction as in Figure 2.16.















A series of meta-PE molecules ranging from discrete oligomers to polymers
have been successfully synthesized. The use of Sonogashira conditions proved to be
very versatile in the synthesis of monomers as well as oligomers and polymers. Flash
column chromatography was utilized extensively to purify products ranging from small
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molecules with one aromatic ring up to discrete oligomers with seven aromatic rings in
the meta-PE backbone. Fifteen different discrete oligomers were synthesized to
investigate the structure-activity relationship in regards to the biological activity of these
compounds. The molecules discussed here are the first reported in the literature that
have free amine side chains on phenylene ethynylene backbones.(4, 44, 49, 50) This
was accomplished by deprotection of the Boc group from these molecules with 4M HC1,
which did not affect the backbone structure as evidenced by fluorescence and NMR.
The majority of these molecules have both P and NP side chains on the backbone which
will aid the formation of FA structures under specific conditions. These structures are
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CHAPTER 3
THE FACIAL AMPHIPHILICITY AND AGGREGATION OF META-
POLY(PHENYLENE ETHYNYLENE)S
3.1 Introduction
It is well known that many biopolymers, such as proteins and RNA, adopt
specific structures in solution.(l, 2) In proteins, segregation of hydrophobic and
hydrophilic domains is routinely used to direct tertiary structure formation or perform
other functions like membrane-activity.(3) One example is amphiphilic (3-sheets which
are formed by patterning polar (P) and non-polar (NP) amino acids with a repeat of two
so that the P and NP groups segregate onto opposite faces of the extended structure.
This forms amphiphilic two-dimensional planes, where the individual strands of the
sheet are held together by multiple hydrogen bonds. In addition, the majority of the P
amino acid groups are charged, giving these structures the potential to exhibit
polyelectrolyte-like behavior. Transferring these facially amphiphilic (FA) structures
into polymeric backbones result in attractive molecules that assume discrete
conformations. They are remarkably different than random or block amphiphilic
polymers which typically adopt random coil configurations in solution.
The study of synthetic facially amphiphilic polymers include rigid rod polymers
based on thiophene, phenylene, and /rara-phenylene ethynylene, as shown in Figure 3.1.
Polythiophenes were prepared with perfectly alternating hydrophobic and hydrophilic
side groups and investigated using Langmuir and scattering techniques.(4, 5) X-ray
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diffraction of the films showed peaks corresponding to ^stacking of molecules and
disordered alkyl chains above the water surface.(4) Diffraction studies of the film at
different surface pressures showed that even in the uncompressed state (zero pressure) a
n-n stacking distance of -3.9 A between chains was present, which upon compression to
35 mN/m decreased only to -3.85 A. This observation suggests pre-association or self-
assembly of the system before compression which would be expected from rigid rod
molecules.
Polythiophene Poly(phenylene ethynylene) Polyphenylene
Figure 3.1: Examples of extended polymeric backbones.
Poly(/?-phenylenes) have recently been reported with P or NP groups attached as
pendant generation 2 or 3 dendrons.(6) By controlling the architecture of the side
chains, stable monolayers were observed with hydrophilic dendrons and hydrophobic
linear chains, but not in the opposite case when hydrophobic dendrons and hydrophilic
linear chains were studied.(6, 7) Presumably, in the latter case, the size difference
between the hydrophobic dendrons and the hydrophilic linear chains caused the
molecules to be asymmetric and "top-heavy," resulting in an unstable monolayer.
Swager and co-workers studied the effect different substituents had on the
orientation of the backbone aromatic rings to the air-water interface for a series of
poly(/?ara-phenylene ethynylenes).(8, 9) Examples of the molecules studied are shown
in Figure 3.2 with the P side chains shown in blue and the NP shown in green. Most of
these polymers are not FA but this study provided very unique insight on the interplay
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between ehain conformation, stacking area occupied for each conformation, and optical
properties. Langmuir films were investigated by UV-Vis and fluorescence at a variety
of surface pressures to determine whether both aromatic rings were parallel (face-on,
Figure 3.3a), perpendicular (edge-on, Figure 3.3b), or one parallel and the other
perpendicular (zipper structure, Figure 3.3c) to the interface.
,CON(C 8H 17 )2 P(CH2CH 20)3CH 3 CON(C8H, 7 )2 pC 10H2 i
V / \ /
(C8H, 7)2N0C H3C(OH 2CH2C)30 (CeH^No/ H3C(0H 2CH2C)3d
C 10H21O^ ^pCoHa, ^(CHjCHjOfcGHa C, 0H 21O
v
pC 10H 21 pCl0H2 ,
c /
\ /
H3C(OH 2CH 2C)30 H3C(OH2CH2C)30
Figure 3.2: Examples of Swager and coworkers para-PPE molecules designed to
have varying structures at the air-water interface (P groups blue, NP green).
By changing the chemistry of the attached side chains, the orientation of the
aromatic rings relative to the air-water interface was controlled and correlations to UV-
Vis and fluorescence spectra were made. For instance, molecule A in Figure 3.2 prefers
to obtain a face-on orientation to the air-water interface while molecule D prefers an
edge-on structure due to the locations of the hydrophobic and hydrophilic substituents.
The other two structures in Figure 3.2, B and C, are more complicated. Due to the
varying side chains, the conformation at the air-water interface is dictated by the surface
pressure of the system. Under low surface pressures, B will assume a face-on structure
like that shown in Figure 3.3a, but as the pressure increases, the second ring will take on
an edge-on structure making the overall polymer assume a zipper structure. Molecule C
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starts out in a zipper structure with the seeond ring in a faee-on configuration, but as the
pressure increases, the polymer is forced to an edge-on structure like that shown in





Figure 3.3: Different conformations assumed by facially amphiphilic PE polymers
at the air-water interface a) face-on, b) edge-on, and c) zipper.
The experiments described above were all performed at the air-water interface
but molecules with phenylene ethynylene (PE) backbones have also been studied in
solution and the solid state. Figure 3.4 shows meta-VE discrete oligomers with ester
side chains that Moore and coworkers have synthesized. When changing the solvent to
one with a higher dielectric constant, these molecules show cooperative transitions
between the extended and helical structure^ 10) This change was monitored by
measuring the intensities of the UV absorption maxima at 290 and 303 nm as well as
NMR titrations changing from chloroform to acetonitrile. The ultimate result was that
the molecular conformation was mostly helical in acetonitrile. When the same
molecules are studied in the solid state, an extended structure with lamellar packing is
favorable.(l 1) The lamellar packing in the solid state was determined from annealed
samples in glass capillaries using small- and wide-angle X-ray diffraction studies.
Increasing the oligomer chain length caused an increase in the spacing, verifying the
lamellar structure rather than helical packing of the chains. With the addition of a
methyl group in the para position to the ester substituent, the helical structure can be
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Figure 3.5: Amphiphilic/wra-PE molecules studied for blue-green light emitting
diodes.
The molecules studied by Moore and coworkers are not FA, and the study of FA
PE molecules in the literature is much more limited.(13, 14) Amphophilic para-PE
discrete oligomers with hydrophilic alkyl hydroxyl ester side chains were synthesized in
a step-by-step method up to the heptamer, shown in Figure 3.5. The hydroxyl ester side
chain was chosen to ensure solubility and amphiphilic character of the molecules.
These molecules were studied in the powder form as well as deposition of a Langmuir
film onto a substrate. At low temperatures, powder X-ray diffraction shows two sharp
reflections in the ratio of 1 :2 corresponding to a lamellar arrangement with a d-spacing
of 3.87 nm. As the temperature increases, the peaks decrease in intensity and above
1 10°C the peaks are essentially non-existent. These molecules also show lamellar
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structures from deposition of Langmuir films onto surfaces. These well-defined
structures were investigated as blue-green light emission devices due to the conjugation
and molecular organization of the oligomers. While these molecules are FA, they are
discrete compounds with a/rcra-PE backbone. The molecules discussed throughout the
rest of the chapter are polymeric and have meta-PE backbones.
3.2 Langmuir Studies
The ability of the polymers discussed in Chapter 2 to adopt FA conformations
was studied at the air-water interface using a Langmuir trough.( 15,1 6) This technique
entails spreading a dilute solution between a set of barriers at the air-water interface.
After the molecules equilibrate on the water surface, the barriers are slowly compressed
at a rate of 0. 1 648 cm/min until maximum compression. The surface pressure








Figure 3.6: Schematic of Langmuir experiment set-up
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electrobalance. As the barriers compress reducing the available area per molecule, the
molecules begin interacting with one another and the surface pressure increases. By
obtaining the surface pressure-area isotherm, the steepest part of the curve can be
extrapolated to zero surface pressure giving the area occupied per molecule, or in this
case, the area per repeat unit of the polymer. The experimental set-up is shown
schematically in Figure 3.6.






60d OC 5H n 17.8 2.3
61d OC 8H 17 7.73 1.3
62d OC 12H25 10.1 1.4
The polymers studied are listed in Table 3.1. While the polymers vary in
molecular weight, the polymer length does not affect the results since the calculations
take into account the number of repeats per polymer chain. 2 These three polymers were
chosen to investigate the conformation at the air-water interface as well as the effect of
alkoxy side chain length. As shown in Figure 3.3, there are three possible structures for
these polymers at the air-water interface; edge-on, face-on, and zipper structure. Two of
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the polymer conformations, edge-on and zipper, are more probable than the face-on
structure since there is no driving force for the unsubstituted ring to lay parallel on the
water surface. Figure 3.7 shows the pentoxy-substituted polymer in the other two
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Figure 3.7: Conformation of meta-PE molecules as an a) edge on structure and
b)zipper structure.
The pressure-area isotherms for these three molecules are shown in Figure 3.8.
Extrapolation of the steepest part of the curve to zero pressure yields the area per repeat
unit of 41, 42, and 45 A2 for polymer 60d, 6 Id, and 62d, respectively. At a surface
pressure of 38 mN/m, the slope of 60d changes sharply suggesting collapse of the
monolayer into multilayers. (8, 1 7) Films of polymers 61 d and 62d do not collapse at
pressures up to -48 mN/m which likely results from the increased length of the alky 1
side chain. (4, 5, 9) Intuitively, upon packing, there is more contact area between
These calculations are further explained in Section 6.9.1.
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polymer chains as the side chain lengthens, thus, increasing the stability of the
monolayer. These areas per repeat unit are comparable to that of 60d, suggesting all
three amphiphilic polymers adopt edge-on structures similar to that presented in Figure
3.7a as opposed to a structure where the rings assume a zipper structure, shown in
Figure 3.7b. If the polymers assume a zipper structure at the interface, the areas per
repeat units would be much larger, on the order of 100 to 200 A2 . The slope of all three
curves is less steep than observed for many rigid amphiphilic polymers(4-6) but similar
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Figure 3.8: Langmuir data for polymers 60d, 61d, and 62d
Another experiment was performed at the air-water interface to investigate the
reversibility and stability of the monolayer of 60d. The initial set-up of the experiment
was similar to that shown in Figure 3.6, only after the initial compression, the barriers
were slowly uncompressed to their original state and recompressed a second time.
Throughout this experiment, the surface pressure was monitored and the results are
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shown in Figure 3.9. At high surface pressures during the first compression, there is a
change in slope due to folding of the monolayer into multilayers. As the barriers are
relaxed, there is an initial sharp drop in surface pressure slope due to the increase in
molecular area. At an area of about 20 A2
,
there is a change in slope most likely related
to multilayer unfolding as the molecules have sufficient room and experience decreased
pressure so they can relax back into a FA structure at the air-water interface. The
polymer chains can then return to the initial uncompressed state as the area per repeat
unit increases and the barriers fully relax. Upon the second compression, the isotherm
follows a very similar path with limited hysteresis. This small amount of hysteresis is
most likely due to the polymer chains already being somewhat oriented. There is still a
change in slope at very high surface pressures accounting for multilayer formation;
however, it is not as pronounced as the first compression. This could be due to the
organization of the alkoxy chains above the plane of the rings. During the first
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Figure 3.9: Reversible stable monolayer formation of 60d,
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which they start to contact each other and have less room. This forces the side chains to
obtain a more ordered extended configuration which was then retained upon relaxation.
Thus, during the multilayer formation of the second compression, there probably was
reduced entropy loss, which resulted in a less dramatic change in slope.
Fitting the data to an equation of state can provide insight into the limiting
molecular area as well as the degree of polymer association before compression. Rigid
rod polymers, as discussed in Section 3.1, tend to have some pre-association due to the
extended nature of the backbone and favorable interactions between polymer chains.
Table 3.2 shows the analysis of the polymer monolayers according to the equation 1 [(A-
A0)= kT/n(DP) where n is the observed surface pressure for a given area per repeat unit
(A), DP is the average number of repeat units per molecule, k is Boltzmann's constant,
and T is the temperature.( 1 8) The data was analyzed between surface pressures of 1 .4
mN/m and 3.0 mN/m.(l 8) Linear regression gives A0 , the limiting molecular area, and
n, the degree of association, which should be near unity for an ideal gas.
Table 3.2: Equation of state used to determine the limiting molecular area and the
degree of association.
structure DP A0 n R2
60d 53.8 41 42 1.01 0.93
6 hi 27.9 42 42 1.78 0.96
62d 24.2 45 46 1.72 0.95
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Two interesting observations are found from the analysis. First, the values of A0
in Table 3.2 show good agreement with those obtained by simple extrapolation of the
pressure-area isotherms to zero pressure. Second, the degree of polymer chain
aggregation is very small or non-existent before compression which suggests the
polymers form a two dimensional gas-like state at high dilution. Typically, a degree of
association near unity represents a gaseous state while higher values indicate there is
association. Peptides have been shown to have degrees of association near 30.(18) The
degree of association for 60d was determined to be unity, in excellent agreement with a
gaseous state, while that of 61 d and 62d are closer to two. This is consistent with 61d
and 62d containing larger hydrophobic alkyl chains that make the polymers more
hydrophobic, increasing the preassociation. Similarly, the increase in alkyl chain length
from pentyl to octyl does affect the maximum stable surface pressure of the film. From
Figure 3.8, it is observed that monolayers of 61d are stable beyond 48 mN/m while
monolayers of 60d collapse at 38 mN/m. In addition, monolayers of 62d, like those
formed by 61 d, are stable above 40 mN/m. Therefore, it appears that a transition in
monolayer stability and pre-association occurs in these polymers between an alkyl
length of five and eight carbons.
Fitting the second compression data in Figure 3.9 to the equation of state
determines the degree of association of the polymer after the first compression and
relaxation, during recompression. Using the equation the same way as above, the
degree of association is again near unity, 1 .05, suggesting little or no polymer
association in the uncompressed state. This is surprising since the polymer chains are in
contact with each other during the first compression and collapse of the monolayer into
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multilayers. Upon relaxation, the multilayer does unfold but one would assume there
eould still be interaction between individual polymer chains due to the favorable
.
interactions of the backbone. The lack of polymer association before the first
compression is not as surprising since the molecules most likely do not assume a FA
structure in the solution used to spread the polymer onto the air-water interface. This
result suggests that not only is the monolayer stable, but it is fully reversible allowing
the polymer chains to relax into a two dimensional gaseous state at high dilution.
The extrapolated area per repeat unit at zero pressure and A0 for the three
polymers is consistent with an edge-on orientation as shown in Figure 3.7a. Both
geometric and molecular dynamics calculations were used to verify this proposed
structure. The length of the repeat unit in an sXUrans conformation is between 10.8 and
12.1 A and the n-n distance between chains was assumed to be 4 A(19, 20) resulting in
an area per repeat between 43 and 48 A2
. Dynamics calculations were performed with
Materials Studio on two oligomers of four polymeric repeat units each. In these
calculations, the two oligomers were placed in a frame and the energy allowed to
minimize. The only constraint put on the system was the planar structure of the
molecules. These calculations provided an area of 44.7 A2 for 60d, agreeing with the
geometric calculations. The geometric and molecular dynamics calculations are
consistent with the adoption of the edge-on structure shown in Figure 3.7a. Other
orientations with one or both aromatic rings parallel to the interface would produce
areas on the order of -140 and 200 A2
,
respectively. (8, 9)
The experimental and calculated data suggests that the aromatic rings have a
separation distance of 4 A at the air-water interface. It is known that para-PE molecules
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prefer to pack at a slightly off-set angle as opposed to directly on top of each other.(2 1 -
23) At the air-water interface, this slip stacked orientation can occur through two
different mechanisms. Either the aromatic rings can adopt a slightly non-perpendicular
angle with the air-water interface (Figure 3.10a) or by adopting a right angle but sliding
one chain along the water surface, with respect to the neighboring chain, into or out of
the plane of the page (Figure 3.10b). The latter orientation is most likely since it
occupies the smallest area(4, 8) although no direct experimental evidence relating to
these details for either orientation has been obtained.
OO CO
nh 3ci NH 3crNH 3ci
CIH3N CIH 3N CIH3N
Figure 3.10: Schematic representation of aromatic rings at the air-water interface
either a) a non-perpendicular angle or b) slip-stacked.
The structure of this monolayer draws comparison to (3-sheet peptides as a result
of the patterning of P and NP groups onto opposite faces of the structure to produce
amphiphilic plates. Both these polymers and P-sheet peptides have P and NP groups
repeating with a pattern of two along the backbone; however, (3-sheets are held together
by hydrogen bonds oriented parallel to the air-water interface which are replaced in
these systems with n-n interactions between adjacent polymer backbones (Figure 3.7).
The typical distance between backbones in P-sheets is 4.7 A(24-26) compared to
approximately 4.0 A for these polymers.
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3.3 Emission Studies in Solution
Emission studies were used to monitor the fluorescence of the polymer systems
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Figure 3.11: Emission studies of a) 60d and b) 61d in varying solvents.
3.1 la) and 62 (Figure 3.1 lb) in different solvents. Both protected polymers (60p and
62p) have somewhat narrow peaks in chloroform (red curves), indicating that this is a
good solvent for the system. This is not surprising since the polymer before
deprotection is not facially amphiphilic, so an organic solvent can solvate both the
backbone and the side chains. Upon deprotection (60d and 62d), the polymers are no
longer soluble in neat chloroform, but they are soluble in DMSO. The spectra taken for
the polymers in DMSO are shown in green. The peak from 60d seems to be red shifted
with the change in solvent, unlike 62d, but both are the same shape as that of the
protected polymer in chloroform, indicating that the chemical structures of the protected
and deprotected polymers are similar and that there are no structural changes upon
deprotection of the amine by acid treatment. The spectra for the deprotected polymers
in 90% chloroform are shown in blue. For 60d, the spectrum seems to be a combination
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of the protected polymer in chloroform and the deprotected polymer in neat DMSO.
The spectra in the same solvent system lor 62d, is also slightly broader than the
previous spectra and the peak is shifted by about 10 nm. The broadening and shifting of
these peaks highly suggests the presence of multiple conformations as well as some
aggregation in the system. This is expected since the chloroform is not particularly a
good solvent for the amine side chains but is a good solvent for the alkoxy side chains
and the backbone structure. It is preferable for the amine moieties to minimize their
interactions with the increasingly poor solvent through aggregation with other polymer
chain segments.
After determining the initial fluorescence in the system, studies were done to
monitor the association of polymer chains in dilute solution as the percentage of a
nonsolvent was increased. Because Figure 3.1 1 shows that DMSO is a relatively good
solvent for the polymer system, the experiment was begun using neat DMSO. The
emission spectrum was monitored as the amount of water, a poor solvent for the
polymer backbone and alkyl groups, was increased. Figure 3.12 shows the change
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observed in the emission speetra of 62d as the percentage of water is increased. The
concentration of the sample was kept constant in order to directly observe the effect on
quantum yield. It can be seen that the intensity of the emission decreases with
increasing water concentration and the band is broadened and red-shifted.
Figure 3.13 shows a comparison between 60d and 62d for DMSO, 50%
water/DMSO, and 90% water/DMSO, which show the same trends as observed for 60d
as discussed above for 62d. These observations suggest intermodular aggregation of
polymer chains in an extended conformation as the water content is increased and not
the formation of a helix where NP groups fold in the interior while P side chains
solvated.(27) This is supported by the data in Figure 3.1 1 showing that it is unlikely
that the observed changes are related to a change in the dielectric constant since spectra
in CHC13 and DMSO are essentially identical. In addition, calculations for the inner
helix dimensions of meta-?E molecules support that the dodecoxy side chains will
definitely not fit into the center of the helix, particularly since three side chains would
be present in each turn of the helix. The pentoxy side chains might be able to fit in the
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Figure 3.13: Comparison of fluorescence in varying solvents for a) 60d and b) 62d
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and 62d are very similar, these two polymers are most likely adopting similar structures.
Therefore, it is eoneluded that supraocular aggregation of the polymer ehains occurs
as the solvent is changed from DMSO to water.
3.4 Turbidity Studies
After observing aggregation in solution using fluorescence, the aggregates were
studied for size. Light scattering lead to multiple problems since the aggregates were
constantly changing with time and the overall molecular weights of the polymers were
relatively small to study this way. However, the onset of aggregation could be studied
by taking scattering measurements with a UV-Vis spectrometer at 500 nm (OD50o).
These optical densities could then be converted to percent transmittance and plotted
















Figure 3.14: Solution turbidity of polymers at varying concentrations,
66
this technique only looks at the scattering from the polymer in solution. In this
experiment, the polymer was first dissolved in DMSO and added to the aqueous
solutions so the final concentration of DMSO was <5%. The resulting solutions were
allowed to equilibrate until the optical density was steady and data was taken until three
consecutive readings had deviations in the absorbance of less than 0.001.
Figure 3.14 compares not only the effect of alkyl chain length but also the effect
of a buffered salt solution, similar to the media used in antibacterial experiments.
Scattering was not observed in water until the onset of aggregation at 40 ug/mL for 60d,
while in buffer there is visual precipitation at 16 ug/mL. This is expected since buffered
solutions have high salt concentrations, which is known to have an effect on the
solubility of organic compounds. Similar trends were seen for the 61 d and 62d
polymers (not shown). As the alkyl length of the side chain is increased, the turbidity of
the solution is amplified from a transmittance of 97.5% for 60d to 95.3% for 62d at
concentrations of 1 6 ug/mL. This suggests that lengthening the alkyl chain enhances the
hydrophobicity of the polymer, causing a decrease in the solubility and an increase in
the turbidity of the solution. This concept of turbidity is important particularly for
understanding the behavior of the polymers in the buffered solutions used to study the
antimicrobial activity of the compounds discussed in Chapter 4.
3.5 Conclusions
Cationic meta-PE polymers were characterized at the air-water interface using a
Langmuir trough and the results show it is possible to design cationic, facially
amphiphilic polymers by appropriately decorating the backbone with P and NP groups.
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This further suggests that there is no need to design a backbone structure with
conformational control to create molecules that assume facially amphiphilic structures
at the air-water interface. The organization at the interface draws direct comparison
with p-sheet peptides due to the patterning of P and NP groups with a repeat of two and
k-k stacking between polymer chains as opposed to hydrogen bonds found between p-
strands. The solution behavior was also investigated and the results are consistent with
aggregation of the polymer chains and not helix formation.
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CHAPTER 4
ANTIMICROBIAL ACTIVITY OF CATIONIC FACIALLY AMPHIPHILIC
PHENYLENE ETHYNYLENE MOLECULES
4.1 Introduction
The antibacterial activity of host defense peptides is due to the disruption of
bacterial phospholipid cytoplasmic membranes as discussed in Chapter 1 . The literature
supports that this activity is not due to a precise chemical makeup but rather the overall
physiochemical properties such as hydrophobic balance, charge, and facial
amphiphilicity. The previous three chapters showed the design, synthesis, and
characterization of new facially amphiphilic molecules. The following discussion
focuses on the antimicrobial activity of these compounds.
Novel approaches to the development of new antimicrobial compounds and
materials remain an important area of research. Many advances in this research area
report using polymeric backbones and tethering known antibiotics, like ciprofloxacin or
vancomycin, with hydrolyzable groups.(l-3) Another approach is to synthesize novel
inherently antimicrobial compounds. For instance, cationic polymers have been
developed as bioactive compounds,(4) including those containing ammonium(5-7) or
phosphonium salts,(8) polylysine,(9) pyridinium salts,(10, 1 1) or polyguanidines and
polybiguanidines.(12) The cationic nature of these molecules is important due to the
electrostatic interaction of the positive charges of the antimicrobial agents with
negatively charged groups present in microbial cytoplasmic membranes.(13) Polymers
typically have an advantage over conventional small molecule antimicrobial agents
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since they are essentially non-volatile and chemically stable.(13) However, a critical
limitation is that the exact polymer composition is hard to define due to the
polydispersity of the sample. For this reason, it is very hard to obtain FDA approval for
polymers as antimicrobial agents. Many of the compounds synthesized to date do not
show selectivity towards bacteria over mammalian cells, rather they are biocidal
towards all types of cells. 3
HN^O
HQ.S
Figure 4.1: Series of water soluble polymers synthesized by Rivas et al.
Rivas and coworkers synthesized a series of water-soluble cationic polymers
along with a anionic polymer, shown in Figure 4. 1 .(1 3) They investigated the
antibacterial activity against Eschericia coli and Staphylococcus aureus and found that
the anionic polymer did not show any bacteriocidal activity while the polycations were
moderately active against gram-negative bacteria. This corroborated the idea that
electrostatic interactions are important and cationic charges can impart antibacterial
activity. They went on to suggest that the decreased efficiency against gram-positive
bacteria was due to differences in membrane composition; specifically the dense
lipopolysaccharides (LPS) of gram-negative bacteria, as shown in Figure 4.2. LPS are
negatively charged and could potentially attract positively charged macromolecules;
A biocide is a chemical agent, such as a pesticide, that is capable of destroying living
organisms.
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however, they are known to repel hydrophobic molecules. These authors also
investigated the kinetics of bacterial death and determined that within the first 60
minutes, the bacterial count was reduced by 90%. Tests also concluded that the
molecules did not show genotoxic activity 4













Gram Negative Gram Positjve
Figure 4.2: Presence of LPS on gram-negative but not on gram-positive bacterial
cell membranes.
Conventional polymers, such as functionalized polystyrene, have also been
synthesized for potential biocidal activity.(7) Gellman and coworkers synthesized
polystyrene molecules from monomers that were either cationic by virtue of protonation
of a dimethylaminomethyl group or contain a quaternary ammonium moiety (Figure
4.3). The polymer obtained from monomer A (polyA) showed significant biocidal
activity against the four bacteria tested as well as human erythrocytes while the polymer
ofB (polyB) showed essentially no activity against bacteria or erythrocytes. These
authors suggested that reversible N-protonation leads to greater biocidal activity than
does irreversible N-quaternization since polyA is much more biocidal than polyB.
However, they also mentioned that polyB displayed antimicrobial activity in an agar-
A genotoxin is a chemical or other agent that damages cellular DNA, resulting in
mutations or cancer.
73
plate assay but not in the liquid-medium assay which insinuates that polyB is most









Figure 4.3: Monomers Gellman et al. used to synthesize a series of functionalized
polystyrene molecules.
Biocidal cationic polymers can be useful for situations where selectivity towards
bacterial cells over mammalian cells is not required such as in many material
applications. However, in many instances, such as for ingestible or injectable antibiotic
use, selectivity is extremely necessary. Host defense peptides represent a large class of
natural compounds with broad spectrum antimicrobial activity that also show selectivity
for bacterial over mammalian red blood cells (RBC).(9, 14) They have captured the
attention of many researchers because of this selectivity towards bacteria, and now there
is a significant body of knowledge of their essential physiochemical properties.(15-18)
The ability of host defense peptides to disrupt phospholipid membranes,
ultimately killing the cell, is thought to come from the adoption of a facially amphiphilic
(FA) structure. (9, 14, 19, 20) Gellman and coworkers demonstrated this concept by
synthesizing a series of amphiphilic helical structures based on synthetic (3-peptides
(Figure 4.4) which mimic the overall structure and activity of Magainin.(21-23) The
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series of |3-peptides had the same net charge while varying the substitution patterns.(21-
23) The most active peptides were those whose substitution pattern leads to the highest
degree of FA. Therefore, they concluded the FA architecture is important for
antibacterial activity and selectivity, consistent with previous findings from synthetic oc-
peptides.(22, 23)
. 3
Figure 4.4: Chemical structure of an amphiphilic helical peptide that mimics the
structure and activity of magainin.
DeGrado and coworkers have patterned (i-peptide helices to contain charged
lysine and nonpolar side chains on opposite sides of the helix.(24) This patterning leads
to stable amphiphilic structures, which showed antibacterial activity with selectivity
values up to 2. Following further purification of the compound, they report an increased
selectivity value of 1 5.(25) In the same study, a selectivity of 1 80 was obtained by
substituting the more hydrophobic P-valine for P-alanine. From this study, they
suggested that the highly flexible compounds were able to show selectivity values equal
to or better than natural host defense peptide analogs.
Another route to mimicking host defense peptides is the use of a peptoid
backbone. Peptoids are similar to peptide backbones; however the traditional a-side
chain is positioned at the nitrogen, creating a tertiary amide. Due to this altered
chemical structure, all of the hydrogen bonding seen both intra- and inter-molecularly in
natural peptides is eliminated. Peptoids were recently shown to adopt stable helical
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structures with bulky a-chiral side chains (Figure 4.5).(26-28) When these helical
molecules were patterned to adopt FA helices, they demonstrated antibacterial
properties.(29) Similar molecules have shown resistance to proteolytic degradation(30)
and this stability makes this backbone attractive for use in many biological applications.
Ri = benzyl, cyclohexyl, ethyl
+ R2 = benzyl, cyclohexyl
NH 3
Figure 4.5: Peptoids with bulky ehiral side chains that form FA helical structures.
The ^-peptides and peptoids demonstrate the power of coupling design with
function but remain structurally similar to natural a-peptides and mimic the helical
nature of host defense peptides. These peptides also require costly and time intensive
synthetic methods. The extension of design principles to simpler oligomers and
polymers will provide fundamental understanding of structure-activity relationships and
lead to new biologically active materials.
4.2 Polymer Antibacterial Activity
Karly work on polymeric systems as abiotic host defense peptide mimics used
arylamide backbones, shown in Figure 4.6.(31) These systems were designed to mimic
the FA architecture and physiochemical properties of host defense peptides without
necessarily providing a helical structure. They demonstrated broad spectrum activity
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against several bacterial strains, however, these polymers were found to be hemolytic5 at
or near their minimum inhibitory concentration (MIC)6 values.(3
1 ) Additionally, these
arylamide polymers contain amide bonds, lending susceptibility toward proteolytic
degradation. The ability to transfer the essential physiochemical properties to simple
entirely abiotic polymers would provide access to fast, inexpensive antimicrobial
materials for various applications including coatings, medical tubing, and consumer
products.
Figure 4.6: Initial peptide mimics based on arylamide backbones.
Due to the FA nature of the polymers discussed in the previous chapters, these
molecules were tested for biological activity. The polymers shown in Figure 4.7 were
the first set of molecules tested for antibacterial activity. In these polymers, the facially
amphiphilic nature comes from the hydrophobic backbone and alkoxy groups coupled
with the hydrophilic amine side chains. The FA extended conformation is strongly
favored at the air-water interface as seen in Chapter 3. This interface is similar to the
oil-water interface of the cytoplasmic membrane. Specifically, these polymers were
chosen to look at the effect of different hydrophobic side chain substituents and varying
Hemolytic agents lyse red blood cells.
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molecular weights. As discussed in Chapter 1 , both the degree of hydrophobic^ and
the size of the molecule play significant roles in antimicrobial activity. Polymers 63d
and 28d provide a direct assessment at constant degree of polymerization of varying
structure (the presence (63d) or absence (28d) of the pentoxy side chain). Since 63d has
an additional pentoxy side chain on each polymer repeat unit, this structure is
considerably more hydrophobic than 28d. Polymers 28d and 64d, on the other hand,
allow us to examine the effect of varying the number of repeat units while keeping the
molecular structure constant. Polymer 64d is a significantly smaller polymer, with an
average of 6 repeat units per chain as opposed to an average of 20 repeat units in 28d.
R=
-0-«pentyl, n = 20, x = 1 (63d)
R= H, n = 20, x = 2 (28d)
R= H, n = 6, x = 2 (64d)
Figure 4.7: Polymers with amine side chains tested for antibacterial activity,
(CH2 ),
NH 3CI
The antibacterial action of these polymers was measured against both gram-
negative (E. coli) and gram-positive (B. subtilis) bacteria following standard
protocols.(32) The bacteria were grown overnight into the stationary phase, diluted
after 12 hours into the lag phase, and grown for three more hours back into the log
phase. This procedure ensures the bacteria grew correctly and allows the experiment to
be performed with cells already growing exponentially in the log phase. The bacteria
6 MIC as defined here is the minimum concentration of a compound that is required to
inhibit 90% of cell growth.
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were rediluted to an optical density at 600 nm (OD600) of 0.001 and seeded into 96 well
plates. The compound of interest was introduced at various concentrations and the plate
was incubated for six hours, as schematically shown in Figure 4.8. The OD600 was read



























Figure 4.8: Schematic of the MIC test.
It is also important to determine the selectivity of each compound. Selectivity,
measured as the ratio of the hemolytic concentration (HC.so) to MIC90 , indicates how
active a compound is towards bacterial rather than red blood cells (RBCs). This value is
useful when comparing the activities of different compounds. For instance, a compound
that has a lower MIC than a second compound is not necessarily better since it could be
very hemolytic (as designated by a low HC 5o value). Typically, the desired target is a
compound that has a low MIC value and a high selectivity value.
The HC50 is defined as the amount of compound needed to lyse 50% of RBCs.
To determine HC50, the compounds of interest were mixed with human blood for thirty
minutes at 37°C. This incubation was relatively short compared to the six-hour




After the incubation, the remaining intact RBCs were removed by centrifugation. This
did not harm the RBCs as monitored by the hemoglobin release from control sampL
with no active compound. The amount of hemoglobin released due to RBC lysis
monitored in the supernatant by determining the absorbance at 414 nm. To determine
the hemoglobin absorbance with 100% disruption of the RBCs, triton-XlOO was added
to the solution, acting as a surfactant and lysing all the RBCs. The HC 50 was
determined either directly from the experiment at the concentrations of active compound
tested or by extrapolating the data to higher concentrations than those tested.
The results of the antibacterial and hemolytic tests are shown in Table 4.1.
Polymer 63d, the most hydrophobic sample, showed no antibacterial activity up to 100
(ig/mL against either of the two strains, probably a result of low solubility. The lack of
activity and solubility of 63d most likely arises from the hydrophobicity of the pentoxy
chain. Polymers 28d and 64d, which have decreased overall hydrophobicity due to the
absence of pentoxy chains, demonstrated increased solubility and activity. A
comparison of 63d and 28d, which are closest in molecular weight and have the same
degree of polymerization (DP=20), finds that 28d is visibly more soluble in the cell
growth medium and has a MIC of 25 ug/mL (4.6 uM). After finding activity in 28d, we
prepared 64d with smaller overall molecular weight based on the previous arylamide
report suggesting that smaller molecules are more biologically active.(31)
Table 4.1 shows that polymer 64d, with identical structure to 28d, is less active
than 28d at 50 ug/mL (31.2 uM) but significantly more selective. The selectivity is
determined to be 10.8 for polymer 64d. This selectivity compares very well with the
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Table 4.1: Summary of antibacterial activity of polymers with primary amines
+ Molecular weight was determined by THF GPC against PS standards
* This is a discrete compound.
t Average degree of polymerization taken from Mn of GPC.
Molecule Side Chain M n +
IVIIC9Q Qig/mL) Selectivity
DP+ Cj. Lull B. subtitts HC
5(/M1C, ,„„
63d OC5Hn 6800 20 - m N/A N/A
28d H 5400 20 25 25 12.5 0.5
64d H 1600 6 50 100 540 10.8
15 Monomer 315* N/A >100 >100 3400 N/A
Magainin 12.5 120 9.6
as
highly active magainin analog, MSI-78(33), which was determined to be 9.6 against the
same E. coli strain used here. Although the overall antibacterial activity of 64d is not
potent as MS1-78, the selectivity is comparable and the first reported for polymeric
analogs designed as host defense peptide mimics.(34) Finally, monomer 15, which was
used to prepare this polymer, was tested and found to be essentially inactive. No
bacterial activity was measured up to 100 ug/mL and extrapolation of the HC50 curve
provided a value of 3400 ug/mL. Therefore, it is clear from the monomer inactivity and
polymer activity, that the FA design is important for activity.
After determining a relationship between activity and the hydrophobicity of the
polymer, several polymeric derivatives utilizing guanidine groups were synthesized.
The addition of this group was utilized to increase the polymer hydrophilicity. The
resulting polymers (Figure 4.9) have three amine groups per repeat unit in comparison
to one in the previous set of polymers (Figure 4.7). This new set of molecules provides
three additional comparisons. There is now a direct comparison of the influence from
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the number of amine gronps (65d vs. 63d) while keeping the degree of polymerization
constant. It also allows a eomparison of varying the polymer moleeular weight while
keeping the strueture the same (65d, 66d. and 67d). Finally, a eomparison between the




-O-rcpentyl; n = 20, 16, or 7; x = 1
R=H;n= 12, 1 1; x = 2
cih3n NH
Figure 4.9: Polymers with guanidine side chains tested for antibacterial activity.
Table 4.2: Summary of polymer antibacterial activity with guanidine side chains.
The biological activities of these polymers were determined with the same
MIC90 (ug/mL)
Molecule Side Chain M
n
DP E. coli B. subtilis
65d OC5Hn 11400 20 >100 >100
66d OC 5H„ 9300 16 >100 >100
67d OC5H13 4300 7 >100 >100
68d H 6100 12 >100 50
69d H 5600 11 >100 100
* Discrete monomers were active: MIC,,- cW/ =50 ng/mL and 6.6 ^g/mL for H and OC 5H n respectively,
method as described above and the results are shown in Table 4.2. The data indicates
that none of these polymers are active against bacteria up to the highest concentration
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tested, 100 Hg/mL. Higher molecular weight polymers with the pentoxy side chains,
65d and 66d, were insoluble at the higher concentrations tested. Most likely, these
polymers are too hydrophobic to display any antimicrobial activity. Polymers 67d, 68d,
and 69d did not have any solubility problems but still did not show significant
antibacterial activity. The result from 67d is somewhat surprising since it is a relatively
short analog of 63d with the additional hydrophilicity from the guanidine group so it
was expected to show antibacterial activity. One probable reason for the inactivity is a
favorable interaction between the guanidine group and the aromatic backbone rendering
the molecule no longer FA which could also explain the inactivity of 68d and 69d.
Therefore, introducing guanidine groups does increase the solubility of these polymers
but does not improve their antibacterial activities. Interestingly, the monomeric
versions were highly active at 6.6 ng/mL and 50 ^ig/mL for the presence and absence of
the pentoxy side chain, respectively. In this case, the monomers are probably acting as
surfactants which are known to be biocidal towards most living cells.
4.3 Discrete Oligomer Antibacterial Activity
After observing an increase in antibacterial activity as the molecular weight
decreased, Table 4.1, two discrete oligomers, 35d and 34d, were synthesized and their
antibacterial activity monitored, as summarized in Table 4.3. The oligomer with the
pentoxy side chain, 35d, shows no selectivity towards bacteria but rather selectivity
toward human erythrocytes. Visual precipitation of this compound from solution can be
seen in the cell growth medium, suggesting that the very hydrophobic nature of this
compound can account for the lack of bacterial activity. As the pentoxy chain is
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removed, the hydrophobicity is decreased and the desired selectivity is seen. The CO
oligomer, 34d, shows activity against E. coli at 0.8 ug/mL and hemolysis at 75 ug/mL.
This indicates a selectivity of almost 90. which is remarkable for a synthetic abiotic
molecule.
The difference in both the bacterial and hemolytic activities between these two
compounds is not surprising. 35d is significantly more hydrophobic than 34d due to the
presence of two pentoxy side chains. The hemolytic activity of 35d is very high (HC 50
<12.5 ug/mL), suggesting that the overall hydrophobicity of the molecule leads to
interactions with the zwitterionic RBC membrane in order to satisfy the hydrophobic
needs of the molecule when exposed to an aqueous environment. The lack of activity
Table 4.3: Discrete oligomer antibacterial activity.
NH3CI NH3CI
MlC(ug/mL) Selectivity
Molecule X X R E. coli B. Subtilis HC 50 HC 50/MIC,_/(
35d 1 I OC 5H N 25 >100 <12.5 <0.5
34d 2 Br H 0.8 1.7 75 88
toward bacterial cells is most likely due to a combination of insolubility and
overwhelming hydrophobicity of 35d. Once the pentoxy side chains are removed
resulting in 34d, the overall hydrophobicity is significantly decreased and the molecule
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appears to have the proper hydrophobic balance ,o interact with the negatively charged
head groups and the hydrophobic tails of the phospholipids ofthe bacteria, membrane.
4.4 Structure-Activity Relationship of Discrete Oligomers
Since increased selectivity was seen with the small discrete oligomers, a
structure-activity relationship was investigated around the mc,a-VY, backbone using the
bromine end groups, the polar amine groups, and the alkoxy chains as handles.
4.4.1 Modifications at the End G roups
The structures and biological activity of the derivatives with varying end groups
are shown in Table 4.4. These molecules all have the same backbone structure and

































ethylamine side chains as 34d. Since the only structural difference is the end group
moieties, the derivatives can be referenced back to 34d.
The introduction of a propargyl amine group, 36d, increases the charge density
of the molecule and makes the overall molecule more hydrophilic than 34d. This
change decreases the biological activity by a factor of 15 and makes the compound
significantly more toxic, rendering the molecule unselective. The introduction of the
propargyl alcohol moiety, either mono- or di-substituted (37d and 38d, respectively),
decreases the charge density compared to 36d, making it similar in charge to 34d.
These new molecules are more biologically active than 36d, but they are also more
hemolytic. The mono-substituted oligomer, 37d, is more selective than the di-
substituted counterpart, 38d; however neither of these modifications results in the
desired selectivity.
In the above modifications, a new alkyne bond is introduced to the end group.
The addition of this alone would significantly increase the hydrophobicity of the
molecule, however each of these modifications also introduce one or two additional
heteroatoms to increase the hydrophilicity of these molecules. Changing both the
hydrophobicity and hydrophilicity of the compounds at the same time complicates
interpretation of the results. If only the additional heteroatoms were considered, the
trend is as expected: namely as the polarity of the end group is increased, the molecules
become increasingly more biologically active (MIC 37d>38d>36d). However, since the
alkyne adds hydrophobicity, all the molecules become too hydrophobic to show
selectivity towards bacterial cells.
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The introduction of ethylamine end groups, 39d, provides an increase in charge
compared to 34d without the triple bond seen in 36d. The resulting oligomer is more
biologically active than 36d (3.2 ng/mL as opposed to 12 ng/mL) with similar hemolytic
concentrations. This difference could be due to the ethylamine group having greater
conformational flexibility than the propargyl amine. 39d retains selectivity towards
bacterial cells, which is rare amongst the derivatives with end group modifications and
attributed here to the flexibility of the cationic amine end groups.
The last modified oligomer in the set, 40d, is absent of end groups. This
derivative is 4 times less active than 34d which has bromine end groups and about 20
times more hemolytic, resulting in a selectivity of 1 .4. The bromine end groups do not
account for the biological activity since the monomer with bromine groups, 15, is not
antibacterial; however, the size contribution and resulting hydrophobicity from the
bromines as compared to the hydrogen analog might play a role in the activity. The
length of 34d is 17.6 A while 40d is 16.4 A: this slight change in chemical structure
results in a significant change in size.
4.4.2 Modifications at the Polar Amine Croups
The derivatives shown in Table 4.5 are modifications to the P amine group. The
original oligomer, 34d, has an ethyl amine group as the P side chain. The first
modification, 46d, shown in Table 4.5 has a guanidine group on the P side chain,
increasing the overall hydrophilicity. This modification slightly decreases the
antibacterial activity but makes the compound much more hemolytic; however 46d is
still selective towards bacteria over RBCs. The second derivative, 47d, has an amide
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group between the aromatic ring and the e.hylamine P group, increasing the hctcroatoms
in the compound and the hydrophilicity. Surprisingly this modification makes the
compound signilicanlly less biologically active and very toxic to RBCs. 1 lowever, this
could be due to the close proximity of the hydrophilic amide moiety and the
hydrophobic backbone, disrupting the overall FA structure.




























The last two derivatives, 48d and 49d, in Table 4.5 probe the effect of the
number of carbons separating the amine from the aromatic backbone. The original
oligomer, 34d, has two, while 48d and 49d have one and three respectively. It is
88
apparent that the length of the P chain has a great effect on the biological activity.
When the length of the carbon chain is decreased by one carbon, as in 48d, the
compound becomes completely inactive (up to 100 ug/mL) against bacteria and
hemolytic at 150 ug/mL. When the length of the carbon chain is increased to three
carbons, as in 49d, the compound becomes highly toxic towards bacteria (1.6 ug/mL)
and RBCs (3.2 ug/mL). It was unexpected that such a slight change in structure would
have such a dramatic effect; however there are some explanations. In derivative 48d,
the cationic amine is much closer to the hydrophobic backbone, which could disrupt the
FA structure and diminish any biological activity. With the charge closer to the
backbone, the molecule would penetrate the lipid bilayer less in order for the charged
amine group to retain interactions with the negatively charged lipid head groups in the
outer leaflet of the bilayer. In the second derivative, 49d, the carbon chain length is
increased, potentially increasing the overall hydrophobicity which results in a biocidal
derivative.






E. coli B. sublilis HC^MIC,,
Coli
48d 1 >100 >100 150 <1.5
50d 2 >100 >10() 150 <1.5
51d 3 >100 >100 300 <3
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While synthesizing 48d, it was possible to separate the longer oligomers, 50d
and Sid shown in Table 4.6, by eolumn chromatography. These molecules provide
insight into the effect of oligomer length on activity. None of these oligomers were
active against bacteria up to the concentrations tested, but they did show variance in the
hemolytic activity. The shorter oligomers, 48d and 50d, were hemolytic at 150 ng/mL
while the longer oligomer, 51d, was hemolytic at 300 ug/mL. This data suggests that
there is a chain length dependence for biological activity: the longer molecule (n=3) is
significantly less biologically (in this case hemolytically) active than the shorter analogs
(n=l,2). Presumably, if the molecules were soluble at concentrations above 100 ug/mL,
then they would show antibacterial activity with 48d having the most activity and/or
selectivity while 51d would have the least activity and/or selectivity.
4.4.3 Modifications to the Alkoxy Side Chains
The set of derivatives with alkoxy side chains are shown in Table 4.7. The
original oligomer, 35d, had a pentoxy side chain. The first derivative, 58d, has a
methoxy derivative in place of the pentoxy chain. This modification makes the
compound essentially inactive towards bacteria but highly hemolytic. At the higher
concentrations tested, this molecule was not soluble, which could account for its
inactivity. Another reason for inactivity could be due to the addition of the polar
methoxy moiety disrupting the FA nature of the molecule. The second derivative, 59d,
has a guanidine group introduced to the P side of the molecule and the pentoxy chain as
the NP substituent. The bacterial activity of 59d (6.4 ug/mL) is increased compared to
35d (25 ug/mL); however, 59d is still toxic to RBCs, rendering it unselective. This
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change in activity could be due to favorable interactions between the guanidine group
and the aromatic backbone, disturbing the FA nature of the molecule.





E. coli B. subtilis HC 50/MIC£. O)/ ,
35d NH3CI OC5H„ 25 >100 <12.5 <0.5




H„ 6.4 3.2 4.6 0.71
HN NH3CI
Of all the derivatives studied in the structure-activity relationship, the original
oligomer, 34d, remains the most selective compound synthesized and tested. This study
has proven that with this meta-PE backbone, it is difficult to determine which
modifications, if any, will be selective towards bacteria. At this time, the suggestions
given for inactivity are only postulations and cannot be fully explained. In general, the
compounds in which hydrophobicity is solely due to the aromatic backbone are more
active than those with alkoxy side chains. This is most likely due to the alkoxy-
substituted molecules being excessively hydrophobic. Also, the addition of guanidine
groups onto the molecules seems to render the molecule inactive, possibly due to
favorable interactions between the guanidine moieties and the aromatic backbone which
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disrupt the FA nature. Lastly, the addition of alkyl end groups to the moleeules
increases the hemolytic activity of the derivatives. Most of the modifications introduced
more heteroatoms to increase the polarity; however alkyl and alkyne substituents were
also added in the process. Both the variations of the overall hydrophobic balance and
the sizes of the molecules are two factors known to affect the biological activity and
selectivity. Further work to determine the mechanism by which these compounds act on
the membrane could potentially elucidate reasons for inactivity and are discussed in
Chapter 5.
4.5 Probing the Bacterial Activity
Since 34d is the most selective compound out of all the molecules prepared,
several tests were run to probe further the antibacterial activity. These tests included
screening for broad-spectrum activity, determining the minimum bactericidal
concentration, probing the activity in the presence of whole blood, determining the rate
at which the compounds kill cells, and investigating the development of bacterial
resistance.
Table 4.8: Activity of 34d in comparison to Polymyxin B.
MIC90 (ng/mL)
Bacterial Species Gram 34d Polymyxin B
Eschericia coli D31 - 0.8 0.5
Klebsiella pneumoniae ATCC 13883 - 1.7 0.5
Bacillus subtilis ATCC 8037 + 1.7 0.5
Staphylococcus aureus ATCC 25923 + 1.7 13.3
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After determining the activity and selectivity towards two strains of bacteria, E.
coli and B. subttlis, the broad-spectrum activity was investigated. Table 4.8 shows the
strains of bacteria tested against both 34d and Polymyxin B. For comparison
Polymyxin B, a natural bacterium-derived polycationic antimicrobial peptide with a
Table 4.9: Broad spectrum activity of 34d.
Bacterial Species Gram MIC90
( 1 1 0/m J ^
0 1 * •
Selectivity
Enterobacter cloacae ATCC 13047 _ 1.7 44






Klebsiella aerogenes ATCC 35150 3.4 22
Klebsiella pneumoniae ATCC 1 3883 - 1.7 44
Moraxella catarrhalis ATCC 25240 0.8 94
Neisseria sicca ATCC 29256 - 3.4 22
Proteus vulgaris ATCC 13315 - 3.4 22
Proteus mirabihs C20 - 12.1 6
Pseudomonas aeruginosa ATCC 10145 - 3.4 22
Pseudomonas stuartii C3S - 12.1 6
Salmonella typhymurium ATCC 2963
1
- 3.4 22
Serratia marcescem ATCC 43861 - 3.4 22
trancisella tularemia ATCC 17135 • 1.0 75
trancisella tularensis ATCC 17137 1.0 75
uULUlUS unirlrut IS Al LL 1UW + l.O 75
Bacillus cereus var. mycoides + 1.7 44
Bacillus globigii ATCC 9372 + 3.4 22
Bacillus subtilis ATCC 8037 + 1.7 44
Enterococcusfaecalis ATCC 19433 + 0.8 94
Listeria monocytogenes ATCC 35152 + 1.7 44
Staphylococcus aureus ATCC 25923 + 1.7 44
Staphylococcus epidemidis ATCC 155 + 0.8 94
Staphylococcus saprophytics ATCC + 0.8 94
Streptococcus agalactiae ATCC 13813 + 0.4 188
Streptococcus gordonii ATCC 33399 + 1.7 44
93
long hydrophobic tail, was added as a control antibiotic and the results corroborated
those reported in the literature. Polymyxin B is derived from strains of soil bacteria
Bacillus polymyxa and is usually used to treat infections of gram-negative bacteria. The
activity of 34d is comparable to that of Polymyxin B for several strains and even better
against S. aureus, a gram-positive bacterium. 34d has the advantage of being broad-
spectrum against both gram-positive and
-negative bacteria while polymyxin B is
mainly used to treat gram-negative infection.
Table 4.9 shows results of further testing 34d against several other strains of
bacteria including both gram-positive and gram-negative bacteria as well as several
antibiotic-resistant strains. With an average MIC of 2 ug/mL. this compound was
bactericidal against most organisms tested. The highest effective concentration of 34d
tested was 12.1 ug/mL, with weakest activities against Proteus mirabilis and
Pseudomonas stuartii while the lowest activity was 0.4 ug/mL against Streptococcus
agalactiae. Compound 34d potently inhibits the growth of several important human
pathogens including Listeria monocytogenes1
,
Pseudomonas aeruginosa8 and
Staphylococcus aureus.9 It also inhibits the growth of the bacteria, Enterococcus
7
L. monocytogenes is a food-born pathogen which causes flu-like symptoms which can
lead to serious infections and even miscarriages in pregnant women.
P. aeruginosa causes various systemic infections including urinary tract, respiratory,
bone and joint, as well as dermatitis, especially in immunosuppressed people. It is a
particular problem in hospitals where it accounts for more than 10% of all hospital-
acquired infections.
S. aureus causes a variety of pus-forming infections as well as toxinoses. These range
from skin infections like boils and styes to more serious infections such as pneumonia
and meningitis. It is also a problem in hospitals where it causes infections in surgical
wounds and medical device implants such as catheters.
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faecalis and Salmonella typhymurium, which are known to resist the action of
antimicrobial peptides. Potent activity is also shown against the pathogens Bacillus
anthracis and Francisella mlarensis which are both known possible bioweapons and
currently monitored by the CDC.
arc
With the broad-spectrum activity of 34d, the minimal bactericidal concentration
(MBC) was investigated. The MBC is defined as the concentration of the active agent
needed to kill 99% of the bacteria as opposed to the MIC which is the concentration
needed to inhibit bacterial growth. Commonly, the MBC of natural host defense
peptides is between two and four times the MIC.(35) In order to determine the MBC,
bacteria were grown in the presence of 34d for six hours, diluted, and then plated on
agar dishes and grown for 24 hours. A small aliquot of the bacteria growth media was
removed after six hours and visualized with a microscope, shown in Figure 4.10. Figure
4.10a shows the control for normal bacteria growth without the addition of 34d. Figure
4.10b shows an aliquot from the experiment with a concentration of twice the MIC.
Qualitatively, it can be seen that there is significantly less bacteria when the active
compound is present.
Figure 4.10: MBC test under the microscope after 24 hours, a) control b) 2MIC.
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After diluting and plating the experiments on agar, bacterial colonies were
grown overnight and quantified. Figure 4.1 1 shows pictures of the bacterial growth on
the control plate and at two concentrations of 34d, the MIC and twice the MIC. Full
bacterial growth, Figure 4.1 la, shows significant colony formation, as expected. The
experiment performed at the MIC, Figure 4.1 lb, still shows bacterial growth, however
there are 50% less colonies present when compared to the control plate. 10 This was
expected since the bacteria have more time (24 hours) to grow than in a typical MIC
experiment (6 hours). Regrowth of bacteria was also seen at the MIC if the experiment
continued for a longer amount of time since the bacteria was only inhibited and not
killed. At twice the MIC, Figure 4.1 lc, there were only a few colonies, representing
more than 99% reduction in bacterial growth. This concentration, twice the MIC,
thus be designated as the MBC. These results highly suggest that at the MIC, 34d
simply bacteriostatic, inhibiting bacterial growth, while the MBC is bacteriolytic,
destroying and lysing the bacterial cells.
can
Figure 4.11: Pictures of the experiment confirming that MBC is twice the MIC. A)
control, B) MIC, and C) 2MIC.
10
Further diluted samples from the liquid experiments were plated on agar and allowed
quantification of the number of colonies formed at each concentration of 34d.
96
While hemolytic assays confirmed the selectivity of 34d, the activity might
decrease if it becomes unavailable for interactions with bacterial cytoplasmic
membranes due to the presence of excess of mammalian cytoplasmic membranes or
other compounds present in whole blood. Based on this assumption, the potential for
saturation kinetics was tested by comparing preincubation versus coincubation
variations of drug, bacterial target cells, and fresh human blood. Briefly, this
experiment was set up in the same way as the MIC experiment, only with the addition of
1% final volume of whole blood. There were three experiments investigated. The first
included mixing blood, bacteria, and 34d together to give the active compound equal
opportunity to act on either the RBC or bacterial membranes. The second experiment
mixed blood and 34d for 30 minutes before introducing bacteria, which allowing the
active compound time to become inactivated by the presence of RBC membrane before
introducing the bacteria. The third experiment mixed the bacteria and 34d for 30
minutes to allow the active compound to interact with bacterial membranes before
introduction ofRBC membranes.
*- Blood, bacteria, and 34d
-m- Blood and 34d
* Bacteria and 34d
2 3 4 5 6 7
concentration (pg/ml_)
Figure 4.12: Whole blood experiment with E. coli showing that 34d is not
inactivated in the presence of red blood cells.
97
Repeated experiments with both gram-negative (E. coli, Figure 4.12) and gram-
positive (B subtilis, data not shown) strains indicated that 34d is not inactivated in the
presence of excess eukaryotic cytoplasmic membrane or against the background of a
rich biological matrix such a whole blood. All three experimental variations resulted in
greater than 90% reduction of cell growth at the respective MIC concentrations (0.8
ug/mL for E coli and 1
.6 Lig/mL for B subtilis) for both bacterial strains. Thus, 34d
does not appear to be inactivated in the presence of whole blood during these
experiments.
Time-kill experiments show bactericidal kinetics indicating that short exposure
times are sufficient for complete activity, similar to host defense peptides, where at
concentrations 4-fold higher than the MIC kill up to 99.999% of the bacteria within 5
minutes.(35) In this experiment, the bacteria were exposed to 34d for the specified
periods of time and the amount of bacteria remaining was quantified. Figure 4.13
shows the results for B. subtilis. This experiment was also done with E. coli to show
that the kinetics are not strain specific. A concentration dependent susceptibility is
obvious: both the MIC and twice the MIC producing a continuous decrease in the
number of surviving cells within the first few minutes and continuing over the full
thirty-minute experiment. At concentrations of half the MIC, the bacterial growth was
significantly hindered compared to the control experiment but not inhibited. The rapid
reduction in the viable count as observed here is a characteristic feature of membrane
permeating agents.(9) This shows that even at low concentrations, 34d still effects
bacterial growth. Continuous incubation showed regrowth of these samples over 24
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hours. This is not surprising since there is a limit to the quantity of bacteria exposed to
34d before an increase in MIC is observed. Early experiments have shown that even a
ten-fold increase in the initial amount of bacteria rendered the active compound
"inactive" suggesting that there is a specific ratio of compound to bacteria needed for
activity. The amount of bacteria used in this experiment is 100-fold more than the
















Figure 4.13:Kinetic Studies with B. subtilis and 34d.
To experimentally measure the ability of bacteria to develop resistance to 34d,
both S. aureus and E. coli were exposed to sublethal concentrations of 34d. After
exposure for 24 hours, the MIC was determined and any change in the value was noted.
This process was continued for 26 days. This dilution method is commonly used in
industrial settings and is the standard accepted in the literature.(36-38) The positive
controls used in this experiment are ciprofloxacin for E. coli and penicillin for S.
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aureus, two antibiotics towards which these bacteria readily develop resistance. The
development of resistance is indicated by a progressive increase in the MIC value over
time.
25 30U 5 10 15 20
Time (days)
Figure 4.14: Resistance studies with S. aureus.
The results for S. aureus are shown in Figure 4.14 and similar results were
obtained for E. coli (not shown). The MIC of the control, penicillin, increased over
time. After three days of exposure, the MIC doubled as the bacteria started to develop
resistance to the commercially available drug. At the end of the experiment, the bacteria
developed significant resistance towards ciprofloxacin, as indicated by the 8-fold
increase in MIC. When exposed to 34d, the bacteria did not show any change in
susceptibility. This is a very important and promising result, suggesting a very low
likelihood of resistance developing upon longer exposures. Even though resistance to
HDPs is not extensively reported, there is evidence that some resistance results from a
reduction of the net negative surface charge on bacterial membranes.(39-43) This
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decreased net negative eharge eould induee resistance against meta-?E molecules, but
they will not be susceptible to other mechanisms of antibiotic resistance such as
proteolytic degradation (see Section 1
.6).
4.6 Prevention of Biofilm Growth
There has been several reports of antimicrobial agent incorporation into
polymeric substrates(44-47), most of which discuss the prevention of biofilm growth on
a substrate over a specified length of time while the active agent leaches out. In order to
look at the prevention of bacterial growth on a surface, 34d was incorporated into
polymer plugs of either polyurethane (PU) or polyvinyl chloride) (PVC). These
samples were prepared by making polymer plugs at the bottom of glass vials. In the
case of PU, the polymer was a viscous liquid and a solution of 34d could easily be
mixed with the polymer. Upon moisture curing, the mixture formed a hard plug. To
make the PVC samples, catheter tubing was dissolved in THF and then mixed with 34d.
Upon evaporation of the solvent, an opaque plug was formed in the vial. In both cases,
34d was introduced as 5% by volume; for every 1 mL of polymer solution 50 uL of 34d
(2 mg/mL in DMSO) was added. 1
1
This strategy incorporates 0.05 and 0.008 wt% 34d
into PVC and PU, respectively. The prepared vials were then inoculated with S. aureus
and the bacterial growth on the surface was monitored.
To make sure that 34d was incorporated within the polymer plug, some surfaces were
rinsed with DMSO to remove any adsorbed 34d. The plugs that were rinsed compared
to plugs that were not rinsed showed no difference in antibacterial activity, indicating
that 34d is most likely incorporated into the plug.
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With the PU samples it was possible to determine the number of living cells by
using a dye that becomes UV active (red) when metabolized by cells. The difference in
absorption between solutions with and without living cells can be quantified. After
incubation and before dye addition, the media was fully changed to monitor only the cell
growth on the surface and not that in solution, since there was significant cell growth in
the supernatant. One potential problem with this experiment is that it does not account
for the bacteria adhered to the vial wall left behind during the media change.
Pictures of the bacterial growth in the supernatant can be seen in Figure 4.15a.
The supernatant of both the control and the treated sample have similar turbidities.
Pictures of the PU sample vials after media exchange are shown in Figure 4.15b. The
control sample, a plug with no incorporation of 34d, shows significant bacterial growth,
as shown by the deep red color of the vial on the right of Figure 4. 1 5b. The treated
sample, far left sample in Figure 4.15b, still retains the yellow color of the media
indicating a reduction in cell adhesion and growth on the PU surface in comparison to
the control sample. This is a significant finding indicating that even with a bacteria-rich
supernatant, attachment and growth on the PU surface is prevented.
1
Figure 4.15: Biofilm growth experiment with PU. A) Sample vials before media
exchange, B) Sample vials after media exchange. In both cases, the control sample
is on the far right and the treated samples on the far left. In A) the middle sample
is an uninoculated
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Upon investigating the PU surfaces under a microscope, Figure 4.16, significant
bacterial coverage is seen on the control sample (Figure 4.16a), while the bacterial
growth on the treated sample (Figure 4.16b) is sparse. These samples were treated with
a live-dead stain to increase the visualization of the cell colonies. The green dye is
small so it can be taken up into both living and dead cells. However, the red dye is large
and can only be taken into the dead cells, which have more permeable membranes.
From these pictures, it is clear there is a reduction in bacterial film formation on the
treated PU samples that corroborates the experiment discussed above with the metabolic
dye: the incorporation of 34d into a PU plug can prevent bacterial adhesion even when























Figure 4.16: Polyurethane studies with biofilm growth A) Untreated (significant
bacterial adhesion) B) Treated (minimal bacterial adhesion)
This experiment was also performed with PVC samples prepared as stated
above. These samples were more challenging than the PU samples since the plugs often
floated in the cell media making the use of the metabolic dye to determine cell surface
adhesion very tricky. Pictures of these vials are shown in Figure 4. 1 7. The untreated
sample (Figure 4.17a) shows full bacterial growth as determined by the turbidity of the
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cell growth media above the plug. The treated sample (Figure 4. 1 7b) has an optically
elear supernatant suggesting no bacterial growth. Examining the media under a
microscope suggests there are no cells present and even with further incubation of the
samples, no cell growth is observed. This result highly suggests full reduction in
bacteria present in the media.
Figure 4.17: Catheter tubing with 34d incorporation a) untreated sample b)
treated sample.
Table 4.10: Summary of prevention of bacterial adhesion to polymer plugs.
Reduction in Cells (%)
Substrate Untreated 5% v/v 34d (wt%)
PVC 0 99 (0.05)
PU 0 80 (0.008)
The data for the PU and PVC samples discussed above is summarized in Table
4. 1 0. Incorporation of 34d into both substrates tested prevented more than 80% of the
bacterial growth when compared to the control samples. However, when probing the
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was
long-term activity of these samples, the question of 34d leaching from the plugs
raised. To investigate this, an experiment was done exposing the plugs to water for
different periods of time at 37°C. Then HPLC was used to monitor the increase of 34d
in the water over time. This experiment was performed over 120 hours and the results
are shown in Figure 4.18. It can be seen that significant leaching of 34d occurs after 70
hours. This is not surprising since 34d is a charged molecule and the PU plug offers a
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Figure 4.18: HPLC leaching experiment (three different polyurethane plugs).
The shape of the curve suggests that during the first several hours the active
compound is leaching at an extremely slow rate, after which the rate significantly
increases until it levels off after 70 hours. When analyzing this data as mass at time t
(M(t)) versus the square root of time (Figure 4. 1 9), the shape of the plot suggests that
release at the initial time points is governed by something other than simple diffusion of
the active compound. This is most likely due to the initial swelling by water of the PU
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plug at early times. Initially, the plug is hard and glassy but at the end of the experiment
it is soft and swollen. This behavior is characteristic of Case II diffusion, where there
plug needs to be swollen by water initially to induce leakage of 34d. The active
compound is not initially solvated in the hydrophobic polymer plug so it cannot easily
diffuse out. When the water begins to swell the plug, it also solvates the oligomer and
promotes leaching. This swelling process most likely happens during the first several


















Figure 4.19: Leaching experiment data replotted. Notice the change in slope after
the initial portion of the experiment.
Leaching of the active compound suggests that the bactericidal action may occur
due to solubilization of the active compound. Leaching continued during the exposure
time of 24 hours for the above experiments. Currently, we are investigating the
reintroduction of an inoculated supernatant to see if there is still prevention of bacterial
adhesion after full leaching of the active compound. The apparent leaching of the active
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compound is not detrimental to the use in biomedical devices, such as catheters, because
often the desired time period for antibacterial activity is between 24 and 48 hours.
4.7 Breast Cancer Cell Activity
The activity of 34d against breast cancer cells was investigated, since the
phospholipid composition of cell membranes of cancer cells has a slight excess of
negatively charged molecules (3 to 6% as opposed to the 10% for bacterial cells).(48)
This change in membrane composition was investigated as a handle to target cancerous
cells over non-cancerous cells. In this set of experiments, the activity of 34d against
two human breast cancer cell lines, MCF-7 (ATCC HTB-22) and TMX2-28, and one
non-cancerous breast cell line, MCF-10A (ATCC CRM 03 17), was investigated. The
cells were grown in media supplemented with 5% bovine growth serum using standard
techniques. In short, the cells were seeded in flasks and allowed to incubate at 37°C
with 5% C02 . After growing to 50% confluence, the cells were removed from the
flasks using trypsin. The trypsin was then removed from solution by centrifugation and
the cells were resuspended into fresh medium. Sterile 96 well plates were seeded at a
density of 10,000 cells/well and allowed to grow overnight yielding 50% confluence.
The molecules were then added to solution and allowed to further incubate for 48 hours.
A dye that becomes optically active upon being metabolized was used to determine the
number of cells in each well.
Table 4.1 1 shows the activity of 34d against the three cell lines. When tested
against the cancerous cell lines, MCF-7 and TMX2-28, 34d inhibits growth of 90%
(IC90) of the cells at 6.3 u.g/mL but starts negatively affecting cell growth at
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Table 4.11: Activity of 34d against three different eukaryotic cell lines. It can be
seen that there is selectivity towards the cancerous cell lines over the
cancerous cell lines.
non






MCF-7 cancerous 6.3 0.5
TMX2-28 cancerous 6.3 10.5
MCF10A non-cancerous 12.5 21.0 N/A
concentrations as low as 1 .6 ug/mL. Against MCF-10A cells, the IC% is 12.5 ug/mL.
This shows that there is a selectivity of 2 towards cancerous breast cells over non-
cancerous breast cells. It can be hypothesized that this selectivity comes from
differences in the phospholipid composition of the cell membrane between cancerous
and non-cancerous cells. This activity against normal breast cells is not dependent on
eukaryotic cell origin because similar activity is seen against HEPG2 cells, a strain of
normal liver cells. Though the selectivity results for eukaryotic cells are not as
promising as those for prokaryotic cells, these findings provide a nice starting point for
developing novel anti-cancer drugs.
4.8 Conclusions
The biological activity of several meta-PE polymers and discrete oligomers was
probed, and results showed that selectivity towards bacteria could be accomplished with
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these simple struetures. Several subtle modifkations to the chemical structure resulted
in dramatic biological differences. Small polymeric samples were as selective as the
natural peptide analog, Magainin, with discrete oligomers proving to be most selective.
The best discrete oligomer, 34d, showed broad-spectrum antibacterial activity as well as
activity towards breast cancer cells. Material incorporation of34d within PU and PVC
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PROBING THE MECHANISM OF ANTIBACTERIAL ACTION
5.1 Introduction
Many host defense peptides exert their antimicrobial action through
permeabilization of cellular membranes. Antimicrobial agents can distinguish between
host and invader cells because of the distinct nature of their cellular membranes. The
exact mechanism of action for host defense peptides against invader cells remains
debated in the literature. There are three general mechanisms of membrane disruption
discussed: the carpet, barrel-stave, and binding mechanisms.
The carpet mechanism suggests that the antimicrobial agent aggregates onto the
membrane, parallel to the surface, forming a "carpet" as the concentration increases.! 1
,
2) This aggregation ultimately causes the membrane to thin and rupture, killing the cell
In the barrel-stave mechanism, the membrane-active compound forms stable trans-
membrane pores via self-assembly, which lead to uncontrolled transport of ions and
small molecules across the membrane, resulting in cell death.(3, 4) The third
mechanism of disruption involves the binding of cationic amphiphilic molecules to the
outer layer of the membrane. This binding is highly favored because exposure of
hydrophobic segments to the aqueous solution is decreased, resulting in an increase of
pressure on the outer leaflet of the bilayer. The unequal pressure between the outer and
inner bilayer causes the membrane to rearrange, creating transient holes in the cell
membrane that results in cell death.(5)
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Peptide concentration is known to have an effect on the mechanism of action.
For instance, I lancock and coworkers have shown that virtually all cationic amphiphilie
peptides cause severe membrane disruption ifhigh enough concentrations are
administered.(6) In order to study the relevant mechanism of action at the MIC, it is
important to carry out experiments at or near this concentration. One of the most
common and convenient ways to study mechanistic action involves the use of isolated
lipid membranes made from pure or mixed lipids. It is important to note that it is
difficult to establish whether the effectiveness against model membranes is biologically
relevant to living cells, since artificial membranes fail to capture many biological
features such as lipid heterogeneity and the presence of membrane proteins. This is
further explained in the following section. I Iowever, lipid membrane studies provide an
important starting point for establishing the mode of action.
5.2 Phospholipid Structure and Membrane Properties
Phospholipids are one of the major constituents that compose cellular
membranes. Each phospholipid is composed of a hydrophobic fatty acid tail and a
hydrophilic head group. This is shown schematically in Figure 5.1a. The composition
of both the phospholipid head group and fatty acid tail can vary widely. Generally, the
fatty acid tail made up of a long carbon chain between C14 and C 2o, can either be
saturated or unsaturated, figure 5.1 b shows the chemical structure of
phosphatidylcholine, a phospholipid with a saturated C15 carbon chain and an
ethylamine group attached to the phosphate head group. The amphiphilie property of
lipids makes them ideal structural components of membranes since in aqueous solution
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they aggregate into a bilayer structure with the hydrophobic portions inside the bilayer
and the hydrophilic moieties toward the aqueous intra- and extra-cellular environments
The bilayer structure serves as an important permeability barrier to the diffusion of
substances into or out of the cell. This membrane is a thin structure, about 8nm thick,
which completely surrounds a cell. If this membrane is broken, the integrity of the cell










Figure 5.1: a) Schematic representation of a phospholipid, b) Chemical structure
of phosphatidylcholine.
An important characteristic of cytoplasmic membranes is their fluidity. The
lipid bilayer can be thought of as a two-dimensional fluid in which the lipid molecules
are free to move laterally but individual molecules are normally constrained to their own
monolayer.(7) The cell does produce enzymes called phospholipid translocators which
catalyze the rapid flip-flop of specific phospholipids from one monolayer to the other,
but this specialized process does not happen arbitrarily. The fluidity of the bilayer
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depends on its composition and temperature. Lipids have a phase transition temperature
at which the bilayer changes from a fluid state to a more rigid crystalline state and this
temperature depends on the length and saturation of the hydrocarbon tail. Bacterial cells
can maintain their fluidity as the environment changes by synthesizing different lipids as
necessary.(7)
Another factor influencing membrane fluidity is the presence of membrane
stiffening agents such as sterols and hopanoids. These are rigid planar molecules that
make up 5-25% of the total lipids in eukaryotic cells, less in prokaryotic cells.(7, 8) In
fact, cholesterol can be found in mammalian membranes at concentrations up to one
molecule for every phospholipid molecule.(8) The strengthening of the membrane
occurs due to the immobilization of the first few CH2 groups of the hydrocarbon chains.
This also makes the bilayer less deformable in the region near the lipid head groups,
decreasing the permeability of the bilayer.
In both prokaryotes and eukaryotes the overall structure of the cytoplasmic
membrane is similar, although there are some key chemical differences.(8) The
chemical differences come from the types of lipids as well as the other membrane
components such as proteins and strengthening agents as discussed earlier. In general,
there are four major phospholipids found in mammalian membranes (head groups are
shown in Figure 5.2): phosphatidylethanolamine (PE), phosphatidylserine (PS),
phosphatidylcholine (PC), and sphingomyelin. In addition, phosphatidylglycerol (PG) is
another lipid primarily found in bacterial membranes. Notice that both PS and PG carry


























Figure 5.2: Chemical structures of lipid head groups.
Table 5.1: Approximate lipid compositions of different cell membranes. Numbers
are percentage of total lipid by weight
Cell Cholesterol PE PS PC PG Sphingomyelin Glycolipids Other
RBC 23 18 7 17 0 18 3 13
E. Coli 0 75 trace 0 20 0 0 5
Table 5.1 shows approximate lipid compositions of the membranes of red blood cells
and E. coli.il) The red blood cell, a eukaryotic cell, is made up of similar amounts of
PE, PC, and sphingomyelin with some PS while E. coli is mostly PE. PG is found at
varying concentrations in bacterial cells depending in species and growth conditions, but
in general, it is roughly 20%.(9, 10)
An important factor to recall from Chapter 1 is that the lipid bilayer of
mammalian cells is asymmetrical while bacterial cell membranes are nearly
symmetrical. In the red blood cell membrane, almost all the lipid molecules that have
choline in the head group (PC and sphingomyelin) are in the outer leaflet of the
membrane while almost all of the phospholipid molecules that contain a terminal
primary amino group (PE and PS) are in the inner membrane. Because the negatively
charged phospholipid, PS, is only found in the inner leaflet, there is a difference in
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charge between the two leaflets of the bilayer resulting in the neutrality of the outer
bilayer. This difference between the neutral and negatively charged outer leaflets of red
blood cell membranes and bacterial membranes, respectively, can lead to selectivity, as
discussed in Chapters 1 and 4.
5.3 Uses of Vesicles in the Literature
Previous studies have described the use of synthetic lipid membranes, or
vesicles, to assess the extent of amphiphilic molecule membrane activity.(l 1-15) The
experiments reported suggest that an appropriate lipid composition contains negatively
charged lipids mixed with zwitterionic lipids to mimic the charge distribution of
bacterial membranes. These lipid vesicles are made via rehydration of lipid films,
resulting in unilamellar vesicles which can then be utilized to monitor membrane
activity. There are three common experiments established in the literature using
vesicles; encapsulation of a fluorescent dye, lipid flip-flop, and peptide translocation.^)
By incorporating a fluorescent dye inside vesicles, the extent and rate of
membrane disruption can be investigated.(16-18) Calcein is commonly used since it
self-quenches at high concentrations (inside the vesicle) and fluoresces (^ex= 490 nm,
X,em=515 nm) upon leakage from the vesicular membrane. This is shown schematically
in Figure 5.3. In general, an increase in the rate of dye leakage over time due to the
addition of antimicrobial peptides is directly related to the increase in the concentration
of the peptides. At low concentrations of peptide, less than 100% of the dye is released
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Figure 5.3: Pictoral representation of vesicle leakage experiment.
The above experiment can further probe membrane activity by incorporating two
dyes encapsulated within the same vesicle.(19) By using two different size dyes, the
selectivity of dye release can be monitored. While calcein is considered to be a
relatively small dye (MW = 622), fluorescently tagged polymers up to molecular
weights of 70,000 can be used as the larger dye. This experiment is shown
schematically in Figure 5.4. The smaller of the two dyes will be released with any
membrane permeabilization, as in the experiment above, however, the larger of the two
# •
Pore formation Detergent-like action
Figure 5.4: Schematic of vesicle pore formation vs. detergent-like action
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dyes will only be released upon complete destruction of the membrane (detergent-like
action). This size selective leakage can be used to investigate pore-formation or
detergent-like action against the membrane.
quencher w
Figure 5.5: Schematic of lipid movement experiments a) symmetrically labeled
vesicles, b) asymmetrically, c) symmetrically labeled vesicles.
The second vesicle experiment, pioneered by Matsuzaki and coworkers,
monitors lipid flip-flop induced by cationic peptides, shown in Figure 5.5.(20) Vesicles
are dynamic systems where the lipids are in motion and have the ability to move within
a monolayer leaflet relatively fast. This lateral diffusion occurs with a diffusion
coefficient of about 10"8 cm2/sec, which means that the average lipid molecule diffuses
the length of a large bacterial cell (~2 urn) in about one second.(7) On the other hand,
movement between the membrane bilayers is usually slow, on the time-scale of hours or
days, due to the unfavorable passage of a hydrophilic head group across the hydrophobic
membrane core.(15) Depending on the lipid, it has been shown that this process occurs
less than once a month for any individual molecule.(7) However, the addition of certain
antimicrobial peptides has been shown to induce rapid lipid flip-flop across the
membrane.(15, 18, 20, 21) One hypothesis is that this lipid movement, or flip-flop, is
indicative of pore formation across the bilayer, as in the barrel-stave mechanism.(20)
Another hypothesis is that after the peptides reach a sufficient concentration, they insert
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into the membrane forming informal aggregates containing both peptides and lipids that
span the membrane. The collapse ofthese channels would permit lipid translocation
aeross the membrane as observed in lipid flip-flop experiments^ 1 5)
A third vesiele experiment, often performed to look at cationic peptide-
membrane interactions, is the measurement ofpeptide translocation.^), 20) These
assays monitor the uptake and enzymatic digestion of peptides in unilamellar vesicles,
as shown in f igure 5.6. In these experiments, tryptophan residues on the peptide
interact with dansyl groups on the lipid head groups within the membrane, showing an
initial increase in lluorescence upon peptide binding. If the peptide is translocated
across the membrane, it is digested by an enzyme encapsulated in the vesicle resulting in
desorption of the peptide from the bilayer and a decrease in dansyl lluorescence. Since
this requires the presence of tryptophan groups on the active compound, it cannot be
utilized with our system.
Pr= protease that digests peptide after translocation
Figure 5.6: Schematic of peptide translocation
Monitoring the interaction of host defense peptides with vesicle membranes,
provides an introduction to the understanding of the mechanism of antibacterial action,
but as staled above, the results might nol be entirely biologically relevant. Examining
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the interactions with intact bacterial cells can provide more realistic insight into the
method of cell disruption. This can be accomplished by doing a cytoplasmic membrane
permeabilization experiment with living cells.(22-27) Here, cells are induced to uptake
a lipophilic dye into the cytoplasmic membrane due to the membrane potential; the dye
self-quenches upon aggregation within the membrane. The dye is released from the cell
upon addition of membrane active compounds which permeate and disrupt the
cytoplasmic membrane. The increase in fluorescence can then be monitored over time.
There are varying degrees of activity of cationic peptides in this type of
expenment.(22-24, 28) Hancock and coworkers demonstrated that the a-helical
peptide CP-29 permeabilizes the membrane of£ coli maximally at the MIC while a
close homologue, CP-26, does not cause dye release at the MIC.(24) In general, many
peptides require four to ten times the MIC concentration to have a depolarization effect
on the membrane and cause dye leakage in this experiment. Polymyxin B, a cationic
peptide, is an extreme case: it permeabilizes the P. aeruginosa membrane only at 50-
fold the MIC.(29)
The previous chapters have discussed a series of meta-PE molecules that mimic
the FA structure and biological selectivity of host defense peptides. This chapter
explores the mechanism of cell membrane disruption that ultimately results in cell
death. Vesicles have been a successful tool in investigating membrane activity of many
different peptides and several of those experiments have been repeated with the meta-
PE molecules discussed in Chapter 2. There is left a great deal of work to determine the
exact mechanism, and additional future experiments are discussed throughout the
chapter.
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5.4 Monitoring Membrane Activity of Cationic FA Molecules on Vesicles
As discussed in Section 5.3, vesicles can be used as cell membranes mimics to
determine membrane activity of antibacterial compounds. Varying the phospholipid
content of vesicle membranes has been used to mimic different types of cells. For
instance, mammalian cell membranes are typically composed of PS, PC, and PE while
bacterial membranes only contain PE and PG. In all the following experiments, the
vesicles have a 10% excess of negatively charged phospholipids (PG or PS) to mimic
the charged phospholipids in the outer leaflet of bacterial cytoplasmic membranes. For
simplicity, vesicles mimicking mammalian cell membranes only consist of PS and PC.
Vesicles were prepared using a reverse phase evaporation method.(30) A
desired amount of lipid solution was transferred to a glass vial and dried using nitrogen
to form a thin film on the wall of the vial. Either buffer (90 mM NaCl, 10 mM Na2P04 ,
pH 7) or calcein solution (40 mM calcein, 1 0 mM Na2P04 , pH 7) was added to the lipid
film to obtain a final concentration of 10 umol lipid/mL of solution. The solution was
then warmed in water and frozen in acetone/liquid nitrogen for three cycles and then
sonicated for 1 5 minutes. This procedure was repeated for another sonication cycle,
ultimately ending with freezing and warming the solution. The vesicles containing
calcein were passed through a size exclusion Sephadex G-25 column to remove the
excess dye and collect the vesicles. All vesicles were used within two days.
To establish if the molecules were membrane active, vesicle leakage
experiments were performed as discussed in Section 5.3. Briefly, calcein self-quenches
inside the vesicles and upon release, the fluorescence increases over time. This
experiment is only used to determine if the molecules are membrane active since it can
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in an intact
not determine exactly how the dye is released; either leakage through holes
membrane or lysis where the membrane is fully destroyed.
The chemical structures and results for the polymeric molecules, 60d, 61d, and
62d, are shown in Figure 5.7. The polymers tested produced leakage curves similar to
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Figure 5.7: Leakage data for polymers a) 60d (R=C5H,,), b) 61d (R=C8H, 7), and c)
62d (R=C, 2H25).
curves show that the amount of dye released is dependent not only on time of exposure
but also on the polymer concentration. The initial rate of dye release is fast but slows
down. It is speculated that this happens due to less free polymer in solution as the
experiment proceeds. Second, the amount of dye release appears dependent on polymer
structure. This cooperative behavior between leakage and polymer concentration is
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consistent with the three mechanisms of membrane disruption proposed for
antimicrobial peptides and discussed in Section 5.1.(32, 34)






Table 5.2 summarizes the amount of dye released after 325 seconds. Notably,
there is a distinct dependence of dye release on the hydrophobic NP chain length. As
the carbon chain length on the antibacterial PE compound increases, the amount of dye
released decreases. This is best explained by the solubility of the polymer. The
concentrations listed in the table are the highest concentrations of the polymers that are
soluble in the aqueous buffered solution. Above those concentrations, the polymer
begins to aggregate and precipitation of the polymer is observed, explaining the
decrease in membrane activity. As expected, 62d, the C 12 polymer is the most
hydrophobic and not soluble at the concentrations needed to induce a high degree of
lysis.
This experiment was also performed with 34d, the CO discrete oligomer, to
i
determine membrane activity as well as to investigate if selectivity could be
demonstrated in vesicle experiments. Figure 5.8 shows the results for two different
vesicle compositions as well as different concentrations of the oligomer. The red line
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Figure 5.8: Vesicle leakage by 34d, the CO oligomer. Red line: PS-PC vesicles.
Rest are PG-PE vesicles at varing concentrations.
the lines show activity against vesicles made from the bacterial lipids, PG-PE. Both sets
of vesicles have 10 mol% excess of negatively charged lipids in their membrane.
Similar observations can be seen for 34d as for the polymers in which dye
release is concentration dependent. The rate is initially fast and becomes slower as the
amount of free oligomer in solution is decreased. However, through this experiment
another important point is made; this compound shows selectivity towards PG-PE
vesicles over PS-PC vesicles. At 20 ug/mL, there is 10% dye release from the PG-PE
vesicles while it takes ten times more 34d (200 ug/mL) to show 5% leakage from the
PS-PC vesicles. This result is significant because it suggests that the selectivity seen in
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the bacterial experiments is based on the membrane structure rather than the
intercellular organization.
After determining that these moleeules were membrane active, lipid movement
experiments were performed. Lipid movement can be detected by preparing vesicles as
discussed above using fluorescently labeled phospholipids to produce symmetrically
labeled vesicles. The fluorescence of the outer leaflet can be then quenched by mixing
the vesicles with sodium hydrosulfite (Na2S 204 ) in buffer for 15 minutes yielding
asymmetrically labeled vesicles. These vesicles were incubated in the presence of
varying concentrations of 34d for up to 15 minutes while monitoring the fluorescence.
This short time period was chosen to avoid errors from the possible slow permeation of
the quencher through the membrane. These experimental parameters provide one of the
most sensitive techniques to examine lipid-active compound interactional 5, 20) Here,
"lipid movement" is used to denote the outcome of lipid flip-flop experiment described
above. This is because the experiment determines lipid movement from the inner to the
outer bilayer (flop). If the reverse experiment was done (flip; outer to inner bilayer) and
matched data was obtained, then it could be denoted as flip-flop. The literature is
confusing in respect to these experiments because several researchers do experiments
that are technically "flop" but denote it as "flip-flop."
This experiment was also used to look at the effect of 34d on two different
vesicle compositions, PG-PE and PS-PC, and the results are shown in figure 5.9. The
percent of the lipid movement was determined by monitoring the decrease in




Figure 5.9: Lipid movement experimental data showing movement of bacterial
lipids is faster than mammalian lipids when exposed to 34d. (Insert is at 40 ug/mL)
are seen between these curves and those in Figure 5.8. Namely, the lipid movement has
a concentration dependence and the kinetics are significantly faster during the first few
minutes of incubation and slow down as there is less free oligomer in solution. This
result further confirms selectivity between vesicles of different compositions. The main
part of the graph shows the same concentration of 34d (20 ug/mL) incubated with
different vesicles for 1 5 minutes. The change in fluorescence in the vesicles made from
bacterial lipids is close to 40% after 10 minutes while the mammalian lipids are closer
to 1 0%. This difference is also seen at higher concentrations (40 ug/mL), shown in the
inset of Figure 5.9.
Comparing the amount of lipid movement (Figure 5.9) to the amount of dye
released (Figure 5.8) illustrates that there is significantly more lipid movement than dye
release in the PG-PE vesicles under the same conditions. After 10 minutes of
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incubation with 20 ug/mL of 34d, almost 40% of the labeled lipids have moved from
the inner to the outer leaflet while after the same amount of time only 10% of the dye
has been released. At 40 ug/mL, after the same time period there is almost complete
fluorescence quenching of the labeled lipids while only about 50% of the dye has been
released from the calcein-loaded vesicles.
There are a few possible explanations for the discrepancies in the results. One
explanation is that the vesicles prepared are different sizes. Even though the procedures
to make the vesicles are identical, there are several parameters that can affect the vesicle
size including the buffer and the specific lipids. To determine if the size of the vesicles
has an effect on the results, one could use an extruder to control vesicle size. A second
explanation is the quantity of vesicles. In previous experiments we saw a relationship
between the amount of membrane present and the concentration needed of an active
compound to disrupt cells or membranes. For instance, if there is less lipid membrane
present in a vesicle experiment then it takes less of the active compound to disrupt the
vesicles. There are significantly less vesicles in the lipid movement experiment than the
calcein experiment, suggesting discrepancies in the results could be due to the higher
ratio of 34d to lipid in the movement experiment. A third explanation is that the
vesicles are not lysed during the lipid movement experiment; rather, vesicles leak while
the membranes remain intact. This possibility can be addressed by the experiment
shown in Figure 5.4 in which vesicles entrap two different dyes of significantly different
sizes so that one will be released during all membrane disruption events (holes or lysis
of the vesicle) and the other will be released only during full lysis.(19)
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One could also monitor vesicles in the presence of these membrane active
compounds under a microscope. This monitoring could either be done with a phase
contrast or fluorescence microscope, depending on what issue was being investigated.
By using a phase contrast microscope, vesicles in solution can be monitored as long as
there is a slight difference in osmotic pressure between the inner solution of the vesicles
and the outer aqueous solution. Vesicles encapsulating a fluorescent dye or containing
labeled phospholipids can be monitored under a fluorescence microscope to investigate
the lysis or the slow leakage of vesicles.
Monitoring vesicles under a microscope also provides insight into membrane
budding and vesicle tubulation. Forming vesicles by budding and tubulation is essential
in a variety of cellular processes such as transport and signaling of molecules. These
processes are promoted by specific proteins assembling at the membrane and proceeds
through well-defined pathways. It has been shown that with the addition of amphiphilic
molecules, vesicle undergo shape changes and can even begin to interact with each
other.(35-37) This is often seen as fusion between vesicle membranes, budding and the
appearance of finger-like protrusions from the membranes, or simply a change in shape
of the membrane. This is related to the interaction of amphiphiles with cells due to their
reliance on signaling pathways as well as formation of vesicles for survival. The
detrimental interference of membrane active molecules with these cellular processes
could result in cell death.
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5.5 Monitoring Membrane Activity of Cationie FA Molecules on Living Cells
After determining that the membrane activity of these compounds was sufficient
to disrupt vesicles focus turned to the membrane stability of living cells. Experiments
exploited a membrane potential-sensitive cyanine dye such as diSC3-5 (Km=622) that
distributes between cells and the medium depending on the cytoplasmic membrane
potential gradient.(24) When a cell membrane is disrupted, the membrane potential
dissipates and the dye is released into the medium, causing an increase in fluorescence.
The bacteria used in this experiment were .V. aureus, and the dye release was monitored
over ten minutes, as shown in figure 5.10. DMSO (1%) was added as a control to
demonstrate that solvent alone did not induced dye release from the cells over the time-
period of the experiment.
time (min)
Figure 5.10: Dye Leakage from S. aureus when exposed to 34d.
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The curve shape is similar to that of the vesicle experiments in Figure 5.8 and
5.9, indicating dependence on concentration as well as on time. When 34d is
introduced to the cells, the dye leakage is fast until the free 34d in solution decreases
and dye release slows down. At the lowest concentration of 34d tested, 0.4 ug/mL, (one
quarter the MIC) about 10% of the dye is released. The highest concentration tested, 3.2
ug/mL, twice the MIC, affords almost full dye release. These results are substantial for
two reasons: some peptides do not depolarize the membrane until four- to ten-fold the
MIC and somewhat surprisingly, 34d starts disrupting the membrane potential below
one-quarter the MIC, indicating that 34d is more effective. Secondly, these results
support the antimicrobial data suggesting that, in general, twice the MIC is the MBC.
5.6 Conclusions
From the experiments described in Sections 5.4 and 5.5, it can be concluded that
the meta-PE molecules do exert their antibacterial action on the cytoplasmic membrane.
In some of the vesicle experiments, selectivity between bacterial lipids and mammalian
lipids was shown, indicating that the differences in membrane composition likely
accounts for the cellular selectivity discussed in Chapter 4. Furthermore, the activity
exerted from 34d at the membrane causes significant leakage, lipid movement, and
disruption of the membrane potential, resulting in cellular stress. Exact mechanisms are
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'H and l3C NMR spectra were obtained at 300 MHz and 125 MHz, respectively,
with a Broker DPX-300 NMR spectrometer. The gel permeation chromatography
(GPC) was performed in THF at room temperature using a PL LC 1 120 pump, a Waters
R403 differential refractometer, and three PLgel columns (\0\ 104 , and 103 A).
Molecular weights are reported relative to polystyrene standards. Emission and
excitation spectra were taken on a Perkin-Elmer LS 50B spectrometer with a xenon
lamp light source. The maximum absorptions of the solutions were 0.1 or less.
Elemental analysis was carried out in the Microanalysis Laboratory at the University of
Massachusetts Amherst. Mass spectral data were obtained at the I Iniversity of
Massachusetts Amherst mass spec facility, which is supported in part by the National
Science Foundation.
6.2 Materials
Toluene was either passed sequentially through columns of activated alumina
(LaRoche A-2) and Q-5 supported copper redox catalyst (Engelhard CI I-0226S) under a
purified nitrogen atmosphere or distilled from sodium benzophenone. Reagent grade
tetrahydrofuran ( THF) was distilled under nitrogen from sodium hen/.ophenonc. All
other solvents were used as received. 3,5 diiodo-4-hydroxy benzonitrile was purchased
from Avocado Research Chemicals Ltd., w-diethynylben/ene and propargyl amine from
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GFS Chemicals, 3,5-dibromo benzoic acid from Lancaster Chemicals, and propargyl
alcohol from TCI chemicals. All other reagents were either purchased from Aldrich
Chemical Co. or Alfa Aesar and were used as received. All lipids were purchased from
Avanti Polar Lipids.
6.3 Synthesis of Alkylated Compounds
6.3.1 General Procedure for Mitsunobu
A 1 00 mL round bottom flask equipped with a magnetic stir bar was charged
with 50 mL dry THF and purged with nitrogen. The solution was then cooled to 0°C in
an ice bath. 2.00 g of 3,5-diiodo 4-cyanophenol (5.39 mmol, 1 mol eq.) was added to
the flask and allowed to stir. 0.5694 g of an alcohol (6.47 mmol, 1 .2 mol eq.) and
2.1 190 g of triphenylphosphine (8.09 mmol, 1.5 mol eq.) were added to the flask.
1 .6354 g diisopropylazodicarboxylate (DIAD) (8.09 mmol, 1 .5 eq.) was added slowly to
the stirring solution. The solution was allowed to warm up to room temperature and stir
under nitrogen overnight. After confirmation of the disappearance of the starting
diiodobenzene by TLC, the mixture was evaporated under reduced pressure. The
residue was chromatographed on a silica gel column using mixed eluent of hexane-
dichloromethane (5:1) to give a white solid.
6.3.2 General Procedure for Reduction
A 500 mL three necked round bottom flask was equipped with a stir bar and
charged with 1 00 mL dry THF and purged with nitrogen. The solution was cooled to
0°C in an ice bath. 90 mL 1 .0 M BH3 THF (88. 1 8 mmol, 1 7 mol eq.) was added to the
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flask and allowed to stir for 10 minutes. 2.2825 g of the benzyl nitrile, 2, (5.188 mmol,
1 mol eq.) was dissolved in 20 mL ofTHF and added to the solution over 10 minutes.
The ice bath was removed and a heating mantle and condenser were installed. The
reaction was allowed to reflux overnight. The heating mantle was removed and the
reaction allowed to cool to 0°C for 30 minutes. Methanol was added cautiously, via
syringe until bubbling ceased. The mixture was evaporated under reduced pressure and
washed three times with methanol. The viscous oil was then taken up in methanol and
cooled to zero. HC1 gas was bubbled through the solution for five minutes. The
solution was removed from the ice bath and ether added until a white precipitate
formed. The white precipitated material was collected and dried under vacuum. In the
case of the dodecyl side chain, the molecule was chromatographed on a silica gel
column to give a white solid. The product was then taken and immediately protected
with Boc due to the instability of the amine.
6.3.3 General Procedure for Boc Protection of Free Amine
A 20 mL screw top vial with a magnetic stir bar was charged with 1 .600 g of the
amine (3.3221 mmol, 1 mol eq.), and 1.0863 g di-/er/-butyl dicarbonate (4.983 lg, 1.5
mol eq.). 12 mL of dimethylformamide was added to the vial and the solution was
allowed to stir. After the solution was homogeneous, 0.2923 g sodium hydroxide
(7.3086 mmol, 2.2 mol eq.) and 4 mL of distilled water were added. The vial was
covered in aluminum foil and allowed to stir overnight. At the end of the reaction, some
white precipitate was present. Addition of more water precipitates the product. The
solid was filtered, dissolved in ether, and dried over magnesium sulfate. The solvent
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was evaporated under reduced pressure. A white solid was collected and dried under
vacuum.
6.3.4 Characterization of Alkoxy Molecules (2-10)
2 was made by the mitsonobu procedure in 89% yield. lH NMR (CDC13): 5 8.04
(s, 2H, phenyl H), 4.00 (t, 2H, CH2 ), 1.94 (m, 2H, CH2), 1.39-1.56 (m, 4H, (CH2)2),
0.95 (t, 3H, CH3 ) ppm. 13C NMR (CDC13 ): 5 1 162.7, 143.5, 115.8, 111.7,91.7,74.4,
30.1, 28.4, 22.9, 4.5 ppm. MS: m/z 440.8 (M+). Anal. Calcd for C 12H 13NOI2 : C, 32.65:
H, 2.95: N, 3.17: 1, 57.60. Found: C, 32.76: H, 3.15: N, 3.1 1: 1, 57.7.
3 was made by the mitsonobu procedure in 90% yield. 'H NMR (CDC13 ): 5 8.04
(s, 2H, phenyl H), 4.00 (t, 2H, CH2), 1.94 (m, 2H, CH2 ), 1.39-1.56 (m, 12H, (CH2 )6),
0.95 (t, 3H, CH3) ppm.
4 was made by the mitsonobu procedure in 87% yield. 'H NMR (CDC13 ): 5 8.04
(s, 2H, phenyl H), 4.00 (t, 2H, CH2), 1.93 (m, 2H, CH2), 1.53 (m, 2H, CH2), 1.26 (m,
16H,(CH2)6), 0.88 (t,3H,CH3 ) ppm. 13C NMR (CDC13 ): 5 162.7, 143.5, 115.8, 111.7,
91.6, 74.4, 32.4, 30.4, 30.1, 30.0, 29.9, 29.8, 26.3, 23.1, 14.6 ppm. Anal. Calcd for
Ci 9H27NOI2 : C, 42.28: H, 5.01: N, 2.60: 1, 47.07. Found: C, 42.38: H, 4.98: N, 2.57: 1,
47.4.
5 was made by the reduction described above and protected immediately. 'H
NMR (DMSO-D6): 8 8.34 (s, 2H, NH2), 7.97 (s, 2H, phenyl H), 3.91 (s, 2H, CH2 ), 3.85
(t, 2H, CH2), 1.81 (m, 2H, CH2), 1.33-1.49 (m, 4H, (CH2)2), 0.90 (t, 3H, CH3 ) ppm.
MS: m/z 445 (M+).
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6 was made by the reduction described above and protected immediately. >H
NMR (DMSO-D6): 5 8.00 (s, 2H, phenyl H), 3.87 (s, 2H, CH2), 2.50 (m, 2H, CH2 ),
1.22-1.84 (m, 10H, (CH2)5), 0.86 (t, 3H, CH3 ) ppm.
7 was made by the reduction described above and protected immediately. 'H
NMR (DMSO-D6): 8 7.82 (s, 2H, phenyl H), 4.08 (s, 2H, CH2), 3.93 (t, 2H, CH2), 1.90
(m, 2H, CH2), 1.22-1.53 (m, 19H, (CH2)2), 0.89 (t, 3H, CH3 ) ppm.
8 was synthesized by the protection stated above in 62% yield. 'H NMR
(CDC13 ): 5 7.66 (s, 2H, phenyl H), 4.96 (s, 1H, NH), 4.19 (d, 2H, CH2), 3.94 (t, 2H,
CH2 ), 1.90 (m, 2H, CH 2 ), 1.46 (s, 9H, 3CH3 ), 1.41-1.55 (m, 4H, (CH2)2), 0.95 (t, 3H,
CH3 ) ppm.
13C NMR (CDC13 ): 8 157.5, 156.1, 139.0, 91.4, 80.3, 73.9, 43.0, 30.1, 28.8,
28.5, 23.0, 14.5 ppm. MS: m/z 545.0 (M+). Anal. Calcd: C, 37.43: H, 4.59: N, 2.57: 1,
46.61. Found: C, 37.36: H, 4.73: N, 2.50: 1, 46.8.
9 was synthesized by the protection stated above in 63% yield. !H NMR
(CDC13 ): 8 7.65 (s, 2H, phenyl H), 4.87 (s, 1H, NH), 4.18 (d, 2H, CH2), 3.93 (t, 2H,
CH2), 1.87 (m, 2H, CH2), 1.46 (s, 9H, 3CH3 ), 1.29-1.58 (m, 10H, (CH2 )5 ), 0.89 (t, 3H,
CH3 ) ppm.
10 was synthesized by the protection stated above in 64% yield. 'H NMR
(CDC1 3 ): 8 7.66 (s, 2H, phenyl H), 4.96 (s, 1H, NH), 4.19 (d, 2H, CH2 ), 3.94 (t, 2H,
CH2), 1.91 (m, 2H, CH2), 1.48 (s, 9H, 3CH3), 1.28-1.57 (m, 18H, (CH2)9), 0.89 (t, 3H,
CH3 ) ppm. ,3C NMR (CDC1 3 ): 8 157.5, 139.0, 91.4, 73.8, 43.0, 32.3, 30.4, 30.1, 30.0,
29.9,29.7,28.7,26.4,23.1, 14.6 ppm. Anal. Calcd for Ci 2H, 3NOI 2 : C, 44.86: H, 5.91
:
N,2.18: 1,39.56. Found: C, 45.61 : H, 6.14: N, 2.13: 1, 39.9.
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6.4 Synthesis of CO Molecules (12-16)
6.4.1 Preparation of Benzyl Alcohol (12)
A round bottom flask equipped with a magnetic stir bar was charged with ether
and purged with nitrogen. Dibromobenzoic acid, 11, (2.00 g, 7.15 mmol.l equiv) was
added to the ether (50 mL) and the solution was cooled to 0°C in an ice bath. A 1 M
solution of LiAlH4 (15 mL, 14.33 mmol, 2 equiv.) was added slowly while the reaction
was vented. The reaction was allowed to warm up to room temperature and stir
overnight in an inert atmosphere. After confirmation by TLC that all the starting
material was gone, ice was slowly added to the solution until all the bubbling stopped.
Cold HC1 was added to the solution until all the solid was dissolved. The product was
then extracted with ether, dried over magnesium sulfate and evaporated to dryness. The
product, 12, was purified by column chromatography using dichloromethane as the
eluent to give a white solid (yield 90%). 'H NMR (CDC13 ): 8 7.58 (t, 1H, phenyl H),
7.45 (d, 2H, phenyl H), 4.67 (s, 2H, CH2 ) ppm. m/z: [M]: 266, [M-Br]: 185.
6.4.2 Preparation of Benzyl Bromide (13)
A round bottom flask equipped with a magnetic stir bar was charged with dry
THF (100 mL) and purged with nitrogen. Benzyl alcohol, 12, (1.90 g, 7.15 mmol, 1
equiv.) was added to the solvent and allowed to dissolve. N-bromosuccinamide (1 .72 g,
9.65 mmol, 1.5 equiv.) was added to the solution. Triphenylphosphine (2.53 g, 9.65
mmol, 1 .5 equiv.) was added slowly and the reaction was allowed to stir overnight.
After confirmation by TLC that all the starting benzyl alcohol was gone, the solution
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was evaporated to dryness. The produet was purified by column chromatography using
1 :
1
dichloromethane:hexane as the eluent. The product, 13, was a white solid (yield
760/c). 'H NMR (CDC13 ): 8 7.61 (t, 1H, phenyl H), 7.48 (d, 2H. phenyl H), 4.43 (s, 2H,
CH2)ppm. m/z: [M+]: 327.7, [M+-Br]: 248.8.
6.4.3 Preparation of Benzyl Cyanide (14)
A round bottom flask equipped with a magnetic stir bar was charged with 3:1
ethanol:water (10 mL) and purged with nitrogen. Benzyl bromide, 13, (1 .00 g, 3.04
mmol, 1 equiv.) and sodium cyanide (0.16 g, 3.35 mmol, 1.1 equiv.) were added to the
flask. The reaction was heated to 70°C for 2 hours or until 13 was consumed. The
product was extracted with dichloromethane and ethyl acetate and dried with
magnesium sulfate. The organic layer was evaporated to dryness and the product was
purified by column chromatography using 1 :4 dichloromethane to hexane. The product,
14, was a white solid (yield 90%). 'H NMR (CDCI3): 8 7.66 (t, 1H, phenyl H), 7.44 (d,
2H, phenyl H), 3.72 (s, 2H, CH2) ppm. m/z: [M+]: 275, [M+-Br]: 194, [M+-Br -CN]:
167.
6.4.4 Preparation of the Free Amine (15)
A round bottom flask was equipped with a stir bar and charged with dry THF
(75 mL) and purged with nitrogen. The solution was cooled to 0°C in an ice bath.
Benzyl cyanide, 14, (1.06 g, 3.85 mmol, 1 equiv.) was dissolved and 1.0 M BH3 THF
(66 mL, 65.43 mmol, 17 equiv.) was added cautiously to the flask and allowed to stir.
The ice bath was removed and a heating mantle and condenser were installed. The
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reaction was allowed to reflux overnight. The heating mantle was removed and the
reaction was allowed to cool to 0°C for 30 minutes. Methanol was added cautiously,
via syringe until bubbling ceased. The mixture was evaporated under reduced pressure
and washed three times with methanol. The viscous oil was then taken up in methanol
and cooled to 0°C. Concentrated HC1 was added to the solution until precipitate
formed. The solution was removed from the ice bath and ether added until more white
precipitate formed. The white precipitated material was collected and dried under
vacuum. The product, 15, was then immediately protected due to the instability of the
amine (yield 78.5%). 'H NMR (DMSO-D6 ): 5 7.94 (s, 3H, NH3C1), 7.73 (t, 1H,
phenyl H), 7.55 (d, 2H, phenyl H), 3.08 (m, 2H, CH2), 2.88 (t, 2H, CH2) ppm.
6.4.5 Preparation of Boc Protected Amine (16)
A round bottom flask was charged with a magnetic stir bar, the amine, 15, (0.95
g, 3.02 mmol, 1 equiv.), and di-ter/-butyl dicarbonate (0.99 g, 4.54 mmol, 1.5 mol
equiv.). Dimethylformamide (8 mL) was added to the vial and the solution was allowed
to stir. After the solution was homogeneous, sodium hydroxide (0.27 g, 6.65 mmol, 2.2
equiv.) and distilled water (4 mL) were added. The reaction was covered in aluminum
foil and allowed to stir overnight. Some white precipitate was present. Addition of
more water precipitates the product. The solid was filtered, dissolved in ether, and dried
over magnesium sulfate. The solvent was evaporated under reduced pressure. A white
solid, 16, was collected and dried under vacuum (yield 92%). *H NMR (CDCI3): 8 7.54
(t, 1H, phenyl H), 7.29 (d, 2H, phenyl H), 4.53 (s, 1H, NH), 3.35 (m, 2H, CH2), 2.77 (t,
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2H,CH2)ppm. C NMR (CDCb): 5 155.8, 143.1, 132.1, 130.7, 122.9,79.5,41.4,
35.5, 28.4, 27.4 ppm. m/z [M+ ]: 379, [M+
-t-butyl]: 323, [M+-Boc]: 278.
6.5 Synthesis of Other Monomers
6.5.1 Preparation of l,3-Dibromo-5-pentyloxymethyl-benzene (17)
A round bottom flask was purged with nitrogen and dry THF (75 mL) was
added. Potassium hydride was allowed to stir in the THF before adding pentanol to the
mixture slowly as the reaction bubbled. 13 (1.5084 g, 4.587 mmol) was dissolved in dry
THF and added to the solution. The reaction turned grey and was allowed to stir
overnight. The reaction was rotovapped down and taken up in ether and extracted with
water, washed with saturated salt solution and dried over magnesium sulfate. The
solution was filtered and rotovaped to a liquid. The product, 17, was separated by
column chromatography in 20% dichloromethane:hexane yielding 69%. *H NMR
(CDCb): 8 7.57 (s, 1H, phenyl H), 7.42 (s, 2H, phenyl H), 7.43 (s, 2H, CH2), 3.63 (t,
2H, CH2), 3.46 (t, 2H, CH2), 1.57 (m, 4H, 2CH 2 ), 0.93 (t, 3H, CH3 ). m/z: [M+]: 334.7,
[M+-0-pentyl]: 248.7.
6.5.2 Preparation of [2-(2,6-Dibromo-4-methyl-phenoxy)-ethyl|-carbamic acid tert-
butyl ester (19)
A 1 00 mL round bottom flask equipped with a magnetic stir bar was charged
with 20 mL dry THF and purged with nitrogen. The solution was then cooled to 0°C in
an ice bath. 0.500 g of 18 (1.8801 mmol, 1 mol eq.) was added to the flask and allowed
to stir. 0.3637 g of (2-Hydroxy-ethyl)-carbamic acid tert-butyl ester (2.2561 mmol, 1 .2
142
mol eq.) and 0.7389 g of triphenylphosphine (2.8202 mmol, 1 .5 mol eq.) were added to
the flask. 0.5703 g diisopropylazodicarboxylate (DIAD) (2.8202 mmol, 1.5 eq.) was
added slowly to the stirring solution. The solution was allowed to warm up to room
temperature and stir under nitrogen overnight. After confirmation of the disappearance
of 18 by TLC, the mixture was evaporated under reduced pressure. The residue was
chromatographed on a silica gel plug using mixed eluent of dichloromethane to give a
clear oil in 72% yield. ]H NMR (CDC13 ): 5 7.32 (s, 2H, phenyl H), 5.31 (s, 1H, NH),
4.07 (t, 2H, CH2), 3.57 (m, 2H, CH2), 2.29 (s, 3H, CH3 ), 1.48 (s, 9H, 3CH3 ).
6.5.3 3,5-Diiodo-benzoic acid 2-[2-(2-methoxy-ethoxy)-ethoxy]-ethyl ester (22)
20 was reacted with excess methanol and potassium carbonate (1 .5 equiv) under
reflux conditions overnight to yield 21. 21 was reacted with triethyleneglycol
monomethyl ether (1.5 eq) and potassium carbonate (1.5 equiv) in acetone under reflux
conditions for 12 hours. The crude reaction was extracted with ethyl acetate and
rotovapped to dryness. The mixture was then purified using column chromatography in
20% ethyl acetate/hexane to yield 22 in 49%. 'H NMR (CDC13 ): 5 8.13 (s, 2H, phenyl
H), 7.86 (t, 1H, phenyl H), 4.50 (m, 2H, 2CH2), 3.85 (m, 2H, CH2 ), 3.73-3.66 (m, 6H,
3CH2), 3.56 (m, 2H, CH2), 3.38 (s, 3H, CH3 ). m/z: [M+] 520, [M
+
-peg] 357.
6.5.4 Preparation of l,3-Dibromo-5-{2-[2-(2-methoxy-ethoxy)-ethoxy]-
ethoxymethyl}-benzene (23)
A round bottom flask was purged with nitrogen and dry THF (75 mL) was
added. Potassium hydride was allowed to stir in the THF before addingl .4955 g of
triethylene glycol monomethyl ether (9.1080 mmol, 2 eq) to the mixture slowly as the
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reaction bubbled. 1.4975 g of 13 (4.554 mmol, leq) was dissolved in dry THF and
added to the solution. The reaction turned grey and was allowed to stir overnight. The
reaction was rotovapped down and taken up in ether and extracted with water, washed
with saturated salt solution and dried over magnesium sulfate. The solution was filtered
and rotovaped to a liquid. The product, 23, was separated by column chromatography ir
20% dichloromethane:hexane yielding 54%. 'H NMR (DMSO): 5 7.73 (s, 1H, phenyl
H), 7.53 (s, 2H, phenyl H), 4.49 (s, 3H, CH2), 3.56-3.32 (m, 12H, 12CH2), 3.22 (s, 3H,
CH3 ). 13C NMR (CDC1 3 ): 5 144.4, 133.0, 129.8, 123.2,41.2,40.9,40.6,40.4,40.1,
39.8, 39.5 ppm.
6.6 Polymerization Procedures
6.6.1 General Procedure for Polymerization
A 20 mL airfree schlenk flask was charged with a magnetic stir bar and dried in
the oven then cooled under nitrogen. 27.0 mg of w-diethynylbenzene (0.2140 mmol,
1.03 mol eq.) was weighed directly into the schlenk flask. 0.1 133 g of the
dihalogenated monomer (0.2078 mmol, 1 mol eq.), 0.0072 g Pd(PPh3 )4 (0.0062 mmol,
0.03 mol eq.), and 0.0023 g Cul (0.0124 mmol, 0.06 mol eq.) were added to the flask.
The flask was then returned to positive nitrogen pressure. 0.6699 mL of distilled
diisopropylamine (DIPA) (4.7797 mmol, 23 mol eq.) and 5 mL of dry toluene were
added via syringe. The reaction was then placed in an oil bath at 78°C and stirred
overnight. The mixture was clear at first and by the next morning it was cloudy. The
reaction was poured into methanol to give a yellow solid.
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6.6.2 General Procedure for Deprotection of Polymers
A 10 mL round bottom flask was charged with a magnetic stir bar. 25mg of Boc
protected polymer was added to the flask. The flask was then cooled to 0°C and 6 mL
of4M HC1 in dioxane was added to the polymer. The solution was allowed to warm up
to room temperature and stir overnight. The solvent was evaporated under reduced
pressure and the solid was washed with ether three times and dried under vacuum to
yield a yellow solid.
6.6.3 Characterization of Polymer Structure and Molecular Weight
The polymers have a "p" after the number if they are "protected" polymers.
After the deprotection by removal of the Boc group, the polymer numbers have a "d"
after them to denote "deprotected."
The polymerization to make 24p was carried out by the Sonogashira conditions
in 52% yield. 'H NMR (CDC13 ): 8 7.69 (m, 1H, phenyl H) , 7.49-7.52 (m, 2H, phenyl
H), 7.36-7.40 (m, 3H, phenyl H), 4.90 (s, 1H, NH), 4.29 (m, 2H, CH2 ), 1.88 (m, 2H,
CH2 ), 1.47 (s, 9H, 3CH3 ), 1.37-1.59 (m, 4H, (CH2)2 ), 0.88 (t, 3H, CH3 ) ppm. GPC: Mn
17,800; Mw 40,500; PDI 2.276.
24p was deprotected to make 24d by the general deprotection stated above. 'H
NMR (DMSO-D6 ): 8 8.40 (s, 2H, NH2 ), 7.79 (s, 2H, phenyl H), 7.62 (m, 4H, phenyl H),
4.32 (m, 1H, NH), 4.03 (m, 2H, CH2 ), 1.82 (m, 2H, CH2), 1.54 (m, 2H, CH2 ), 1.32 (m,
2H, CH2), 0.78 (t, 3H, CH3 ) ppm. UV (DMSO): 6=30,000, ^max (297nm), sh (332 nm).
The polymerization to make 25p was carried out by the Sonogashira conditions
in 50% yield. 'H NMR (CDC1 3 ): 8 7.69 (m, 1H, phenyl H) , 7.50 (m, 2H, phenyl H),
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7.36-7.40 (m, 3H, phenyl H), 4.89 (s, 1H, NH), 4.29 (m, 2H, CH2), 1.88 (m, 2H, CH2),
1.47 (s, 9H, 3CH3 ), 1.37-1.59 (m, 12H, (CH2 )6), 0.87 (t, 3H, CH3) ppm. GPC: Mn
7,700; Mw 10,300; PDI 1.331.
25p was deprotected to make 25d by the general deprotection stated above. 'H
NMR (DMSO-D6): 8 8.43 (s, 2H, NH2), 7.76 (s, 2H, phenyl H), 7.61 (m, 4H, phenyl H),
4.30 (m, 1H, NH), 4.03 (m, 2H, CH2), 1.82 (m, 2H, CH2), 1.27-1.00 (m, 8H, CH2), 0.71
(t, 3H, CH3 ) ppm. UV (DMSO): ^max (295nm), sh (337 nm).
The polymerization to make 26p was carried out by the Sonogashira conditions
in 41% yield. 'H NMR (CDC13): 8 7.70 (m, 1H, phenyl H), 7.51 (m, 2H, phenyl), 7.37-
7.42 (m, 3H, phenyl H), 4.87 (s, 1H, NH), 4.31 (m, 2H, CH 2 ), 1.89 (m, 2H, CH2), 1.21-
1.57 (m, 18H, (CH2)9), 0.86 (t, 3H, CH 3 ) ppm. GPC: Mn 10,100; Mw 13,800; PDI
1.369.
26p was deprotected to 26d by the general deprotection stated above. 'H NMR
(DMSO-D6): 8 8.40 (s, 2H, NH2), 7.56-7.75 (m, 6H, phenyl H), 4.16 (m, 1H, NH), 4.00
(m, 2H, CH2), 1.78 (m, 2H, CH2 ), 1.48 (m, 2H, CH2 ), 1.05 (m, 16H, (CH2)2 ), 0.72 (t,
3H, CH3) ppm. UV (DMSO): ?imax (294 nm), sh (337 nm).
The polymerization to make 27p was carried out by the Sonogashira conditions
in 54% yield. !H NMR (CDC13 ): 8 7.69 (m, 1H, phenyl H) , 7.49-7.52 (m, 2H, phenyl
H), 7.36-7.40 (m, 3H, phenyl H), 4.90 (s, 1H, NH), 4.29 (m, 2H, CH2 ), 1.98 (m, 2H,
CH2 ), 1.74 (m, 2H, CH 2), 1.49 (s, 9H, 3CH3 ), 1.27-1.40 (m, 3H, CH, CH2 ), 1.15 (m, 3H,
CH3 ), 0.97 (t, 3H, CH3 ) ppm. GPC: Mn 10,100; Mw 16,100; PDI 1.6.
27p was deprotected to make 27d by the general deprotection stated above. *H
NMR (DMSO-D6): 8 8.47 (s, 2H, NH2 ), 7.79 (s, 2H, phenyl H), 7.60 (m, 4H, phenyl H),
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4.21 (m, 1H, NH), 4.03 (m, 2H, CH2), 1.87 (m, 2H, CH2 ), 1.65 (m, 2H, CH2), 1.32 (m,
2H, CH2), 1.08 (t, 3H, CH3 ), 0.90 (t, 3H, CH3 ) ppm. UV (DMSO): Km (299 rim), sh
(333 nm).
The polymerization to make 28p was carried out by the Sonogashira conditions
in 57% yield. >H NMR (CDCI3): 6 7.72 (m, 1H, phenyl H)
,
7:50-7.60 (m, 2H, phenyl
H), 7.37-7.30 (m, 3H, phenyl H), 4.60 (s, 1H, NH), 3.41 (m, 2H, CH2), 2.83 (m, 2H,
CH2), 1.47 (s, 9H, 3CH3 ) ppm. GPC: Mn 5,500; Mw 8,100; PDI 1.471.
28p was deprotected to make 28d by the general deprotection stated above. "H
NMR (DMSO-D6): 5 8.03 (s, 2H, NH2), 7.77 (s, 2H, phenyl H), 7.59 (m, 4H, phenyl H),
3.11 (m, 2H, CH2 ), 2.96 (m, 2H, CH2 ) ppm. UV (DMSO): Xmax (308nm), sh (289 nm).
The polymerization to make 30 was carried out by the Sonogashira conditions in
47% yield. I cannot find the NMR and do not have any more sample to retake the
spectrum. GPC: Mn 4,800; Mw 10,100; PDI 2.264.
The polymerization to make 31p was carried out by the Sonogashira conditions
in 57% yield. lH NMR (CDC13 ): 5 7.47 (s, 2H, phenyl H), 7.32 (s, 2H, phenyl H), 5.74
(s, 1H, NH), 5.15 (s, 1H, NH), 4.43 (t, 2H, CH2), 4.30 (m, 4H, 2CH2 ), 3.55 (m, 2H,
CH2), 2.34 (s, 3H, CH3 ), 1.89 (m, 2H, CH2), 1.48 (s, 18H, 3CH3 ), 1.57-1.28 (m, 4H,
2CH2), 0.88 (t, 3H, CH3 ) ppm. GPC: Mn 23,500; Mw 54,300; PDI 2.312.
31p was never successfully deprotected to make 3 Id.
The polymerization to make 32 was carried out by the Sonogashira conditions in
57% yield. 'H NMR (CDC13 ): 8 7.62 (s, 1H, phenyl H), 7.52 (s, 2H, phenyl H), 4.60 (s,
2H, CH2), 3.71 (m, 8H, 4CH2 ), 3.56 (m, 4H, 2CH2), 3.37 (s, 3H, CH3 ) ppm. GPC: Mn
10,900; Mw 16,700; PDI 1.534.
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The polymerization to make 33 was carried out by the Sonogashira conditions in
570/c yield. 'H NMR (CDCI3): 6 8.10 (s, 4H, phenyl H), 7.88 (s, 111, phenyl H), 4.53 (s,
2H, CH 2 ), 3.99-3.88 (m, 10H, 5CH 2 ), 3.80 (s, 3H, CH3) ppm. GPC: Mn 5,100; Mw
19,600; PDI 3.837.
The polymerization to make 63p was carried out by the Sonogashira conditions
in 52% yield. lH NMR (CDC1 3 ): 8 7.69 (m, 1H
S phenyl H) , 7.49-7.52 (m, 2H, phenyl
H), 7.36-7.40 (m, 3H, phenyl H), 4.90 (s, 1H, NH), 4.29 (m, 2H, CH 2), 1.88 (m, 211,
CH 2 ), 1 .47 (s, 9H, 3CH 3 ), 1 .37-1 .59 (m, 4H, (CH 2 )2 ), 0.88 (t, 3H, CH3) ppm. GPC: Mn
8,500; Mw 11,000; PDI 1.3.
63p was deprotected to make 63d by the general deprotection stated above. 'H
NMR (DMSO-D6 ): 8 8.40 (s, 2H, NH 2 ), 7.79 (s, 211, phenyl H), 7.62 (m, 4H, phenyl H),
4.32 (m, 1 H, NH), 4.03 (m, 2H, CH2 ), 1 .82 (m, 2H, CH 2 ), 1 .54 (m, 21 1, CH 2 ), 1 .32 (m,
2H, CH 2 ), 0.78 (t, 3H, CH3 ) ppm. UV (DMSO): 6=30,000, Xmax (297nm), sh (332 nm).
The polymerization to make 64p was carried out by the Sonogashira conditions
in 57% yield. 'H NMR (CDCI3): 8 7.72 (m, 1 H, phenyl H), 7.50-7.60 (m, 2H, phenyl
H), 7.37-7.30 (m, 3H, phenyl H), 4.60 (s, 1H, NH), 3.41 (m, 2H, CH2 ), 2.83 (m, 2H,
CH2), 1.47 (s, 9H, 3CH3 ) ppm. GPC: Mn 1,800; Mw 8,900; PDI 2.873.
64p was deprotected to make 64d by the general deprotection stated above. 1 1
1
NMR (DMSO-D6): 8 8.03 (s, 2H, NH 2 ), 7.77 (s, 2H, phenyl H), 7.59 (m, 411, phenyl H),
3.1 1 (m, 2H, CH 2 ), 2.96 (m, 2H, CH 2 ) ppm. UV (DMSO): Xmax (308nm), sh (289 nm).
The polymerization to make 65p was carried out by the Sonogashira conditions
in 52% yield. *H NMR (CDCI3): 8 11.57 (s 9 1H, NH), 8.55 (s, 1 H, NH), 7.70 (m, 1H,
phenyl H) , 7.53-7.34 (m, 5H, phenyl H), 4.58 (m, 2H, CH 2 ), 1 .89 (m, 2H, CH 2 ), 1 .48 (s,
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18H,6CH 3 ), 1.52-1.40 (m, 4H, (CH 2 )2), 0.89 (t, 3H, CH 3 ) ppm. GPC: Mn 1 1.400; Mw
21,000; PDI 1.83.
65p was deprotected to make 65d by the general deprotection stated above. lH
NMR (DMSO-D6); 5 9.65 (s, 1H, NH), 9.05 (s, 1H, NH), 8.87 (s, 1H, NH), 8.12 (s, 1H,
NH), 7.65 (m, 6H, phenyl H), 4.27 (m, 4H, 2CH 2 ), 3.97 (m, 2H, CH 2), 1.80 (m, 2H,
CH2), 1.49 (m, 2H, CH2), 1.21 (m, 2H, CH 2 ), 0.77 (t, 3H, CH 3 ) ppm.
The polymerization to make 66p was carried out by the Sonogashira conditions
in 46% yield. 1 H NMR (CDC13): 5 1 1.57 (s, 1H, NH), 8.55 (s, 1 H, NH), 7.70 (m, 1 H,
phenyl H)
,
7.53-7.34 (m, 5H, phenyl H), 4.58 (m, 2H, CH2 ), 1.89 (m, 2H, CH 2 ), 1.48 (s,
1 8H, 6CH3), 1 .52-1
.40 (m, 4H, (CH 2 )2 ), 0.89 (t, 3H, CH 3) ppm. GPC: Mn 9,300; Mw
15,500; PDI 1.67.
66p was deprotected to make 66d by the general deprotection stated above. lH
NMR (DMSO-D6): 5 9.65 (s, 1H, NH), 9.05 (s, 1H, NH), 8.87 (s, 1H, NH), 8.12 (s, 1H,
NH), 7.65 (m, 6H, phenyl H), 4.27 (m, 4H, 2CH 2 ), 3.97 (m, 2H, CH 2 ), 1.80 (m, 2H,
CH2), 1.49 (m, 2H, CH2 ), 1.21 (m, 2H, CH2 ), 0.77 (t, 3H, CH 3 ) ppm.
The polymerization to make 67p was carried out by the Sonogashira conditions
in 44% yield. 'H NMR (CDC13 ): 8 1 1 .57 (s, 1H, NH), 8.55 (s, 1 H, NH), 7.70 (m, 1H,
phenyl H)
,
7.53-7.34 (m, 5H, phenyl H), 4.58 (m, 2H, CH 2 ), 1.89 (m, 2H, CH2), 1.48 (s,
18H, 6CH3 ), 1.52-1.40 (m, 4H, (CH2)2 ), 0.89 (t, 3H, CH3 ) ppm. GPC: Mn 4,300; Mw
6,200; PDI 1.43.
67p was deprotected to make 67d by the general deprotection stated above. 'H
NMR (DMSO-D6): 8 9.65 (s, IH, NH), 9.05 (s, III, NH), 8.87 (s, 1H, NH), 8.12 (s, 111,
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NH), 7.65 (m, 6H, phenyl H), 4.27 (m, 4H, 2CH2 ), 3.97 (m, 2H, CH2 ), 1.80 (m, 2H,
CH2), 1.49 (m, 2H, CH2), 1.21 (m, 2H, CH2), 0.77 (t. 3H. CH3 ) ppm.
The polymerization to make 68p was carried out by the Sonogashira conditions
in 46o/o yield. 'H NMR (CDC13 ): 5 1 1.57 (s, 1H, NH), 8.55 (s, 1H, NH), 7.70 (m, 1H,
phenyl H), 7.53-7.34 (m, 5H, phenyl H), 3.58 (m, 2H, CH2), 2.75 (m, 2H, CH2), 1.48 (s,
18H, 6CH3 ) ppm. GPC: Mn 6,100; Mw 15,300; PDI 2.512.
68p was deprotected to make 68d by the general deprotection stated above. 'H
NMR (DMSO-D6): 8 9.65 (s, 1H, NH), 9.05 (s, 1H, NH), 8.87 (s, 1H, NH), 8.12 (s, 1H.
NH), 7.65 (m, 6H, phenyl H), 4.15 (m, 2H, CH2), 2.87 (m, 2H, CH2 ) ppm.
The polymerization to make 69p was carried out by the Sonogashira conditions
in 46% yield. !H NMR (CDCI3): 5 1 1.57 (s, 1H, NH), 8.55 (s, 1H, NH), 7.70 (m, 1H,
phenyl H), 7.53-7.34 (m, 5H, phenyl H), 3.58 (m, 2H, CH2), 2.75 (m, 2H, CH2), 1.48 (s,
18H, 6CH3) ppm. GPC: Mn 5,600; Mw 8,700; PDI 1.538.
69p was deprotected to make 69d by the general deprotection stated above. *H
NMR (DMSO-D6): 8 9.65 (s, 1H, NH), 9.05 (s, 1H, NH), 8.87 (s, 1H, NH), 8.12 (s, 1H,
NH), 7.65 (m, 6H, phenyl H), 4.15 (m, 2H, CH2), 2.87 (m, 2H, CH2) ppm.
6.7 Synthesis of Discrete Trimers
6.7.1 General Procedure for the Preparation of Discrete Oligomers
An airfree schlenk flask was charged with a magnetic stir bar and dried in the
oven then cooled under nitrogen, w-diethynylbenzene (0. 1 7 g, 1 .34 mmol, 0.25 mol
equiv.) was weighed directly into the schlenk flask. The halogenated monomer (2.04 g.
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5.38 mmol, 1 equiv.), Pd(PPh3 )4 (0.19 g, 0. 16 mmol, 0.03 equiv.), and Cul (0.06 g, 0.32
mmol, 0.06 equiv.) were added to the flask. The flask was then returned to positive
nitrogen pressure. Distilled diisopropylamine (DIPA) (17.3 mL, 123.6 mmol, 23 equiv.)
and dry toluene (60 mL) were added via syringe. The reaction was then placed in an oil
bath at 65°C and stirred overnight. The reaction was evaporated to dryness and the
product was purified by column chromatography first using dichloromethane and then
1% acetone/dichloromethane. If the product was still yellow in color after
chromatography, the impurity could be removed by titration with methanol to yield a
white solid.
6.7.2 General Procedure for the Deprotection of Discrete Oligomers
A round bottom flask was charged with a magnetic stir bar and the boc-protected
trimer (50 mg). The flask was then cooled to 0°C and 4M HC1 in dioxane (5 mL) was
added to the trimer. The solution was allowed to warm up to room temperature and stir
overnight. The solvent was evaporated under reduced pressure and the solid was
titrated with ether three times and dried under vacuum to produce a white solid
(quantitative yield).
6.7.3 Characterization of Discrete Oligomers
34p was prepared as described above in 30% yield. 'H NMR (CDC13 ): 8 7.68 (t,
1H, phenyl H), 7.56 (t, 2H, phenyl H), 7.51 (t, 1H, phenyl H), 7.48 (d, 1H, phenyl H),
7.37 (d, 1H, phenyl H), 7.34 (m, 2H, phenyl H), 7.31 (m, 2H, phenyl H), 4.58 (s, 2H,
2NH), 3.38 (m, 4H, 2CH2), 2.79 (t, 4H, 2CH2 ), 1.46 (s, 18H, 6CH3 ) ppm.
I3C NMR
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(CDC13 ): 8 156.1, 141.7, 135.1, 132.8, 132.5, 132.0, 131.1, 129.0, 125.4, 123.6, 122.7.
90.0, 88.9, 79.9, 41.8, 36.1, 31.3, 28.7 ppm. m/z [M++Na]: 745.3 [M +
-2Boc +2Na]:
567.2. The TLC for the purification of this compound is shown at the end of this
section in DCM.
34p was then deprotected to 34d as described above in quantitative yield. !H
NMR (DMSO-D6): 5 7.92 (s, 4H, 2NH2 ), 7.77 (t, 1H, phenyl H), 7.71 (t, 2H, phenyl H),
7.65 (t, 1H, phenyl H), 7.62 (m, 2H, phenyl H), 7.58 (d, 1H, phenyl H), 7.52 (m, 2H,
phenyl H), 3.11 (m, 4H, 2CH2 ), 2.92 (t, 4H, 2CH2 ) ppm. 13C NMR (CDCI3): 8 138.7,
134.6, 133.0, 131.8, 131.6, 128.6, 125.3, 122.9, 122.5, 89.8, 87.9, 60.3,58.2, 48.0,41.6,
40.4, 32.9 ppm.
35p was prepared as described above in 23% yield. !H NMR (CDC13 ): 8 7.69
(d, 1H, phenyl H), 7.66 (t, 2H, phenyl H), 7.50 (d, 2H, phenyl H), 7.48 (d, 1H, phenyl
H), 7.39 (m, 4H, phenyl H), 4.85 (s, 2H, 2NH), 4.24 (d, 4H, 2CH2 ), 4.15 (t, 4H, 2CH2),
1.91 (m, 4H, 2CH2), 1.48 (s, 18H, 6CH3), 1.60-1.37 (m, 8H, 4CH2 ), 0.92 (t, 6H, 2CH3 )
ppm. m/z [M++Na]: 983.2 [M+
-t-butyl +Na]: 927.2 [M+-2t-butyl +Na]: 871.2. The TLC
for the purification of this compound is shown at the end of this section in 20%
DCM/Hexane.
35p was deprotected to 35d as described above. *H NMR (DMSO): 8 8.29 (s,
5H, NH), 8.04 (s, 2H, phenyl H), 7.71 (s, 2H, phenyl H), 7.65-7.56 (m, 6H, phenyl H),
4.12 (t, 4H, 2CH2), 3.99 (s, 4H, 2CH2), 1.82 (m, 4H, 2CH2), 1.47 (m, 4H, 2CH2 ), 1.35








Figure 6.1: TLC of 34p (dichloromethane) and 35p (20%hexane/dichloromethane)
Arrows point to product. S=starting dihalogenated material, C = cospot, P= crude
reaction mixture.
6.8 Synthesis of Structure-Activity Relationship Monomers and Discrete
Oligomers
All oligomers were synthesized according the procedure listed in Section 6.7.1
and deprotected by the procedure in Section 6.7.2 unless otherwise noted. The
monomers were functionalized before doing the oligomerization reaction.
6.8.1 Characterization of Discrete Oligomers with Varying End Groups
36p: 'H NMR (CDC13 ): 5 7.68 (t, 1H, phenyl H), 7.50-7.46 (m, 4H, phenyl H),
7.38-7.33 (m, 3H, phenyl H), 7.24 (s, 2H, phenyl H), 4.85 (s, 2H, 2NH), 4.55 (s, 2H,
2NH), 4.16 (m, 4H, 2CH2 ), 3.38 (m, 4H, 2CH2 ), 2.80 (t, 4H, 2CH2), 1.46 (s, 36H,
12CH3 ) ppm. m/z +Na: 893.6.
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36d: lH NMR (DMSO): 8 8.45 (s, 4H, NH), 7.95 (s, 4H, NH), 7.75 (m, 1H,
phenyl H), 7.68-7.50 (m, 6H, phenyl H), 7.42 (m, 2H, phenyl H), 4.02 (s, 4H, 4CH 2),
3.15 (m, 4H, 2CH2), 2.95 (m, 4H, 2CH 2 ) ppm.
37p:
lH NMR (CDCI3): 5 7.70 (m, 1H, phenyl H), 7.57 (m, 1H, phenyl H), 7.51-
7.48 (m, 3H, phenyl H), 7.39-2.33 (m, 4H, phenyl H), 4.58 (s, 2H, 2NH), 4.38 (d, 2H,
CH2 ), 3.40 (m, 4H, 2CH2 ), 2.80 (t, 4H, 2CH2), 1.47 (s, 18H, 6CH3) ppm. m/z: 673.4.
37d: Not sufficient amount of sample to tell any more than the removal of Boc.
38p: 'H NMR (CDCI3): 5 7.72-7.65 (m, 2H, phenyl H), 7.59-7.46 (m, 4H,
phenyl H), 7.38-7.35 (m, 3H, phenyl H), 7.27 (s, 1H, phenyl H), 4.59 (s, 2H, 2NH), 4.50
(d, 4H, 2CH2), 3.39 (m, 4H, 2CH2), 2.79 (t, 4H, 2CH2), 1.46 (s, 18H, 6CH3) ppm. m/z:
673.4.
38d: Not sufficient amount of sample to tell any more than the removal of Boc.
39p: 'H NMR (CDCI3): 8 7.69 (m, 1H, phenyl H), 7.47 (m, 2H, phenyl H), 7.35
(m, 2H, phenyl H), 6.75 (s, 2H, phenyl H), 6.65 (s, 2H, phenyl H), 6.44 (s, 2H, phenyl
H), 4.85 (s, 2H, 2NH), 4.62 (s, 2H, 2NH), 3.39 (m, 8H, 4CH 2 ), 3.28 (m, 4H, NH), 2.72
(t, 4H, 2CH2), 1.47 (s, 36H, 12CH3 ) ppm. m/z: [M
+
+Na] 903.6, [M+ +2Na -Boc] 825.3,
[M+ +2Na -2Boc] 725.3, [M+ +2Na -3Boc] 625.4.
39d: 'H NMR (CDC13 ): 8 8.15 (m, 4H, 2NH2 ), 8.04 (m, 4H, 2NH2), 7.66 (m, 1H,
phenyl H), 7.57-7.45 (m, 4H, phenyl H), 7.26 (m, 1H, phenyl H), 7.00-6.97 (m, 1H,
phenyl H), 6.70 (d, 2H, phenyl H), 6.60 (s, 1H, phenyl H), 3.17 (t, 4H, 2CH2), 2.88 (m.
8H, 4CH2), 2.80 (t, 4H, 2CH2 ) ppm.
40p: 'H NMR (CDCI3): 8 7.72 (t, 1H, phenyl H), 7.51 (t, 2H, phenyl H), 7.49 (d,
1H, phenyl H), 7.43-7.48 (m, 4H, phenyl H), 7.34 (m, 2H, phenyl H), 7.32 (m, 2H,
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phenyl H), 7.28 (s, 1H, phenyl H), 7.21 (m, 2H, phenyl H), 4.58 (s, 2H, 2NH), 3.41 (m,
4H, 2CH 2 ), 2.82 (t, 4H, 2CH 2 ), 1.46 (s, 18H, 6CH 3 ) ppm. m/r. 587.3.
40d: 'H NMR (DMSO): 8 7.87 (s, 4H, NH), 7.77 (t, 1H, phenyl H), 7.72-7.63
(m, 2H, phenyl H), 7.62-7.58 (m, 2H, phenyl H), 7.55-7.32 (m, 8H. phenyl H), 3.10 (m,
4H, 2CH2), 2.90 (t, 4H, 2CH2 ) ppm.
46p: 'H NMR (CDCI3): 5 8.45 (t, 2H, phenyl H), 7.66 (t, 1H, phenyl H), 7.57 (t,
2H, phenyl H), 7.51 (t, 1H, phenyl H), 7.48 (t, 1H, phenyl H), 7.38-7.34 (m, 5H, phenyl
H), 3.69 (m, 4H, 2CH2 ), 2.87 (t, 4H, 2CH 2 ), 1.49 (s, 36H, 12CH3) ppm. m/r. 673.4.
46d: Not sufficient amount of sample to tell any more than the removal of Boc.
47p: 'H NMR (CDCI3): 5 7.98 (t, 2H, phenyl H), 7.93 (t, 2H, phenyl H), 7.78 (t,
2H, phenyl H), 7.69 (t, 1H, phenyl H), 7.52-7.50 (m, 4H, phenyl H), 7.38 (t, 1H, phenyl
H), 5.05 (t, 2H, 2NH), 3.57 (m, 4H, 2CH2 ), 3.45 (m, 4H, 2CH2 ), 1.49 (s, 18H, 6CH3)
ppm. m/z [M+Cl"]: 843.5.
47d: 'H NMR (DMSO): 8 7.96 (s, 4H, 2NH), 7.82-7.77 (m, 2H, phenyl H), 7.70
(m, 2H, phenyl H), 7.65-7.52 (m, 6H, phenyl H), 3.10 (s, 4H, 2CH2 ), 2.93 (m, 4H,
2CH2 ) ppm.
48p: 'H NMR (CDC1 3 ): 8 7.70 (t, 1H, phenyl H), 7.65 (t, 2H, phenyl H), 7.52
(m, 3H, phenyl H), 7.49 (m, 3H, phenyl H), 7.40-7.37 (m, 1H, phenyl H), 5.07 (s, 4H,
2CH2), 1.52 (s, 18H, 6CH3) ppm. m/z: [M+ +Na] 719.2, [M+ +Na -t-butyl] 663.2, [M +
+Na -2t-butyl] 607. 1
.
48d: 'H NMR (DMSO): 8 7.79 (m, 1H, phenyl H), 7.70-7.62 (m, 3H, phenyl H),
7.61 (d, 1H, phenyl H), 7.57 (m, 2H, phenyl H), 7.51 (s, 3H, phenyl H), 5.45 (s, 2H,
NH), 4.52 (s, 4H, 2CH 2 ) ppm.
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49p: 'H NMR (CDC1 3 ): 8 7.69 (t, 1H, phenyl H), 7.53 (m, 2H5 phenyl H), 7.49
(m, 1H, phenyl H), 7.37 (d, 1H, phenyl H), 7.33 (m, 1H, phenyl H), 7.30 (m, 2H. phenyl
H), 7.28 (s, 1H, phenyl H), 4.57 (s, 2H, 2NH), 3.19 (m, 4H, 2CH2 ), 2.64 (t, 4H, 2CH2),
1.84 (m, 4H, 2CH2), 1.47 (s, 18H, 6CH3) ppm. m/z: [M+ +Na] 773.3, [M+ +Na
-t-butyl]
717.2, [M+ -Boc] 649.1, [M+ +Na
-2Boc] 572.2.
49d: lH NMR (DMSO): 5 7.89 (s, 4H, 2NH 2 ), 7.77 (m, 1H, phenyl H), 7.65-
7.63 (m, 2H, phenyl H), 7.61 (d, 1H, phenyl H), 7.56 (m, 2H, phenyl H), 7.48 (m, 2H,
phenyl H), 2.77-2.67 (m, 8H, 4CH2), 1.87 (m, 4H, 2CH2 ) ppm.
50p: 'H NMR (CDCI3): 8 7.71-7.66 (m, 5H, phenyl H), 7.55-7.50 (m, 10H,
phenyl H), 7.38 (t, 3H, phenyl H), 5.12 (s, 2H, 2NH), 5.07 (s, 4H, 2CH2 ), 1.47 (s, 27H,
9CH3 ) ppm. m/z: [M+ +Na] 1049.2, [M+ +Na -t-butyl] 993.2, [M+ +Na
-2t-butyl -Boc]
834.3.
50d: 'H NMR (DMSO): 5 7.78-7.52 (m, 17H, phenyl H), 5.45 (s, 3H, 3NH),
.
4.52 (s, 6H, 3CH2) ppm.
51p: 'H NMR (CDC1 3 ): 5 7.75-7.63 (m, 6H, phenyl H), 7.56-7.50 (m, 13H,
phenyl H), 7.44-7.37 (m, 4H, phenyl H), 5.12 (s, 4H, 4NH), 5.07 (s, 8H, 4CH2 ), 1.53 (s,
36H, 12CH3)ppm.
51d: 'H NMR (DMSO): 8 7.79-7.50 (m, 24H, phenyl H), 5.45 (s, 4H, 4NH),
4.52 (s, 8H, 4CH2 ) ppm. m/z: [M
+
+Na] 1379.1.
58p: Missing NMR and no more sample to retake.
58d: 'H NMR (DMSO): 8 8.05 (s, 4H, 2NH2), 7.75-7.45 (m, 8H, phenyl H),
6.50 (s, 6H, 2CH3 ) 3.10 (m, 4H, 2CH2), 2.95 (m, 4H, 2CH2 ) ppm.
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59p: 'H NMR (CDCI3): 8 12.47 (s, 2H, 2NH), 8.56 (t, IH, NH), 7.73 (d, 2H,
phenyl H), 7.67 (t, IH, phenyl H), 7.52 (m, 2H, phenyl H), 7.43 (d, 2H, phenyl H), 7.38
(t, IH, phenyl H), 4.54 (d, 2H, 2NH), 4.15 (t, 4H, 2CH2), 1.92 (m, 4H, 2CH 2 ), 1.52 (s,
36H, 12CH3 ), 1.60-1.42 (m, 4H, 2CH2), 1.27 (t, 8H, 4CH 2 ), 0.92 (t, 6H, 2CH3 ) ppm.
m/z: [M+Na] 1321.3, [M+
-Boc] 1 199.3, [M+
-2Boc] 1098.2, [M+
-3Boc] 998.2, [M+ -
4Boc] 897.2.
59d: Not sufficient amount of sample to tell any more than the removal of Boc.
6.8.2 Synthesis and Characterization of Monomers for SAR Study
43: An airfree schlenk flask was charged with a magnetic stir bar and dried in
the oven then cooled under nitrogen. The halogenated monomer, 16, (0.050 g, 0.1389
mmol, 1 equiv.), Pd(PPh3 )4 (0.0038 g, 0.0033 mmol, 0.025 equiv.), and Cul (0.0006 g,
0.0032 mmol, 0.025 equiv.) were added to the flask. 41 (0.0077 g, 0.1384 mmol, 1.05
mol equiv.) was added directly into the schlenk flask. The flask was then returned to
positive nitrogen pressure. Triethylamine (1 .5 mL, from a sure seal bottle) was added.
The reaction was then placed in an oil bath at 65°C and stirred overnight. The reaction
was orange the next morning and it was evaporated to dryness and the product was
purified by column chromatography in 10% ethyl acetate/dichloromethane yielding
52.4%. 'H NMR (CDCI3): 5 7.46 (t, IH, phenyl H), 7.32 (t, IH, phenyl H), 7.22 (t, IH,
phenyl H), 4.50 (m, 3H, NH, CH2 ), 3.36 (m, 2H, CH2), 2.76 (m, 2H, CH2 ), 1.48 (s, 9H,
3CH3) ppm.
44: An airfree schlenk flask was charged with a magnetic stir bar and dried in
the oven then cooled under nitrogen. The halogenated monomer, 16, (0.0613 g, 0.1618
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mmol,
1 equiv.), Pd(PPh3 )4 (0.0047 g, 0.0040 mmol, 0.025 equiv.), and Cul (0.0008 g,
0.0040 mmol, 0.025 equiv.) were added to the flask. 42 (0.0276 g, 0. 1 780 mmol, 1
.
1
mol equiv.) was added direetly into the sehlenk flask. The flask was then returned to
positive nitrogen pressure. Triethylamine (4mL, from a sure seal bottle) was added.
The reaction was then plaeed in an oil bath at 65°C and stirred overnight. The reaction
was orange the next morning and it was evaporated to dryness and the product was
purified by column chromatography in 5% ethyl acetate/dichloromethane yielding 47%,
'H NMR (CDC1 3 ): 8 7.43 (t, 1H, phenyl H), 7.30 (t. 1H, phenyl H), 7.19 (t, 1H, phenyl
H), 4.80 (s, 1H, NH), 4.57 (s, 1H, NH), 4.16 (m, 2H, CH2 ), 3.35 (m, 2H, CH2 ), 2.76 (t,
2H, CH2), 1.48 (s, 18H, 6CH3) ppm.
45: An airfree sehlenk flask was charged with a magnetic stir bar and dried in
the oven then cooled under nitrogen. The halogenated monomer, 16, (0.05 g, 0.1318
mmol, 1 equiv), potassium phosphate (0.056 g, 0.264 mmol, 2 equiv), salicylamide
(0.0051 g, 0.0263 mmol, 0.2 equiv), and copper iodide (0.0013 g, 0.0066 mmol, 0.05
equiv) were added directly into the sehlenk flask. The flask was kept under positive
pressure of nitrogen and 0.4 mL DMF (sure seal) and ethylene diamine boc (0.023 g,
0.145 mmol, 1.1 equiv.) were added. The reaction was placed in an oil bath at 90°C
overnight and was yellowish/red the next morning. The product was extracted with
ethyl actetate/5% aqueous sodium hydroxide and rotovapped to dryness. The product
was run through a silica plug yielding 52.8%. 'H NMR (CDC1 3 ): 5 6.66 (s, 1H, phenyl
H), 6.60 (s, 1H, phenyl H), 6.34 (s, 1H, phenyl H), 4.85 (s, 1H, NH), 4.61 (s, 1H, NH),
3.36 (m, 4H, 2CH2), 3.23 (s, 1H, NH), 2.67 (t, 2H, CH2), 1.46 (s, 18H, 6CH3) ppm.
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52: A round bottom flask was charged with a magnetic stir bar and Hushed with
nitrogen. The halogenated monomer, 11, (49.7 mg, 0.1775 mmol, 1 equiv.), EDC
(0.0580 g, 0. 1 95 mmol, 1 .
1
equiv), HOBt (0.0264 g, 0. 1 95 mmol, 1 . 1 equiv.), and
ethylene diamine hoc (0.031
3 g, 0.1 95 mmol, 1.1 equiv.) were added to the flask. Dry
DMF (1.5 mL, sure seal) was added and the reaction was allowed to flush with nitrogen
and stir over night. The product was extracted with water and dichloromethane and
rotovapped to dryness yielding 63%. 'll NMR (CDCI3): 5 7.92 (s, 211, phenyl II), 7.79
(s, 1 H, phenyl H), 5.02 (s, 1 1 1, Ni l), 3.54 (m, 2H, CH2), 3.44 (t, 2H, CH 2 ), 1 .48 (s, 91 1.
3CH3) ppm.
53: A round bottom flask was charged with a magnetic stir bar and flushed with
nitrogen. 12 (l.OOOg, 3.759 mmol, 1 equiv.) and sodium azide (0.2932 g, 4.51 1 mmol,
1
.2 equiv.) were added to the flask and dissolved in 20 mL dry DMF (sure seal).
Triphenyl phosphine (2.1693 g, 8.27 mmol, 2.2 equiv.) was added slowly. The reaction
was submerged in a 90°C oil bath overnight. The next morning the reaction was
quenched with water and extracted with dichloromethane. The product was purified by
column chromatography in dichloromethane and then taken up in methanol, cooled to
0°C, and precipitated with HC1. The solid was collected and dried under vacuum
yielding 75%. 'H NMR (CDCI3): 5 7.63 (s, 1H, phenyl H), 7.50 (s, 2H, phenyl H), 4.47
(t, 2H, CH2 ), 3.15 (t, 2H, NH) ppm.
54: A round bottom flask was charged with a magnetic stir bar, the amine, 53,
(0.7078 g, 2.36 mmol, 1 equiv.), and d\-(er(-buty\ dicarbonate (0.7741 g, 3.55 mmol, 1.5
mol equiv.). Dimethyl formamide (9 mL) was added to the vial and the solution was
allowed to stir. After the solution was homogeneous, sodium hydroxide (0.208 g, 5.207
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mmol, 2.2 equiv.) and distilled water (3 ml) were added. The reaction was covered in
aluminum foil and allowed to stir overnight. Some white precipitate was present.
Addition of more water preeipitates the product. The solid was filtered, dissolved in
ether, and dried over magnesium sulfate. The solvent was evaporated under reduced
pressure. The product was further purified by silica column chromatography in 10%
dichloromethane/hexane to yield a white solid, 54, in 93% yield. lH NMR (CDC13): 8
7.63 (s, 1H, phenyl H), 7.47 (s, 2H, phenyl I I), 5.03 (s, 2H, CH 2 ), 1.52 (s, 9H, 3CH3)
ppm. m/z: [M + ] 366, [M + -Boc] 266.
55: An airfree schlenk flask was charged with a magnetic stir bar, dried in the
oven, and flame dried while cooling under nitrogen. The flask was charged with dry
THF (1.0 mL, distilled from sodium) and acetonitrile (0.0312 g, 0.7602 mmol, 2.5
equiv.). The solution was cooled to -78°C before adding 2.87 M «-butyl lithium (0.286
mL, 0.8217 mmol, 2.7 equiv.). This solution was allowed to stir for an hour at
-78°C
and was yellowish in color with some solid. After an hour, a solution of 13 (0.1 g,
0.304 mmol, 1 equiv.) in 0.4 mL THF was added and the solution turned reddish. The
solution was allowed to stir for another hour before warming to room temperature and
adding water. The product was extracted with dichloromethane and purified by column
chromatography on silica in dichloromethane yielding 75%. (Note: This reaction is size
dependent. On a larger scale (4 g) the yield was 10 %.) 1 1 1 NMR (CDC1 3 ): 5 7.62 (s,
1H, phenyl H), 7.35 (s, 2H, phenyl H), 2.93 (m, 4H, 2CH2 ), 2.65 (t, 2H, CH2) ppm.
56: A round bottom flask was equipped with a stir bar and charged with dry
THF (20 mL) and purged with nitrogen. The solution was cooled to 0°C in an ice bath.
55, (0.3 g, 1.03 mmol, 1 equiv.) was dissolved and 1.0 M BH3 THF (17.6 mL, 17.6
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was
mmol, 17 equiv.) was added cautiously to the flask and allowed to stir. The iee bath
was removed and a heating mantle and condenser were installed. The reaction was
allowed to reflux overnight. The heating mantle was removed and the reaction was
allowed to cool to 0°C for 30 minutes. Methanol was added cautiously, via syringe until
bubbling ceased. The mixture was evaporated under reduced pressure and washed three
times with methanol. The viscous oil was then taken up in methanol and cooled to 0°C.
Concentrated HC1 was added to the solution until precipitate formed. The solution
removed from the ice bath and rotovapped to a white solid in 43% yield. 'H NMR
(MeOD): 8 5.50 (s, 1H, phenyl H), 5.36 (s, 2H, phenyl H), 1.69 (s, 2H, CH2), 1.50 (t,
2H, CH2), 1.24 (t, 2H, CH2) ppm.
57: A round bottom flask was charged with a magnetic stir bar, the amine, 56,
(0.1467 g, 0.445 mmol, 1 equiv.), and di-tert-butyl dicarbonate (0.1456 g, 0.667 mmol,
1.5 mol equiv.). Dimethylformamide (2 mL) was added to the vial and the solution was
allowed to stir. After the solution was homogeneous, sodium hydroxide (0.0392 g,
0.979 mmol, 2.2 equiv.) and distilled water (0.8 mL) were added. The reaction was
covered in aluminum foil and allowed to stir overnight. Some white precipitate was
present. Addition of more water precipitates the product. The solid was filtered,
dissolved in ether, and dried over magnesium sulfate. The solvent was evaporated
under reduced pressure. A white solid, 57, was collected and dried under vacuum (yield
75%). 'H NMR (CDC13 ): 5 7.51 (s, 1H, phenyl H), 7.33 (s, 2H, phenyl H), 4.55 (s, 1H,
NH), 3.15 (m, 2H, CH2 ), 2.60 (m, 2H, CH2), 1.79 (m, 2H, CH2 ), 1.46 (s, 9H, 3CH3 )
ppm.
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6.9 Characterization of Facial Amphiphilicity and Aggregation
6.9.1 Langmuir Data
A Langmuir trough equipped with a Cahn electrobalance was used for
monolayer measurements. The surface pressure measurements were obtained using a
Wilhelmy plate attached to the Cahn electrobalance. The barriers were compressed at
0.1648 cm/min. The film was made by spreading 50 uL of a solution containing 0.5
mg/mL of polymer in 5% DMSO/CHCl 3 on the surface. For the reversibility
experiment, the barriers were compressed, allowed to relax, and recompressed. The
surface pressure was monitored during the whole experiment.
A program was written in LabView to run barrier compression in the Langmuir
trough and determine the surface pressure of the water for each i th data point. This
program was written by a previous student in Dr. Hsu's group and is no longer
available. The following equations were used to process the raw data into surface
pressure-area isotherms.
To determine the starting area per repeat unit (A0) of the polymer molecule:
MW
' repealA A ( ^ > \
^0 - ^trOUghK gy )
Where MWrepeat is the molecular weight of the repeat unit, NA is Avogadro's
number, C is the concentration of the polymer solution, and V is the volume of the
polymer solution added.





Where L0 is the starting length between the barriers, AL is the final change ir
length between the barriers, i is the data point number, N, is the total number of data
points, and W is the width of the trough.










is the slope of the calibration curve of surface tension, nwater is the
surface pressure of pure water, U
x
is the surface pressure of the ith data point, Ap , ate is the
area of the Whilhelmy plate, and Ica , is the intercept of the surface tension calibration
curve
From these calculated areas and surface pressures, the surface-pressure isotherm
can be generated. The steepest part of the slope can be extrapolated to zero surface
pressure to determine the area per repeat unit of the molecule. If the area per molecule
is desired then, instead of using the molecular weight per repeat unit (MWrepeat) in the
equations above, the total molecular weight of the polymer could be used.
6.9.2 Emission Studies
The fluorescence of the polymer solutions was initially monitored in several
solvents to determine the effect of solvation of the polymer fluorescence. After
determining the initial emission, the fluorescence was monitored with increasing
percentage of water. A stock solution of polymer was made in DMSO as to keep the
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concentration constant throughout the experiment. The samples were at a concentration
where the UV absorbance was less that 0. 1 so that inner filter effects were minimal.
Fluorescence was also monitored with the addition of polymer solution in DMSO to the
buffer used for the lysis data. The percentage of water in these experiments ranged from
96% to 98.5%.
6.9.3 Turbidity Data with Varying Polymers
Turbidity experiments were run with polymer dissolved in a DMSO solution at
lmg/mL added in varying concentrations to either water or a buffered solution (90 mM
NaCl, 10 mM Na2P04 , pH 7). Mixed solutions were then allowed to equilibrate for
several minutes before measuring the optical density at 500 nm (OD500). OD500 was
measured for six consecutive runs, and the numerical values were averaged. Data was
then plotted as percent transmission versus concentration.
6.10 Antimicrobial Activity
6.10.1 Antimicrobial Testing
Compounds were dissolved in DMSO to make a stock solution, which was then
diluted into 96-well plates and diluted with Mueller Hinton (MH) medium to a constant
volume. All bacteria were either taken from stock glycerol solutions or from a frozen
stock, diluted into MH medium, and grown overnight at 37°C. Subsamples of these
cultures were grown for 3 hours, the OD6oo was measured, and then the cells were
diluted to 0.001 OD60o. The diluted cell solutions (approximately 10 5 cells/mL) were
then added to the 96-well plate and incubated at 37°C for 20 hours. The MIC values
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reported in Table 1 are the minimum concentration necessary to inhibit 90% of the cell
growth. This was determined by measuring cell growth at OD600 after 20 hours in two-
fold serial dilutions of the abiogenic polymer following standard protocols.(l) All
reported values represent a minimum of duplicate experiments.
6.10.2 Hemolysis Assay
Hemolysis experiments were performed by incubating a 0.35% (v/v) suspension
of fresh human erythrocytes in 10 mM TRIS buffer containing 150 mM NaCl at pH 7.0
with varying amounts of polymer. Hemolysis samples were prepared by combining 80
uL of the washed RBC suspension and 20 uL total of buffer and polymer solution in 96-
well plates. After incubation for 30 minutes at 37°C, the suspensions were concentrated
at lOOOx "g" for 5 minutes. An aliquiot of the supernatant was diluted with buffer and
the OD414 of the solution was measured to quantitate released hemoglobin. Complete
hemolysis was measured by adding 1% Triton X-100 to the RBC's and measuring
OD414. Non-linear exponential curve-fitting plots of OD414 vs. polymer concentration
resulted in HC50 , the hemolytic dose required to lyse 50% of the RBCs.
6.10.3 Minimal Bactericidal Concentration
Minimal bactericidal concentrations (MBC) were measured by preparing serial
ten-fold dilutions from the growth inhibition assay, and plating them on nutrient agar
plates. The plates were incubated overnight at 37°C and the colonies were counted the
next morning. The MBC is defined as the minimum concentration at which a 99.9%
reduction in the number of colonies of the original inoculums occurred.
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6.10.4 MIC in the Presence of Whole Blood
The antibacterial activity in the presence of whole blood was examined in sterile
96-well plates in a final volume of 100 uL per well. Aliquots of 80 uL of a bacterial
suspension diluted to an OD600 of 0.001 were added to 20 uL of a mixture of 1% whole
blood, the compound in DMSO, and medium. The concentration of the active
compound decreased in 2-fold serial dilutions while the amount of whole blood
remained constant at 1%. Three independent experiments were performed: (a) co-
incubation of blood, compound, and the suspension of bacteria; (b) a mixture of blood
and compound was preincubated for 30 minutes at 37°C, after which the suspension of
bacteria was added; (c) the compound was first mixed with the suspension of bacteria
and preincubated for 30 minutes at 37°C, after which the blood was added. Growth
inhibition was determined by plating out dilutions of 1:100 of each well after incubation
of the completed mixtures at 37°C for 6 hours. Antibacterial activity is expressed as the
minimum inhibitory concentration (MIC90) at which 90% inhibition of growth was
observed after incubating the spread plates for 1 8 hours.
6.10.5 Killing Kinetics
Time-kill studies were performed for the Gram-negative E. coli D3 1 and the
Gram-positive B. subtilis ATCC 8037 to measure the time dependence of bactericidal
activity following the guidelines of the NCCLS (NCCLS 1999) with small variations.
Generally, cells grown in Mueller-Hinton broth to OD -0.2 in mid-log phase were
adjusted to OD 0.02, and amended with a range of the compound in question at
concentrations from 0 to 2 times the MIC90 for each strain. Aliquots from the assay
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were removed at eertain time intervals (0, 5 mm, 10 min, and 30 min), immediately
diluted 1 : 1 00 to remove the effeets of the drug, and visualized under the microscope.
At each time point, three samples were quantified and averaged to produce the number
of bacterial survivors.
6.10.6 Resistance Studies
E.coli and S. aureus were used to look for the development of resistance toward
the discrete oligomer.(2-4) Control antibiotics used were ciprofloxacin for E.coli and
penicillin for S.aureus. For each compound, the amount needed to achieve one half the
MIC90 value in 200uL of M-H media was determined and metered out with media to
make lOuL. Cultures of the bacteria were grown overnight at 37°C with agitation and
the OD60o values determined. The cultures were diluted to an OD600 of 0.001 in fresh M-
H and 190uL of each was metered out into the well of a 96-well polystyrene plate
containing the proper antibiotic. After roughly 24h the OD600 was determined using a
96-well plate reader and the cultures were diluted again to an OD60o of 0.001, 190uL
were then added to new wells containing the proper antibiotic. Every 4 days four tubes
are inoculated with £.co///active compound, £.co/z/ciprofloxacin, S.aureus/active
compound, and S.aureus/peniciWm, grown overnight at 37°C, diluted in the morning and
regrown into the log phase (~2.5-3h) in fresh M-H media. These log cells are then used
for determining the MIC values and to look for an increase in concentration for the




6.11.1 Making the Polymer Plugs
Two different polymers, polyurethane (PU, from the Army lot #RLE16133C02)
and polyvinyl ehloride) (PVC, Self-Cath® by Mentor, 14Fr Ref 414), were used to test
the incorporation of the antibacterial compound into materials. To make the
antibacterial incorporated polymer plugs, a solution of the antibacterial compound
(2mg/mL) was added to the polymer solution to a final concentration of 5% v/v active
compound/polymer substrate (in the case of PVC, the polymer was first dissolved in
lg/5mL THF). Then 0.25 mL of the mixture was placed in the bottom of a glass vial.
The plugs were allowed to harden overnight and then were placed in a vacuum oven for
12 hours to remove all residual solvent. To make the control plugs, 0.25 mL of the
solution of the polymer was added to the vial and treated the same as the antibacterial
samples. The final weight percent of the treated polymer plugs were 0.05% and 0.008%
for PVC and PU respectively.
6.11.2 Testing the Materials Antibacterial Properties
Both sets of polymer plugs were tested for their antibacterial properties.
Generally, the bacterium were grown overnight and diluted to an OD60o of 0.001 in fresh
media to use as inoculums. 1 mL of fresh media was added to the vial with the polymer
plug and was inoculated with 50 uL of the bacterial solution. The samples were
incubated for 24 hours at 37°C with gentle shaking.
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For the PU samples, the media was then gently removed and 500 uL of fresh
media was added so that the biofilm was not disturbed and the unattached cells were
removed. 2.5 uL of 10 mg/mL solution ofTTC was added to make a 0.005 o/o v/v
solution and the sample was incubated for another ninety minutes. Following
incubation, a red color developed indicating metabolism of the dye by the bacteria. 150
uL of the solution was transferred into a 96 well plate and read on the plate reader at
490 nm.
The PVC samples could not be quantified in this way since the plugs often
floated off the bottom of the glass vial. After incubating for 24 hours, the media was
analyzed under the microscope and no bacteria were observed. The solution above the
plug was also visibly clear.
6.11.3 Leaching Experiment
To determine if the active compound was leaching, an HPLC (high performance
liquid chromatography) experiment was performed. In this experiment, the prepared PU
plugs (treated and untreated samples) were incubated with pure water and 10 uL
aliquots were removed at specific time points (0, lh, 2h, 4h, 6h, 8h, 12h, 27h, 36h, 48h,
72h, 96h, 120h). Each of these samples was diluted to lmL volumes with pure water
and run on the HPLC in pure water. The initial data was collected at all wavelengths;
however it was analyzed at 190 nm. This wavelength is where the intensity of the
control sample is maximal. The area of the peak was compared to a control sample with
the concentration of active compound expected if 100% of it leached out.
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6.12 Testing Breast Cancer Cell Activity
Two human breast cancer cell lines, MCF-7 (ATCC HTB-22) and TMX2-28,
and one non-cancerous breast cell line, MCF-10A (ATCC CRL-10317), were used in
this study. The MCF-7 and TMX2-28 cells were grown in DC 5 cell growth media while
the MCF-10A cells were grown in MEGM, both supplemented with 5% bovine growth
serum. The cells were grown using standard techniques. In short, the cells were seeded
in flasks and allowed to incubate at 37°C with 5% C02 . When the cells reached 50%
confluence they were split into several flasks. After growing again to 50% confluence,
the cells were removed from the flasks using trypsin. The trypsin was then removed
from solution by centrifugation and the cells were resuspended into fresh medium.
Sterile 96 well plates were seeded at a density of 10,000 cells/well and allowed to grow
overnight yielding 50% confluence. The molecules were then added to solution and
allowed to further incubate for 48 hours. An XTT kit (purchased from Roche) was used
to determine the amount of metabolizing cells in each well.
6.13 Lysis Data
6.13.1 Preparation of the Vesicles
Vesicles were prepared using the film rehydration method. The desired amount
of lipid solution was transferred to a glass vial and dried using nitrogen to form a thin
film on the wall of the vial. Either buffer or calcein solution (40 mM calcein in pH 7
mM Na2P04 buffer) was added to the lipid film to a final concentration of 10 umol
lipid/mL of solution. The solution was then warmed in water and frozen in
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acetone/liquid nitrogen for three cye,es and then sonicated for , 5 minutes making the
solution less clear. This procedure was repeated for another sonication cycle, ultimately
ending with freezing and warming the solution. In the case of the calcein encapsulated
vesicles, the vesicles were then run through a size exclusion Sephadex G-25 column to
remove the excess dye and collect the vesicles. The vesicles were used within two days
for best results
6.13.2 Leakage Experiments
Calcein leakage experiments were performed by using vesicles in a pH 7.0
sodium phosphate buffered solution and adding various amounts of polymer in
DMSO.(5-7) Emission at 515 nm was monitored over time. The excitation wavelength
was 490 nm. The percentage ofDMSO in any given experiment was less than 4%. The
vesicles were not lysed by the presence ofDMSO, as tested by the addition of pure
DMSO. After monitoring the fluorescence of the polymer, 50 uL of 0.2% triton X-100
was added to determine the intensity at 100% lysis.
6.13.3 Lipid Movement Experiments
The lipid movement experiments were performed by using asymmetrically
labeled vesicles.(8) In this case, the vesicles were prepared using 0.5 mol % head-group
NBD-PS lipids to make symmetrically labeled vesicles. The NBD fluorescence of the
outer leaflet of the vesicle was quenched by dithionite reduction by adding 75 uL of 1
M
sodium hydrosulfite/lM Tris to 1 mL of vesicles and allowing incubation for 15
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minutes. Only the amount of vesieles to be used was asymmetrically quenched sinee the
quencher in the aqueous solution was not removed.
The fraction of the NBD-lipids that had moved from the inner to the outer leaflet
of the vesicles with the addition of the active compound was determined by dithionite
quenching. The asymmetric vesicles (25 uL) were added to buffer (lmL). 10 uX of
quencher solution was added to the 1 .025 uL solution to make a total volume of 1 .035
ML. To this solution, varying concentrations of the active compound was added from a
stock solution of 2mg/mL keeping the DMSO concentration less than 5%. DMSO did
not have an effect on lipid movement as determined by adding pure DMSO. The
fluorescence was monitored at 530 nm (exciting at 450). The resulting fluorescence
values were normalized to the intensity prior to addition of the active agent.
6.14 Membrane Activity with Living Cells
Cytoplasmic membrane permeability was measured using the membrane
potential-sensitive cyanine dye diSC3-5.(9-14) This dye is known to distribute between
the cells and the medium depending on the membrane potential gradient. Once the dye
is inside the membrane, it aggregates and self-quenches. With the addition of a
membrane permeabilizing agent, the dye is released and fluorescence over time can be
monitored. In this experiment, S. aureus ATCC 25923 was used and grown at 37°C
with shaking until mid-logarithmic phase. The cells were collected by centrifugation,
washed once with buffer (5mM HEPES, pH 7, 5mM glucose) and resuspended until an
optical density (OD6oo) of 0.05. The cells were incubated with 0.4 uM diSC3-5 for an
hour for maximal uptake of the dye after which 100 mM KG was added to equilibrate
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the cytoplasmic and external potassium ion concentration. The cells were mixed with
the concentration of active compound desired and the fluorescence was monitored using
a Perkin-Elmer Model LS5 spectrophotometer with an excitation wavelength of 622 nm
and an emission wavelength of 670 nm. The dye release with the addition of 1%
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CONFORMATIONAL CHANGES OF FACIALLY AMPHIPHILIC META-
POLY(PHENYLENE ETHYNYLENE)S IN AQUEOUS SOLUTION
A.l Introduction
Many natural molecules take on different conformations depending on their
environment and sequence. These conformations can be stabilized by noncovalent
interactions such as hydrogen bonding, the hydrophobic effect, or van der Waals
forces.(l) A challenging but interesting problem is faced when trying to prepare
synthetic, non-biological molecules that will react similarly to changes in their
environment. Success in this area may provide a simpler model for complex
macromolecules and lead to insight on the formation of secondary, tertiary, and
quaternary structures of natural molecules. Although folded structures induced by
specific metal-ligand and hydrogen bonding have been widely studied,(2-6) there are
only a few reports on the use of solvophobic(7-9) or tt-te stacking interactions(10, 1 1) to
control conformation. Alternately, it is known that when traditional synthetic
macromolecules, such as polymers, are placed in poor solvents, they form collapsed,
dense globular structures lacking well-defined order and when placed in a good solvent
the molecules assume an expanded, random coil structure but still lack internal
order.(12, 13)
There has been recent interest in molecules that form well defined, ordered
structures in solution.(14-16) Fleet and co-workers synthesized oligomers of furanose
with only four repeat units that adopt secondary structures held together by hydrogen
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bonding.(17) 0-ammo acid oligomers as short as six residues have been reported to
form stable helices.(18, 19) Zuckermann and co-workers synthesized oligo-N-
substituted-glycines of various lengths and despite the achirality of the backbone and the
lack of internal hydrogen bonds, these molecules form helical structures.(20) In
addition, aromatic amides adopt well-defined crescent and helical structures.(21-25) A
common theme of this research is that the molecules studied are discrete oligomers
where the structure can be controlled by changes in temperature or pH.
Moore and co-workers reported aromatic hydrocarbon backbones based on meta-
phenylene ethynylene (m-PE) in which solvent was used to influence an extended
random coil or helical structure^, 9, 26) By attaching polar triethylene glycol side
chains to the nonpolar m-PE backbone, high dielectric constant solvents induce
collapsed (helical) structures which minimize solvent-backbone interactions while
maximizing solvent-side chain contacts. Structural investigations into helix stability
have included the addition of methyl groups(27) and metal-ligands(6) to the helix
interior, aromatic ring electronics,(8) and hydrogen bonding.(28) By manipulating the
linker functionality between the ethylene glycol chain and the PE backbone, it is
possible to influence the stability of the collapsed, helical structure in solution.(8, 29)
The coil-helix folding transition of these oligomers has been conveniently monitored by
UV-Vis and fluorescence spectroscopy(8, 29) and confirmed by chiral guest induced
circular dichroism.(27) Like other studies on folding oligomers, only discrete chain
length m-PEs have been studied so that the influence of molecular weight polydispersity
is not known.
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We have been interested in the study of facially amphophilic polymers based on
^-poly(phenylene ethynylene)s(30) (m-PPE) and langmuir experiments performed
on these molecules confirmed their amphiphilicity at the air-water interface by adopting
an extended structure^ 1) During this research, we observed a clear difference in
properties between facially amphiphilic m-PPEs with and without alkyl side chains.
The fact that molecules of m-PPE lacking an alkyl side chain consistently provided
different results from those with an alkyl substituent prompted us to investigate the
possibility of helix formation in polymeric m-PPEs with cationic, polar side chains.
The alkyl side chain would be located in the helix interior upon folding and the absence
of this group would allow helix formation.
A.2 Experimental
The synthesis of polymers 70d and 25d followed previously reported procedures
and polymers 71 d and 32 were synthesized using similar procedures.QO) 'H and 13C
NMR spectra were obtained at 300 MHz with a Bruker DPX-300 NMR spectrometer.
The gel permeation chromatography (GPC) experiment was performed in THF at room
temperature using a PL LC 1 120 pump, a Waters R403 differential refractometer, and





and 103 A). The system was calibrated with polystyrene
standards. Absorption spectra were measured on a Hewlett Packard 8453
spectrophotometer. Emission and excitation spectra were taken on a Perkin-Elmer LS
50B spectrometer with a xenon lamp light source.
To determine the corrected n values listed in Table 1, 25d was fractionated by
the GPC. Refractive index detector was used to monitor peak elution and 0.3 mL
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fractions were collected during the elntion totaling 20 samples. These fractions were
then analyzed by MALDI-ToF. The fraction that included the top of the peak, as
determined by GPC, was used to calculate n\ This data was obtained a, the University
of Massachusetts Amherst mass spec facility, which is supported in part by the National
Science Foundation.
The fluorescence and UV-vis was monitored with increasing percentage of
water. A stock solution of polymer was made in DMSO as to keep the polymer
concentration constant throughout the experiment. The concentrations explored ranged
from 50 to 5000 ug/mL to test for concentration independence. For fluorescence, the
samples were prepared at a concentration where the UV absorbance was less that 0.1 so
that inner filter effects were minimal. For UV spectra, the OD values were around 0.75.
Circular Dichroism (CD) was monitored on a JASCO J720 spectrometer at
ambient temperature in 0.1 cm rectangular quartz cuvettes using concentrations of 0.100
mg/mL. The concentration of polymer and the number of equivalents (100) of the chiral
acid were calculated based on the molecular weight of the monomer unit.
A.3 Results and Discussion
Both helical and extended structures of meto-phenylene ethynylene's have been
observed confirming the rich conformational flexibility available from this molecular
backbone. Helical structures were driven by solvophobic collapse(8, 9) while extended
conformations are governed by patterning of polar and nonpolar side chains(31, 32) or
the reduction of free volume in the solid state.(33, 34) The four polymers discussed in
this paper are shown in Table A. 1 along with molecular weight information based on
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GPC standards and MALDI-ToF experiments. Polymers 70d, 25d, and 71d contain
polar groups with eationic amines while 32 has triethylene glycol side chains. In
addition, 70d and 25d have nonpolar alkyl side chains in contrast to 71d and 32.
Polymer 32 was prepared in order to make direct comparisons to Moore's structure;
although, 32 is a polydisperse sample while Moore studied discrete oligomers.(8)
Table A.l: Molecules used in this study.
Polymer Structure Mn PDI n* corrected n*
8,420 1.40 16 8
8,450 1.31 20 10
6,760 1.48 20 10
10,900 1.53 31 16
0(CH2CH20) 3CH3
* These values are based on GPC data calibrated to polystyrene standards.
The corrected n values are based on MALDI-ToF data for polymer 25d
When studying the aggregation behavior of facially amphiphilic w-PPEs 70d
and 25d, fluorescence spectroscopy showed small wavelength shifts (-10 nm) upon
water addition consistent with intermolecular distances of -4.9 A.(35) Much larger red
shifts would be expected for a highly collapsed structure with aromatic distances less
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Figure A.l: Fluorescence spectra of polymer 70d (la) and polymer 71d (lb) inDMSO (solid) and 90% H20/DMSO (dashed). The concentration of 70d and 71d
were held constant in each experiment so direct comparison of intensity was made,
in which the polymer adopts a random coil conformation based on NMR, absorption,
and emission spectroscopy, while water is a poor solvent resulting in precipitation of
polymers 70d and 25d at high water content.
Figure A.l shows the fluorescence spectra of polymers 70d and 71d in two
different solvents, DMSO and 90% H20/DMSO, while keeping the polymer
concentration constant. The spectra for 70d, Figure la, has an intense peak in DMSO,
however, as water is added up to 90% H20/DMSO, the emission spectra decreases in
intensity, broadens, and red shifts slightly by 10 nm. In contrast, when similar
experiments were performed with 71 d, very different spectra were obtained in 90%
H2O/DMSO compared to those of polymers 70d and 25d.(30) The fluorescence spectra
of polymer 71 d has an intense peak in DMSO with A,max of 383 nm compared to 70d at
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377 nm but broader than that observed for 70d by 40 nm at full width half-height
(FWHH). The small differences in ^max can be explained by electron density of the two
polymers since 71d does not have the ether substituent of 70d. The increase in width at
FWHH observed for 71d may indicate that DMSO is a better solvent for 70d, which
might not be surprising given the absence of the alkyl side chain in 71d.(39) This is
further supported by the spectrum obtained in 95% chloroform/DMSO in which lmax is
381 nm; however, the peak is substantially narrower than those obtained in DMSO.(39)
This suggests the DMSO spectrum may be a combination of those observed in 95%
CHCI3/DMSO and 90% H20/DMSO. Upon changing to 90% H20/DMSO, the signal
for 71d decreases intensity and red shifts approximately 50 nm. This broad, featureless
red-shifted band can be explained by close n-n stacking of the aromatic rings.(29)
Regardless, the changes are consistent with spectra obtained by Moore and co-workers
for helical conformations(29); however, random collapse, to provide close aromatic
contacts without helix formation, could also give rise to these observations.(40) The
differences observed in the emission spectra between 70d and 71d in 90% H20/DMSO
strongly suggest different conformational or aggregational modes are present.
In fact, conformational changes are more likely than aggregation based on the
observation that 70d precipitated from 90% H20/DMSO solutions at 50 ug/mL after 2
days while 71d remains soluble in this solvent at 100 times the concentration (5000
ug/mL) over months. Polymer 25d is also observed to precipitate from 90%
H20/DMSO solutions after two days at concentrations of 50 ug/mL. Polymer 70d is
believed to aggregate through an extended amphiphilic structure^ 1 ) organized into
layers(32) which is likely to give macroscopic precipitation as more molecules are
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added to the aggregate. Interestingly, the lack of precipitation from 71d in 90%
H20/DMSO would indicate random collapse of the polymer chains is not responsible
for the changes observed by fluorescence spectroscopy since this is expected to result in
precipitation over time.(41
)
Figure A.2: Pictures of polymer 70d (left) and 71d (right) in (A) natural light and
(B) long wave UV light. Notice the differences in the solution. Polymer 70d has a
turbid nature with visible aggregates while 71d remains optically clear.
Shown in Figure A.2a are photographs of polymers 70d and 71d in 90%
H20/DMSO solution taken under natural light in which 70d has precipitated out of
solution while polymer 71 d is still optically clear and in solution as observed by the
slight yellow color due to the higher concentration of polymer. Figure A.2b was taken
under long wavelength UV illumination and shows that only the particles formed by
precipitation of 70d fluoresce while 71d shows homogeneous emission from the
solution. The lack of precipitate from 71 d but dramatic change observed in the
emission spectra suggests this polymer adopts a new conformation in 90% H20/DMSO
which is quite different from 70d and would be consistent with intramolecular helix
formation. It is clear that 70d cannot adopt helical conformations because three
dodecyloxy side chains are much too large for the interior cavity formed by the helix
while 71d does not have this steric problem due to the lack of alkyl side chains. It is
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also possible that 71d adopts some other structure by intermodular self-assembly
whieh does not lead to macroseopie precipitation. For example, the formation of
eylindrical micelle-like structures(42, 43) in which the polymer backbone extends along
the cylinder length cannot be ruled out. However, this is not consistent with close **
stacking suggested by the emission spectrum. Initial 'H-NMR investigations have not
provided insight into these changes and vapor pressure osmometry cannot be performed
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Figure A.3: (a) Titration curve for polymer 71d when changing solvents from
DMSO to 90% H20/DMSO. The inset shows the absorbance spectra for polymer
71d at the beginning and end points of the curve, (b) Titration curve for polymer
32 when changing solvents from
UV-Vis spectroscopy has proven extremely beneficial for characterizing the
random coil to helix folding reaction in m-PEs by monitoring the relative populations of
transoid and cisoid confirmations, respectively.(29) Moore and co-workers were able to
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produce sigmoidal titration curves from discrete m-PE oligomers with Methylene glycol
ester side chains by monitoring the ratio of peaks at 289 nm and 305 nm as the solvent
was changed from acetonitrile to chloroform. In their system, strongly cooperative
unfolding is seen for oligomers longer than 12 units, while broad non-cooperative
transitions are seen for shorter chain lengths. Most of their work has focused on ester
m-PE derivatives, although, the influence of aromatic ring electron density was
investigated.(29) For benzyl ethers, similar to 32, UV-Vis and emission spectra were
consistent with helix formation but no titration curves were provided. In this regard, we
examined UV-Vis titration curves of 71d in DMSO and water as well as the polymeric
analog of Moore's triethylene glycol benzyl ether, 32, in chloroform and acetonitrile.
The insets of Figures A.3a and A.3b show UV-Vis curves for 71d in DMSO and 90%
H20/DMSO and 32 in chloroform and 90% acetonitrile/chloroform, respectively. These
end points show the characteristic changes observed for the coil to helix transitions of
m-PE, which in Moore's work have been confirmed by circular dichroism spectroscopy
(CD).(27) However, titration curves shown in Figures A.3a and A.3b for 25d and 32,
respectively, do not show cooperative unfolding reactions. The lack of a distinct
transition may be due to the relatively low molecular weight of these polymers so that
large populations of short chains are present. These short chains would contribute
significantly to a non-cooperative transition as observed by Moore for discrete
oligomers of 8 and 10 repeats. The reported molecular weights are referenced to
polystyrene standards, which are known to overestimate the molecular weight of rigid
polymers by 1 .5 to 2.0.(45-48) In addition, MALDI-ToF spectra were obtained by
fractionation of the GPC peak and suggest the molecular weights are between 0.5 and
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0.6 the value obtained from GPC. The kind of transitions observed in Figure 3 have
also been attributed to multichain interactions,(49) however, it is believed that, in this
case, it is intramolecular folding since the results are independent of time and
concentration (50-5000 ug/mL). In addition, intermodular associations, like those to
form cylindrical micelles, would not be expected to increase the population of cisoid
conformations as observed by the UV-Vis experiments. Also, Moore and co-workers
report that the oligomer of polymer 32 needs a more polar solvent (ie. water) in order to
undergo a strong transition in UV and fluorescence spectroscopy,(8) however, 32 is not
soluble in neat acetonitrile so that addition of water cannot be performed due to the
presence of chloroform.
From UV-Vis titration curves, changes in 308/290 ratio, and emission in polar
solvents, a helical conformation of 71d cannot be firmly concluded. As a result, CD
experiments were performed; however, 7Id does not contain any chiral centers and so
an equal population of right and left handed helical conformations would be expected.
Chiral additives have been used previously to induce a preference of one handedness in
helical structures.(50) Therefore, we speculated that the addition of chiral carboxylic
acids could result in associations with the primary amines of 71d and influence helical
handedness.(50-52) When the chiral carboxylic acid, D-mandelic acid, was added to
solutions of 71d in 90% H20/DMSO, a CD spectrum was obtained with a negative
ellipticity characteristic of the absorption spectra for this polymer as shown in Figure
A.4. In addition, the same experiment performed in DMSO resulted in no observed
change in ellipticity. The CD spectrum of D-mandelic acid in 90% H20/DMSO without
71 d also resulted in a spectrum with no change in molar ellipticity. The appearance of a
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negative molar ellipticity from solutions of 71d in 90% H20/DMSO with D-mandelic
acid but no change in molar ellipticity from DMSO solutions is consistent with a helical
conformation of 71d in 90% H20/DMSO. Chiral guest experiments were also
conducted but no change in ellipticity could be observed.(27)
Wavelength (nm)
Figure A.4: Circular dichroism spectra of 71d in DMSO (red line) and 90%
H20/DMSO (blue line) with D-mandelic acid (100 equivalents). The appearance of
a signal only in 90% H20/DMSO suggests a helical conformation is likely.
A.4 Conclusions
The solution conformations of facially amphiphilic polymers based on m-PPE
backbones were studied. Those with alkyl substituents clearly form extended structures
even in 90% H20/DMSO solution,(31, 32) while polymers without alkyl side chains
appear to adopt alternative conformations with spectroscopic features similar to helical
structures reported in the literature.(29) CD spectroscopy in the presence of a chiral
carboxylic acid additive showed a signal consistent with a helical structure. Although,
intermolecular self-assembly into cylindrical or other structures cannot be entirely ruled
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out, these other structures are not consistent with the UV-Vis spectra. The benzyl ether
function may not produce the most stable helical conformations, according to Moore,
and this might also influence the results discussed here. However, it can be safely
concluded that m-PPEs without alkyl groups adopt different conformations and
structures in solution than those with alkyl groups. Polymers with significantly higher
molecular weights should eliminate the influence of small chains on the titration curves
and are a future synthetic target. This is the initial report of polydisperse phenylene
ethynylenes folding in solution toward helical structures and demonstrates some of the
difficulties that will be encountered during these studies. The ability to control
molecular conformation by side chain decoration of the backbone with polar and non-
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